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ZUSAMMENFASSUNG I  
Zusammenfassung 
Große Arzneimittelmengen gelangen nach ihrer Anwendung in das Abwasser und 
erreichen, da sie durch die Abwasseraufbereitung häufig nur partiell eliminiert werden, 
die aquatische Umwelt. Trotz des intensiven Einsatzes von Pharmaka in der modernen 
Medizin ist relativ wenig über ihr Vorkommen und Verhalten in natürlichen 
Gewässer/Sediment-Systemen bekannt. 
Entwicklung analytischer Methoden  
In der vorliegenden Arbeit wurden analytische Methoden entwickelt, die eine 
empfindliche Bestimmung von verschiedenen Analgetika, Lipidsenkern, Antibiotika, 
sowie Carbamazepin, Diazepam, Ivermectin, Iopromid und einigen ihrer Metabolite in 
Sedimenten von Oberflächengewässern erlauben. Diese Methoden umfassen eine 
sequenzielle Ultraschall-Lösungsmittelextraktion, Festphasenextraktion und die 
Detektion der Analyten durch Flüssigkeitschromatographie-Tandem Massen-
spektrometrie (LC-Tandem MS). Des Weiteren wurden neue Methoden für die 
empfindliche Quantifizierung dieser Substanzen in wässrigen Umweltmatrices erstellt. 
Die Analyten wurden dabei durch Festphasenextraktion angereichert und ebenfalls 
durch LC-Tandem MS bestimmt. Für die Arzneimittelrückstände im Sediment wurden 
Bestimmungsgrenzen zwischen 0,4 und 20 ng/g erreicht, während die Bestimmungs-
grenzen in wässrigen Matrices zwischen 0,04 und 0,5 µg/l lagen. Zusätzlich wurden 
analytische Methoden für die Quantifizierung von 14C-markierten Pharmaka in 
Oberflächenwasser und Sediment durch Radio-Dünnschichtchromatographie (DC) 
entwickelt.  
Verhalten von Arzneimitteln in Wasser/Sediment Systemen   
Eine Auswahl von zehn Pharmaka und Pharmakametaboliten wurde während eines 
Zeitraums von 100 Tagen in Wasser/Sediment Systemen, angelehnt an die OECD 
Richtlinie 308, untersucht. Die 14C-markierten Testsubstanzen Diazepam, Ibuprofen, 
Iopromid und Paracetamol wurden durch Radio-DC bestimmt, wogegen die 
unmarkierten Substanzen Carbamazepin, 10,11-Dihydro-10,11-dihydroxycarbamazepin, 
II ZUSAMMENFASSUNG 
Clofibrinsäure, 2-Hydroxy-ibuprofen, Ivermectin und Oxazepam mittels LC-Tandem 
MS detektiert wurden.  
Da Carbamazepin, Diazepam und Clofibrinsäure im Wasser/Sediment-System eine 
hohe Persistenz zeigten, liegt eine geringe Abbaubarkeit in natürlichen Oberflächen-
gewässern nahe. Dagegen wurden Oxazepam und 10,11-Dihydro-10,11-dihydroxy-
carbamazepin während des Testverlaufs zu mehr als 50 % eliminiert. Für diese beiden 
Substanzen kann daher von einer prinzipiellen Abbaubarkeit in Oberflächengewässern 
ausgegangen werden. Das Kontrastmittel Iopromid wurde im Versuchszeitraum 
vollständig in mehrere stabile Transformationsprodukte umgewandelt. Die Entstehung 
dieser Transformationsprodukte wurde ebenfalls in ergänzenden Bodensäulenversuchen 
beobachtet (s. u.); d.h. diese können unter sehr verschiedenen Umweltbedingungen 
gebildet werden. Die Konzentrationen von Ivermectin und Paracetamol in der 
Wasserphase der Testsysteme nahmen sehr schnell ab, wobei jedoch Paracetamol in 
großem Umfang nicht extrahierbare Rückstände bildete. Eine schnelle Elimination aus 
der Wasserphase aquatischer Systeme ist für beide Substanzen zu erwarten. Das 
Analgetikum Ibuprofen und sein Humanmetabolit 2-Hydroxy-ibuprofen wurden im 
Testsystem ebenfalls schnell eliminiert, was eine leichte Abbaubarkeit dieser 
Substanzen in natürlichen Oberflächengewässern erwarten lässt. Für Diazepam, 
Oxazepam, Carbamazepin und Ivermectin muss, wegen ihrer Affinität zum Sediment, 
von einer potenziellen Akkumulierbarkeit in natürlichen Sedimenten ausgegangen 
werden.   
Das Versickerungsverhalten von sechs der zehn ausgewählten Pharmaka wurde in 
verschiedenen wassergesättigten Böden nach OECD Richtlinie 312 getestet und deren 
Mobilität, insbesondere hinsichtlich ihres Potenzials zur Grundwasserkontamination, 
beurteilt. Die Testergebnisse legen nahe, dass das Versickerungspotenzial für 
Diazepam, Ibuprofen, Ivermectin und Carbamazepin niedrig ist. Das letztgenannte 
Ergebnis ist überraschend, da Carbamazepin häufig im Grundwasser nachgewiesen 
wurde. Dieser Widerspruch könnte dadurch erklärt werden, dass die Tests mit 
Oberboden durchgeführt wurden, während in der Realität der Pharmakaeintrag in das 
Grundwasser über Infiltration kontaminierter Wässer durch Flusssedimente und 
ZUSAMMENFASSUNG III  
Unterböden erfolgt. Clofibrinsäure und Iopromid zeigten sich in den Tests als sehr 
mobil, so dass von diesen ein deutliches Grundwasserkontaminationsrisiko ausgeht.  
Die meisten der hier getesteten Arzneimittel und Arzneimittelmetaboliten wurden, 
ähnlich wie bei vergleichbaren Tests mit anderen Umweltchemikalien, z.B. Pestiziden, 
als hoch persistent oder sogar nicht abbaubar eingestuft. Ein Umweltrisiko durch 
Arzneimittelrückstände in aquatischen Systemen kann daher nicht ausgeschlossen 
werden. Abschließend bleibt festzuhalten, dass das Umweltverhalten von bereits auf 
dem Markt vorhandenen Pharmaka generell im Zulassungsverfahren berücksichtigt 
werden sollte, solange eine Exposition bestimmter Umweltkompartimente nicht 
auszuschließen ist.  
IV SUMMARY 
Summary 
Pharmaceutical residues are not totally eliminated during municipal sewage 
treatment and are thus discharged into the aquatic environment via STP effluents. 
Despite the extensive use of pharmaceuticals in modern medicine, relatively little is 
known about the occurrence and the fate of pharmaceuticals in sediments and 
environmental waters.  
Development of analytical methods 
Analytical methods have been developed in the present work, allowing for the 
sensitive determination of several analgesics, lipid regulators and antibiotics, as well as 
for carbamazepine, diazepam, ivermectin, iopromide and some of their metabolites in 
river sediment. Sediment analysis was accomplished by sequential ultrasonic solvent 
extraction, solid phase extraction for a clean-up and detection via liquid 
chromatography–tandem mass spectrometry (LC-tandem MS). Additionally, new 
methods have been created for the sensitive analysis of these compounds in various 
environmental waters. The analytes in the aqueous samples were enriched by solid 
phase extraction and detected via LC-tandem MS. For the determination of 
pharmaceuticals in sediments LOQs between 0.4 and 20 ng⋅g-1 were attained, whereas 
those in environmental waters ranged from 0.04 to 0.5 µg⋅L-1.  
Furthermore, analytical methods were developed for the analysis of 14C-labelled 
pharmaceuticals in surface water and river sediment samples via radio-thin layer 
chromatography (radio-TLC).  
Fate of pharmaceuticals in water/sediment systems 
In the second part of this project, the fate of ten selected pharmaceuticals and 
pharmaceutical metabolites were investigated in water/sediment tests according to 
OECD Guideline 308 over a period of 100 d. The 14C-labelled test substances diazepam, 
ibuprofen, iopromide and paracetamol were analyzed by radio-TLC, whereas 
carbamazepine, 10,11-dihydro-10,11-dihydroxy-carbamazepine, clofibric acid,  
2-hydroxy-ibuprofen, ivermectin and oxazepam were analyzed via LC-tandem MS.  
SUMMARY V  
Carbamazepine, diazepam and clofibric acid were persistent in the water/sediment 
system, suggesting their low degradability in natural surface waters. Oxazepam and 
10,11-dihydro-10,11-dihydroxy-carbamazepine disappeared by more than 50 % which 
indicates that an appreciable elimination in surface waters might occur. The contrast 
medium iopromide was totally metabolized in the water/sediment tests under formation 
of several stable TPs which were also formed in soil column experiments, performed 
according to OECD guideline No. 312. Obviously, these metabolites can be formed 
under very different environmental conditions. Ivermectin and paracetamol disappeared 
rapidly in the water/sediment systems and should also be eliminated to a high degree 
from aquatic water compartments. A high level of non-extractable residues was formed 
from paracetamol. Ibuprofen and its’ metabolite 2-hydroxy-ibuprofen were rapidly 
eliminated, suggesting their ready degradability in aquatic systems. The affinity of 
diazepam, oxazepam, carbamazepine and ivermectin for the sediment compartment 
indicates a potential risk for accumulation of these compounds in natural sediments.  
In addition, the leaching behaviour of six selected pharmaceuticals was tested in 
different soils. Based on the results of this assessment their mobility in different soils 
and their potential to contaminate groundwater was evaluated. The test results indicated 
that the leaching potential could be rated as low for diazepam, ibuprofen, ivermectin 
and for carbamazepine. The last result is surprising, since carbamazepine is often 
detected in groundwater. This discrepancy might be explained by the fact that the 
leaching tests were performed with topsoil, whereas in reality the groundwater 
contamination occurs mainly over river sediments and subsoils from receiving waters. 
Clofibric acid and iopromide were very mobile under the experimental conditions and 
thus, groundwater contamination would be possible if the soil is exposed to these 
pharmaceuticals.  
In comparison to other chemicals, notably pesticides, the distribution pattern of the 
compounds tested over the persistence classes showed a high percentage of high 
persistence or even non-biodegradability, leading to the conclusion that an 
environmental risk cannot be excluded. Summarizing these findings, it is recommended 
to include the investigation of the fate of pharmaceuticals already available on the 
market in the drug registration process as long as exposure in a specific environmental 
compartment is possible. 
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1 INTRODUCTION 
Environmental pollution has become an important issue for the society. Virtually any 
human activity leads to an environmental contamination with substances of 
anthropogenic origin (Schwarzenbach et al., 2003). Besides pesticides or heavy metals 
pharmaceuticals, being extensively used for medicinal purposes, belong to these 
anthropogenic substances. They were widely ignored as environmental contaminants 
until the early 1990th. Since then, the environmental risk caused by pharmaceuticals has 
become an important issue in environmental sciences (e.g. Golet et al., 2002a, Halling-
Sorensen et al., 1998, Jones et al., 2002, Römbke et al., 1996, Stuer-Lauridsen et al., 
2000, Van Wezel and Jager, 2002, Velagaleti and Robinson, 2001), mainly because an 
increasing number of pharmaceuticals, i.e. analgesics, antibiotics, antiepileptics, 
antiphlogistics, beta-blockers, contraceptives, diagnostics, lipid regulators, tranquilizers 
and corresponding metabolites have been detected in the environment (Golet et al., 
2001, Heberer, 2002a, Hirsch et al., 1999, Hirsch et al., 1998, Hirsch et al., 2000, 
Kolpin et al., 2002, McArdell et al., 2003, Stumpf et al., 1996, Stumpf et al., 1999, 
Ternes, 1998, Ternes and Hirsch, 2000, Ternes et al., 1998a, Ternes et al., 1999a, 
Ternes et al., 1999b).  
More than 2900 pharmaceutical substances are currently licensed in Germany for 
human and veterinary medicine. For most compounds, the total amounts sold are not 
available. Nevertheless, a good estimation of the annual quantities prescribed can be 
obtained based on the accessible number of prescription items multiplied by the defined 
daily dose (DDD) of a particular compound. In the case of free available 
pharmaceuticals, i.e. analgesics, this calculation leads to underestimations, since the 
amounts dispensed in non-prescription products are not considered.  
Detailed data on the prescribed quantities of several selected pharmaceuticals is 
shown in Table 1.1 (Rote Liste Service GmbH Frankfurt/Main, 2001, Schwabe and 
Paffrath, 2000). Annual consumption rates of frequently prescribed pharmaceuticals 
range from a few kilograms, i.e. for hormones, up to more than a hundred tons, i.e. for 
ibuprofen and iopromide.  
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Table 1.1:  Annual prescription items of selected pharmaceuticals and estimated 
total amounts used in Germany in 2001   
Compound Therapeutic use Total prescription items (×106)a 
Amounts usedc 
 (t⋅year-1) 
Diclofenac Antiphlogistic  494 86 
Ibuprofen Antiphlogistic 107 344 
Erythromycin Antibiotic  20.6 19 
Roxithromycin Antibiotic  20.8 10 
Sulfamethoxazole Antibiotic  23.6 54 
Trimethoprim Antibiotic  23.6 11 
Carbamazepine Antiepileptic 78.0 88 
Metoprolol Beta blocker 455 93 
Sotalol Beta blocker 120 27 
Iopromide Contrast medium - 130b 
Ethinylestradiol Hormone  355 0.047 
Bezafibrate Lipid regulator 43.2 33 
Diazepam Tranquilizer 44.3 1.1 
a taken from Schwabe and Paffrath, 2000, Schwabe and Paffrath, 2002, b Steger-Hartmann et al., 1999, 
c Bund/Länderausschuss für Chemikaliensicherheit (BLAC), 2003 
Corresponding data for England, Denmark and Australia have been published by 
Jones et al., 2002 and others (Jørgensen and Halling-Sorensen, 2000, Khan and 
Ongerth, 2002, Stuer-Lauridsen et al., 2000), all displaying the extensive circulation of 
the pharmaceuticals in developed countries. 
1.1 Theoretical background 
1.1.1 Pharmacokinetics 
A major factor determining the occurrence of pharmaceuticals in the aqueous 
environment is their pharmacokinetic behaviour which describes the time course of a 
drug and its’ metabolites in the body after any kind of administration (Merck & Co. 
Inc., 1999). The metabolism of pharmaceuticals occurs in two consecutive phases as 
shown in Figure 1.1. Phase I reactions involve the formation of new or modified 
functional groups including oxidation, reduction, hydrolysis, hydration, condensation 
and isomerization reactions, which usually all result in an increased polarity. In phase 
II, the metabolites are conjugated with endogenous molecules to obtain an elevated 
water solubility. The most important conjugation reaction for xenobiotics is 
glucuronidation. Finally, the water-soluble metabolites are excreted via urine and feces 
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(Eisenbrand and Metzler, 1994, Forth et al., 1996, Merck & Co. Inc., 1999, Mutschler, 
1997). 
Xenobiotic Phase I Metabolite
Phase I
 Oxidation
 Reduction
 Hydrolyisis
Phase II
Conjugation
Oxazepam-glucuronideOxazepam
Temazepam
Nordazepam
Diazepam
Cl N
N
O
CH3
Cl N
NH
O
OH
Cl N
O
OH
N
CH 3
Cl N
NH
O
Cl N
NH
O
O Glucuronic
acid
Phase II Metabolite
 
Figure 1.1:  General scheme for the metabolization of a xenobiotic and the meta-
bolization of diazepam in humans (Mutschler, 1997) 
1.1.2 Exposure pathway 
Production and application of human and veterinary pharmaceuticals leads to a 
potential environmental exposure and potentially to an accumulation in certain 
environmental compartments. The main exposure routes of human pharmaceuticals are 
expected to be through their use by patients in private households, in hospitals and by 
disposal of pharmaceuticals through toilets. After their use, pharmaceuticals are 
excreted unchanged and/or as metabolites in feces and urine and hence are present in 
wastewater (Mutschler, 1997). 
Similar to other compounds of anthropogenic origin, the fate of the pharmaceuticals 
residues during sewage treatment can follow one or a combination of three types of 
behaviour: a) (bio)degradation (mineralization), b) sorption of the residues onto sewage 
sludge or c) no elimination. The latter results in their presence in treated wastewater 
(Halling-Sorensen et al., 1998, Hartig et al., 1999, Heberer, 2002b).  
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Hence, compounds that are not readily degradable enter the environment either with 
the digested sludge or as dissolved pollutants in the sewage treatment plant (STP) 
discharges. The latter scenario results in the contamination of the receiving waters and 
finally, the aquatic environment (Golet, 2002, Golet et al., 2001, Golet et al., 2002b, 
Heberer, 2002a, Heberer, 2002b, Heberer et al., 2002, Richardson and Bowron, 1985, 
Stumpf et al., 1999, Ternes, 1998, Ternes et al., 1999a, Zuccato et al., 2000).  
Pharmaceutical residues have also been found in groundwater. They were often 
traced back either to an impact of municipal or industrial wastewater, animal farming, 
an infiltration of contaminated surface water or landfill seepage over vulnerable water 
aquifers (Campagnolo et al., 2002, Hirsch et al., 1999, Holm et al., 1995, Lindsey et al., 
2001, Sacher et al., 2001, Ternes, 2000). It is further conceivable, that contamination 
occurs with the discharges of the pharmaceutical industry. 
Environmental exposure routes for veterinary pharmaceuticals can mainly be 
attributed with the distribution and application of dung, urine and manure as fertilizer 
from medicated animals (Boxall et al., 2001, Campagnolo et al., 2002). Direct carry-
over into the water compartment from medical treatment of aquacultures has also been 
linked (Cannavan et al., 2000, Davies and Rodger, 2000, Hektoen et al., 1995).  
In contrast to pesticides, pharmaceuticals are applied during the entire year. Potential 
steady-state concentrations can thus result in the environmental waters, as they are 
continuously introduced via the sewage effluents.  
1.1.3 Occurrence and fate 
Numerous studies have been conducted to investigate various aqueous matrices for 
the presence of pharmaceutical residues, comprising the target compounds and 
metabolites. In fact, these residues have been found to be ubiquitous in environmental 
waters (Daughton and Ternes, 1999, Heberer, 2002a, Jones et al., 2001). 
The main contributing factor for the occurrence of pharmaceuticals in the aquatic 
environment is the elimination efficiency of the sewage treatment process (Alcock et 
al., 1999, McArdell et al., 2003, Ternes, 1998, Ternes et al., 1999a, Ternes et al., 
1999b). Particular weather conditions, i.e. rainstorm events, may result in a reduced 
elimination efficiency (Ternes, 1998). 
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Many pharmaceuticals are excreted to a large extent as transformed phase I 
metabolites and/or after conjugation to hydrophilic groups as phase II metabolites. 
Conjugates are easily cleaved in the STP, causing a re-formation of the original 
pharmaceuticals (Belfroid et al., 1999, Ternes et al., 1999a, Ternes et al., 1999b). This 
might lead to higher concentrations in the STP effluent than in the raw wastewater. 
Pharmaceuticals are principally designed to persist in the body after administration. 
That might be the reason that many pharmaceuticals are relatively resistant towards 
degradation under environmental conditions and pass through the STP without major 
elimination, such as the lipid regulator clofibric acid, the antiepileptic carbamazepine or 
the contrast medium diatrizoate (Putschew et al., 2000, Ternes, 1998, Ternes and 
Hirsch, 2000). 
Residues of various pharmaceuticals are present in the low µg⋅L-1 range in STP 
effluents. Discharge of the STP effluent into the receiving waters leads to a dilution of 
the pharmaceutical residues which occur up to the high ng⋅L-1 range in contaminated 
surface water. Once introduced into the surface waters, pharmaceuticals may undergo 
biodegradation, most likely due to co-metabolic processes. For some pharmaceuticals, 
i.e. diclofenac, photo induced degradation may occur from natural solar radiation 
(Andreozzi et al., 2003, Andreozzi et al., 2002, Buser et al., 1998, Lam et al., 2003, 
Steger-Hartmann et al., 2001). Additionally, depending on the lipophilicity and specific 
sorption properties of a particular compound, distribution to the sediment and 
suspended matter occurs (Schwarzenbach et al., 2003). This might result in a change in 
the transformation behaviour, when sorbed to particular matter, or in a formation of 
bound residues. However, the extent of pharmaceutical sorption to environmental 
matter is hardly known.  
1.1.4 Fate studies 
The determination of the environmental fate of a compound is a complex issue. 
Transformation and distribution processes are strongly dependant on the specific 
environmental conditions, which leads to a sophisticated linkage of individual system 
parameters. In general, there are two major approaches for environmental studies. Field 
studies allow for the elucidation of a substances behaviour under realistic conditions, 
whereas laboratory experiments display only certain details of the entire scenario. Since 
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field studies are quite costly, intensive and frequently the data are difficult to interpret, 
their realization is mostly limited to certain cases, justifying the effort to be undertaken. 
In this light, laboratory tests are powerful tools for the elucidation of individual 
environmental processes, providing high comparability and reproducibility, due to 
standardized conditions.  
In the last several years, numerous test systems have been established allowing for 
the investigation of a chemical’s fate and effects under a variation of relevant 
environmental conditions in terrestrial, aquatic and other scenarios (Brodsky et al., 
1997, Freitag et al., 1985, Freitag et al., 1982, Hill et al., 1994). Respective standardized 
test procedures are provided by several organizations and institutions, i.e. OECD, 2003b 
(Table 1.2) and SETAC, 1995. They are an important part of the ERA of environmental 
relevant chemicals. 
Table 1.2:  Available OECD Guidelines for the testing of the degradation of 
chemicals in terrestrial and aquatic laboratory test systems 
Test OECD Guideline No. 
Ready biodegradability (several variations) 301 
Inherent biodegradability (several variations) 302 
Simulation tests – aerobic sewage treatment 
A: Activated Sludge units B: Biofilms 303 
Inherent biodegradability in soil 304 
Biodegradability in seawater 306 
Aerobic and anaerobic transformation in soil 307 
Aerobic and anaerobic transformation in aquatic 
sediment systems 308 
Aerobic mineralization in surface water – 
simulation biodegradation test 309 
Leaching in soil columns 312 
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1.2 Objectives  
Pharmaceuticals are essential for our health system and are applied in high quantities 
for preventive, curative and diagnostic purposes. The main environmental exposure 
pathway is the introduction of pharmaceuticals and their metabolites via wastewater into 
the aquatic environment.  
To date, little is known about the fate and the distribution behaviour of 
pharmaceutical residues in aquatic compartments. Particularly, the role of surface water 
sediments in the elimination of pharmaceutical contaminants is widely unknown since 
appropriate analytical methods for sediments are rare. However, the number of 
pharmaceuticals which are quantifiable in environmental waters is restricted to 
approximately 100 compounds, including only a few metabolites.  
Hence, the major aim of the current study was the sensitive and reliable 
determination of the environmental fate of selected pharmaceuticals and their 
metabolites. In detail, the objectives of the present work were: 
 the development and the validation of analytical methods for the substance 
specific determination of pharmaceuticals and corresponding metabolites in 
river sediment and in the aqueous matrices groundwater, soil leachates, surface 
water and wastewater, based on LC tandem MS techniques; 
 the adaptation of the developed methods for the analysis of 14C-labelled 
pharmaceuticals in surface water and river sediment using radio-TLC-
techniques;  
 the elucidation of the fate and distribution behaviour of selected 
pharmaceuticals in water/sediment test systems according to OECD Guideline 
308 (OECD, 2002), using the analytical methods developed; 
 the investigation of the leaching behaviour of selected pharmaceuticals in soil 
column experiments according to OECD Guideline 312 (OECD, 2003a).   
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2 SELECTION OF ANALYTES  
The selection of target analytes was mainly focused on the environmental relevance 
of the pharmaceuticals and their metabolites which is derived from consumption rates, 
the environmental occurrence, the environmental persistence and possible (eco)toxic 
effects.  
For the investigation of pharmaceuticals in water/sediment test systems, the number 
of substances to be tested was restricted to 10 compounds. The leaching behaviour was 
investigated using six pharmaceuticals.  
2.1 Lipid regulators and antiphlogistics 
Fibric acid-derivatives, such as bezafibrate, gemfibrozil and clofibric acid esters are 
administered in humans to reduce the blood triglyceride- and cholesterol level. Their 
structures are shown in Table 2.1. The DDD amounts to 400 – 600 mg for bezafibrate 
and to 900 mg for gemfibrozil. In 2001, a total of more than 25 tons of bezafibrate has 
been prescribed in Germany, while gemfibrozil was not registered (Table 1.1). 
Clofibrate, etofyllinclofibrate and etofibrate are pro-drugs and as such cleaved in the 
body into the active metabolite clofibric acid. Bezafibrate, gemfibrozil and clofibric 
acid are excreted largely as glucuronides and/or unchanged with the urine (Forth et al., 
1996, Mutschler, 1997). 
The non-opioid analgesics display a wide application range, due to their combined 
analgesic, antipyretic and inflammatory effects (Mutschler, 1997). Their chemical 
structures are shown in Table 2.1. Their extensive use after prescription (see Table 1.1) 
is further increased by their dispense over the counter (Jones et al., 2002). In particular, 
ibuprofen is used in quantities of > 100 t⋅y-1 and its’ human and environmental 
metabolites 2-hydroxy-ibuprofen and carboxyl-ibuprofen have been identified in 
environmental waters (Stumpf et al., 1998, Winkler et al., 2001). Paracetamol belongs 
also to the group of antiphlogistics which are prescribed and used in extremely high 
quantities. Its fate in the aquatic environment was already studied in 1985 (Richardson 
and Bowron, 1985). Lipid regulators and especially antiphlogistics have a high 
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environmental relevance due to their high consumption rates shown in Table 1.1 and the 
low degradability of several compounds. As a result these pharmaceuticals occur 
ubiquitous in environmental waters (Heberer, 2002a, Heberer and Stan, 1998, Scheytt et 
al., 1998, Stumpf et al., 1999, Ternes, 1998, Ternes, 2000).  
Table 2.1:  CAS registry numbers, chemical structure and use/origin of acidic 
pharmaceuticals 
Compound CAS RN Structure Use/origin 
Bezafibrate 41859-67-0 N
O
COOH
O
Cl
H  
Lipid regulator   
Clofibric acid 882-09-7 Cl O COOH  
Metabolite of three 
lipid regulators 
Gemfibrozil 25812-30-0 O COOH
 
Lipid regulator 
Diclofenac 15307-86-5 N
Cl
Cl
H
HOOC
 
Antiphlogistics  
Fenoprofen 53746-45-5 O COOH
 
Antiphlogistics  
Ibuprofen 15687-27-1 COOH
 
Antiphlogistics  
2-Hydroxy 
ibuprofen 51146-55-5 
COOH
HO  
Metabolite of 
ibuprofen 
Indomethacin 53-86-1 N
C
O
Cl
H3CO
CH3
CH2 COOH  
Antiphlogistics  
Ketoprofen 22071-15-4 COOH
O
 
Antiphlogistics  
Naproxen 22204-53-1 COOH
O  
Antiphlogistics  
Paracetamol 103-90-2 NHHO COCH3  Antiphlogistics  
Meclofenamic 
acid 644-62-2 
N
COOH H Cl
Cl  
Surrogate standard 
Fenoprop 93-72-1 
Cl
Cl
Cl
CH3
COOHCHO
 
Surrogate standard 
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2.2 Carbamazepine and tranquilizers 
The antiepileptic carbamazepine is a tricyclic substance and was used at an annual 
level of 88 t in 2001 (Table 1.1 and Table 2.2). It was thus the most important 
antiepileptic in terms of quantity. Medicinal application of carbamazepine is indicated 
in the treatment of epilepsy symptoms, trigeminal neuralgia, diabetic neuralgia, alcohol 
deterrent and other symptomatologies (Mutschler, 1997, Novartis, 2000). After oral 
administration, approximately 70 % of the administered carbamazepine is excreted in 
the urine, composed mainly by the hydroxylated and conjugated carbamazepine 
metabolite 10,11-dihydro-10,11-dihydroxy-carbamazepine, with only 3 % of unchanged 
carbamazepine (Mandrioli et al., 2001, Novartis, 2000). 
Table 2.2:  CAS registry numbers, chemical structure and use/origin of neutral 
pharmaceuticals 
Compound CAS RN Structure Use/origin 
Carbamazepine 298-46-4 N
C
O
NH2
 
Antiepileptic 
10,11-Dihydro-
10,11-
dihydroxy-
carbamazepine 
- N
C
O
NH2
OHHO
 
Human metabolite 
of carbamazepine 
Diazepam 439-14-5 Cl N
N
O
CH3
 
Psychiatric drug 
Oxazepam 604-75-1 Cl N
NH
O
OH
 
Psychiatric drug 
and 
metabolite of 
diazepam 
10,11-Dihydro- 
carbamazepine 3564-73-6 
N
C
O
NH2
 
Surrogate standard 
 
Diazepam and oxazepam belong to the group of 1,4-benzodiazepines and are utilized 
as tranquilizers (Mutschler, 1997). Their DDD is relatively low at 5 – 40 mg, due to 
their high potency, resulting in annual consumptions of 400 – 1100 kg. Diazepam is 
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mainly metabolized to oxazepam and oxazepam-glucuronides, which are then renally 
excreted. 
The ubiquitous occurrence of carbamazepine derives from its’ relatively high 
prescription rates and that it is not appreciable removed when passing municipal STPs. 
In contrast, the consumed amounts of diazepam and oxazepam are relatively low (Table 
1.1), but the very high potency of the tranquilizers raises concerns about possible 
ecotoxicological effects. 
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2.3 Iopromide and derivatives 
Iodinated X-ray contrast media are widely applied as diagnostics for the 
roentgenoscopy of body tissues, at single doses of up to 200 g (structures given in Table 
2.3). As a prerequisite for their use in high quantities in humans, these compounds 
display minimal toxicity, high water solubility and inertness to biochemical 
transformations. Iopromide is a non-ionic compound, which is applied in Germany at 
approximately 130 t per year (Steger-Hartmann et al., 1999). Since iopromide is quite 
stable, it is poorly eliminated during sewage treatment and thus, is introduced into the 
receiving waters. Iopromide was detected in surface and groundwater up to the µg⋅L-1 
level (Putschew et al., 2001, Steger-Hartmann et al., 1999, Ternes, 2000, Ternes and 
Hirsch, 2000). 
Table 2.3:  CAS registry numbers, chemical structure and use/origin of iopromide, 
iopromide derivatives and paracetamol 
Compound CAS RN Structure Use/origin 
Iopromide 73334-07-3 
O N
OH
OH
II
I
NH
O
NH
OHO
O OH
 
X-ray contrast 
medium 
5-Amino-2,4,6-triiod-
isophthalic acid 
(ATI) 
35453-19-1 
I
H2N I
I
O
OH
OH
O  
Potential TP of 
iopromide 
Desmethoxyacetyl-
iopromide 
(DAMI) 
154361-51-0 
I
H2N I
I
O
N
NH
O
OH
OH
OH
OH
 
Potential TP of 
iopromide 
ATI-(2,3-dihydroxy-
propyl)-amide 
(ATH) 
111453-32-8 
I
H2N I
I
O
OH
NH
O
OH
OH
 
Potential TP of 
iopromide 
Desmethoxy-
iopromide 
(DMI) 
76350-28-2 
I
NH I
I
O
N
NH
O
OH
OH
OH
OH
O
 
Surrogate 
standard 
 
SELECTION OF ANALYTES 13  
2.4 Ivermectin 
Ivermectin is a lipophilic broad-spectrum parasiticide with a macrolide structure used 
for the treatment of humans, livestock and other animals against endoparasites 
(structure shown in Table 2.4). In detail, ivermectin is the pharmaceutical of choice for 
the human therapy of river blindness (onchocerciasis), applied in a single dose of  
10 – 15 mg once per year. Additionally, it is used as feed additive in aquaculture to 
alleviate sea lice infestations in farmed salmon. Hence, ivermectin combines a high 
pharmacological potency and a direct cross-over into the terrestrial and aquatic 
environment (Campbell, 1989, Davies et al., 1998, Edwards et al., 2001, Mutschler, 
1997, Van Wezel and Jager, 2002).   
Table 2.4:  CAS registry numbers, chemical structure and use/origin of parasiticides 
Compound CAS RN Structure Use/origin 
Abamectin 
71751-41-2, 
B1a 
65195-55-3 
 
R
H
OH
H
H
CH3
O
OO
O
O
H3C
HO
H
H3C
HH3C
OCH3
O
O
O
O
OCH3
CH3
CH3
OH
H
C C2H5
CH3
H
R=                             Abamectin B 1a
R=                             Abamectin B 1bCH(CH3)2  
surrogate standard 
Ivermectin 
B1a 
71827-03-7, 
70161-11-4, 
B1b 
70209-81-3 
R
H
OH
H
H
CH3
O
OO
O
O
H3C
HO
H
H3C
HH3C
OCH3
O
O
O
O
OCH3
CH3
CH3
OH
H
C C2H5
CH3
H
R=                             Ivermectin B 1a
R=                             Ivermectin B 1bCH(CH3)2  
parasiticide, 
pesticide 
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2.5 Selection of test compounds 
The water/sediment studies were conducted with ten compounds from various 
pharmacological classes (Table 2.5). Compounds were selected considering the 
annually consumption rates, the environmental occurrence, the biodegradability and the 
pharmacological properties. The selection included also 4 human metabolites which are 
excreted in high portions. With the exception of oxazepam, paracetamol, 2-hydroxy-
ibuprofen and 10,11-dihydro-10,11-dihydroxy-carbamazepine the same compounds 
were also tested in the leaching study. 
Table 2.5:  Selection of compounds for water/sediment studies 
Compound Major key-points for selection Form applied 
Iopromide 
extensive application 
environmental occurrence 
low biodegradability 
14C-labelled 
   
Diazepam environmental occurrence high potency 
14C-labelled 
Oxazepam 
 
main human metabolite of 
diazepam 
 
non-labelled 
Paracetamol extensive application environmental occurrence 
14C-labelled 
Ibuprofen 
 
extensive application 
environmental occurrence 
 
14C-labelled 
2-Hydroxy-ibuprofen ibuprofen metabolite non-labelled 
Clofibric acid 
 
environmental occurrence 
low biodegradability 
 
non-labelled 
Carbamazepine 
extensive application 
environmental occurrence 
low biodegradability 
non-labelled 
   
10,11-Dihydro-10,11-
dihydroxy-carbamazepine 
main human metabolite of 
carbamazepine non-labelled 
   
Ivermectin environmental occurrence high potency non-labelled 
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3 MATERIALS AND METHODS 
3.1 Methods for the characterization of water, sediment and soil 
samples 
Equipment and materials 
 Organic C analyser: TOCOR 2, Maihak AG, Hamburg 
 Muffle furnace, Nabler Typ L51/SP, Nabler Industrieofenbau, 
Lilienthal/Bremen; 
 pH-meter: CG 822, Schott-Geräte GmbH, Hofheim; 
 Oxygen-meter: Microprocessor OXI 196 (electrode EO 196-1,5), WTW, 
Weilheim; 
 Conductivity measurement: e.g. LF 96-A, WTW, Weilheim; 
 Total hardness: Aquamerck® Gesamthärte, Merck Eurolab, Frankfurt/M; 
 Nitrate: Spectroquant® Nitrate Test, Merck Eurolab, Frankfurt/M;  
 Phosphate: Spectroquant® Phosphate Test, Merck Eurolab, Frankfurt/M; 
 Chemicals: CHCl3, CaCl2, HCl conc., Merck Eurolab, Frankfurt/M. 
TOC of aqueous samples 
The total organic carbon content (TOC) of liquid samples were measured via an 
automatic TOC analyser (TOCOR 2, Maihak AG, Hamburg). Prior to the measurement 
3 drops of HCl conc. were added to each sample (30 mL) to remove carbonate bound 
carbon. 
Nitrate content, phosphate content and hardness of aqueous samples  
The total hardness and concentrations of nitrate and phosphate in the overlying water 
were measured using Aquamerck® and Spectroquant® test kits (Merck Eurolab, 
Frankfurt/M). 
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pH and redox potential of sediment and soil 
The pH values of sediment was measured directly in the wet substrate according to 
DIN 38 414, Teil 5. The pH values of soils were determined in a suspension of soil in a 
solution of 0.01 mol/L CaCl2 according to ISO 10390 (International Organization for 
Standardization, 1994). The redox potential of sediment was measured directly in the 
wet substrate according to DIN 38404, Teil 6.  
Maximum water holding capacity of soil 
The maximum water holding capacity of soil samples were determined according to 
Annex C of the ISO Guideline 11268-2 (International Organization for Standardization, 
1998). Therefore a defined quantity (e.g. 5 g) of the soil substrate was saturated with 
water for about three hours in a glass tube where the bottom was plugged with filter 
paper. Afterwards the sample was placed for a period of two hours on a layer of very 
wet Kleenex for draining in a closed vessel. The sample was weighed, dried to constant 
mass at 105 °C and re-weighed. The water capacity (WHC) was calculated according to 
the formula: 
 100/D x D - T - S  mass)dry  of %(in  WHC =  (3.1) 
where: 
S:  water-saturated substrate + mass of tube + mass of filter paper; 
T:  tare (mass of tube + mass of filter paper); 
D:  the dry mass of substrate. 
Microbial biomass of sediment 
The amount of microbial biomass carbon in sediment samples was determined via the 
fumigation-extraction-method (FE-method) according to ISO 14240-2 (International 
Organization for Standardization, 1997). For that, sediment samples were divided in two 
sub samples (equivalent to 25 g dry weight). One sub sample was fumigated prior to the 
extraction while from one sub sample the organic carbon was extracted immediately by 
horizontal shaking for 45 min with 100 mL 0.01 M CaCl2. For fumigation the sediment 
sub sample was filled into a petri dish and incubated for 20 hours at 25° ± 2 °C in a 
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CHCl3-atmosphere. After removal of all CHCl3 from the sediment sample the organic 
carbon was extracted by horizontal shaking for 45 min with 100 mL 0.01 M CaCl2. 
Thereafter the fumigated sample and the untreated one were filtered and the TOC of the 
extract was measured. The microbial biomass carbon (Cmic ) was calculated according to 
the formula: 
 ECCmic /kE  )(Ccarbon  biomass microbial =  (3.2)
where EC is (organic C extracted from fumigated sediment) - (organic C extracted from 
non-fumigated sediment) and kEC is 0.45 (Joergensen, 1995, Joergensen, 1996, 
Joergensen and Mueller, 1996). The results were expressed as µg Cmic /g soil (dry 
weight). 
Dry weight and organic carbon content of sediment and soil 
Samples of sediment and soil were weighed and dried overnight at 105 ± 2°C. After 
cooling in a desiccator, the specimens were weighed again. The water content of the 
samples is expressed in percent of wet weight (ww). 
The dried sediment and soil specimens were transferred to pre-heated, pre-weighed 
porcelain dish, and weighed. HCl (4 mol/L) was mixed with the specimens to remove 
carbonate bound carbon. After incubating for two to four hours, the specimens were 
dried overnight at 60 ± 2°C. The specimens were weighed after cooling in a desiccator 
and ashed in a muffle furnace at 550 ± 10°C. After cooling in a desiccator, the 
specimens were weighed again. The weight loss (loss on ignition, LOI) in percent of dry 
weight of the sample was calculated by subtracting the ash weight of the specimen from 
the dry weight of the specimen. The LOI was divided by the dry weight of the specimen 
and multiplied by 100 to result in the LOI in percent of dry weight of the specimen. The 
OC of the specimen was calculated by dividing the LOI in percent of dry weight by the 
factor 1.72 to correct for volatile sediment and soil components other than CO2 to result 
in the OC in percent of dry weight of sediment and soil. 
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3.2 Water/sediment tests 
The OECD Guideline 308 “Aerobic and anaerobic transformation in aquatic 
sediment systems”, based on BBA guideline IV 5-1 describes a laboratory test method 
to assess aerobic and anaerobic transformations of organic chemicals in aquatic 
sediment systems (Biologische Bundesanstalt für Land- und Forstwirtschaft, 1990, 
OECD, 2002). In general, this test is required for pesticides and industrial chemicals 
which are directly applied to water or which are likely to reach the aqueous 
environment by the routes described in chapter 1.1.2. Since surface layers of sediment 
can be either aerobic or anaerobic, the test methods include both conditions. The aerobic 
tests simulate an aerobic water column over an aerobic sediment layer that is underlain 
with an anaerobic gradient.  
Aim of the described tests were : 
 Measurement of the distribution of the test substance and its’ metabolites 
between water and sediment compartment.  
 Determination of transformation rates and mineralization rates 
 Balancing of radioactivity for 14C-labelled test substances 
 Quantification and identification (if possible) of transformation products 
 Calculation of dissipation times 
Deviating from the guidelines described, the tests were conducted with one aerobic 
sediment only, and due to the limited availability of appropriate 14C-labelled standards 
also non-labelled analytes were utilized as test compounds.  
Sampling and storage of native water and sediment 
Sediment and water were taken from the Wickerbach creek in Flörsheim (close to 
Frankfurt, Southwest Germany) (Figure 3.1) at a sampling site which was located close 
to the source of the creek. Since the creek is not used as a receiving water for STPs it is 
widely pristine (Umland-Verband Frankfurt / Region Rhein-Main, 1992).  
In order to sample mainly sediment under aerobic conditions, the sampling depth was 
restricted to 5 cm. The sediment was wet sieved (2 mm mesh) and homogenized with an 
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electric stirrer. Water and sediment were stored together with a water/sediment ratio of 
3:1 at 4°C in the dark for a maximum of 28 d. Water and sediment were characterized 
according to OECD guideline 308 (Table 3.1). 
 
Figure 3.1:  Sampling of sediment and water 
Table 3.1:  Characteristics of water and sediment used for test systems 
Parameter Sediment Parameter Water 
pH 7.7 pH 8.5 
Redox potential (mV) 269 Redox potential (mV) 382 
Corg (% dry weight) 1.4 TOC (mg carbon⋅L-1) 4.7 
Organic matter  
(% dry weight) 2.4 
Oxygen content 
(mg⋅L-1) 7.8 
Microbial biomass 
(µg carbon⋅g-1 dry sediment) 41 
Nitrate 
(mg⋅L-1) 6.2 
Water content (%) 20 Phosphate (mg⋅L-1) 0.9 
Clay (%) 9.9 Hardness (ppm CaCO3) 222 
Silt (%) 12.6 Conductivity (µS⋅cm-1) 515  
Sand (%) 77.5   
Soil type Loamy sand   
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Equipment and Materials 
 Glass flasks amber, 500 mL (Schott, Mainz, Germany) 
 Glass attachments for test vessels (Schott, Mainz, Germany)  
 PTFE-gasket (Schott, Mainz, Germany) 
 Soda lime granules with indicator (Merck, Darmstadt, Germany) 
Set-up of the test system 
The test system consisted of a 500 mL amber glass flask filled with 200 g sediment 
and 300 mL creek water (Figure 3.2). A CO2-trap filled with 30 g granulated soda lime 
was tidy coupled with the top of the flask. Thus, an exchange of air was possible, while 
CO2 was efficiently trapped. Further, the test vessels were wrapped with aluminum foil, 
to minimize photochemical reactions. Although, non-labelled compounds do not allow 
for a quantification of the mineralization product 12CO2 in the used experimental set-up, 
CO2-traps were coupled to the test vessels in all tests to achieve comparability to the 
tests with 14C-labelled pharmaceuticals. 
Soda lime
Glass wool
Air
Water
Sediment
CO2-trap
Test vessel
Gas exchange
Glass wool
 
Figure 3.2:  Water/sediment test system 
MATERIALS AND METHODS 21  
Prior to spiking with pharmaceuticals, the water/sediment systems were equilibrated 
under test conditions for at least 7 d. During the equilibration and the test period the test 
systems were slowly shaken avoiding a disturbance of the separation of sediment layer 
and overlying water as well as an excess suspension of sediment fines. 
The pharmaceuticals were spiked as aqueous solutions into the water phase of the 
test systems using water-miscible organic solvents (e.g. ethanol). In any case the 
concentration of the organic solvent in the overlying water did not exceed 0.5 %. 
Spiking levels of the individual compounds are listed in Table 3.2. These relatively high 
concentrations were chosen to enable a detection of 1 percent of the initial analyte 
concentration. For iopromide and diazepam which were the first compounds tested, a 
spiking level of 500 ng⋅g-1 µg/kg was chosen. Since the necessary detection limits were 
attained easily even at lower spiking levels, the spiking level was decreased to 100 
ng⋅g-1 for all further test substances. The vessels were slowly shaken for the test period 
of 100 d in an air-conditioned room at 20 ± 2°C.  
 For each sampling time two water/sediment vessels were sacrificed in parallel. 
Hence, 24 test systems were prepared per tested pharmaceuticals, to allow for 10 
sampling times, 2 solvent controls and 2 controls (Figure 3.3). Solvent controls were 
prepared in order to observe the influence of the used organic solvent in the application-
solution to the water/sediment system. The error bars in chapter 4.1 show the mean 
absolute deviation between the two test vessels sampled, their lower and their upper 
ends refer directly to the individual measurement values made. 
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Figure 3.3:  Test-vessels of the 14C-iopromide test before sampling after 24 h 
Table 3.2:  Spiking levels of pharmaceuticals 
Compound Concentration  (ng⋅g-1 sediment) 
14C-Iopromide 500 
14C-Diazepam 500 
Oxazepam 100 
14C-Ibuprofen 100 
2-Hydroxy-ibuprofen 100 
14C-Paracetamol 100 
Carbamazepine 100 
10,11-Dihydro-10,11-dihydroxy-carbamazepine 100 
Clofibric acid 100 
Ivermectin 100 
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Sampling of the water/sediment test systems 
Samples were taken immediately after spiking and after 0.25, 1, 2, 7, 14, 28, 56 and 
100 d. For that, the entire water and sediment phase of each test-system were taken. 
Then, the supernatant water phase was decanted and homogenized using a magnetic 
stirrer. Sediment was manually homogenized. Water samples containing radio-labelled 
compounds were filtered through a paper filter, to remove suspended matter, and were 
divided into 15 mL aliquots. Possible analyte sorption to the filter was always checked. 
The sediments were divided into portions of 2× 10–20 g and 2× 80–90 g. For non-
labelled test compounds, the water phase was divided into aliquots of 75 mL and 
225 mL, and the sediments were stored in two portions of 100 g. In the radiotracer tests, 
the soda lime of the CO2-traps was transferred into PE-bags, while the soda lime 
granules were rejected in the tests with non-labelled compounds. All samples were 
finally frozen at –20°C and stored until analysis. The aliquot size for analysis was 
selected, to allow for the LOQs listed in Table 3.3.   
Table 3.3:  LOQs for analysis of system compartments 
Analysis LOQ in water (% C0) LOQ in sediment (% C0)
Quantification of non-labelled 
analytes 
≤ 1 ≤ 1 
Quantification of radioactivity ≤ 1 ≤ 1 
Radio-TLC ≤ 2.5 ≤ 1 
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3.3 Soil-column leaching experiments 
Equipment and materials 
 Cylindrical sectionable glass columns (350 mm long, 50 mm diameter) with 
glass tubes and glass drip outlets including metal rack; 
 Glass sinter discs D1 (diameter 50 mm), Merck Eurolab, Frankfurt, Germany; 
 Vibration device used for filling and packing the soil columns; 
 Peristaltic pump Ismatec IPS 12 including tubes (Tygon), Wertheim, Germany; 
 Chemicals: CaCl2, ethanol, methanol, acetone, (HPLC Grade), Merck, 
Frankfurt, Germany; 
 Standard laboratory equipment: PTFE-tubes, spoons, pipettes, amber glass 
bottles;  
Experimental set-up 
All tests were performed according to the OECD guideline No. 312 “Leaching in soil 
columns” (Brodsky et al., 1997, OECD, 2003a).  
Air-dried and sieved soils (< 2 mm mesh) were packed in sectional glass columns to 
a height of approximately 30 cm (Figure 3.4). To obtain uniform packing, the soil was 
added in small portions under gentle vibration of the column. Subsequently, the soils 
were saturated with artificial rain (0.01 mol⋅L-1 CaCl2) to their maximal water holding 
capacities. The test substances were applied on the top of the soil columns as aqueous 
solution or dissolved in organic solvent at a concentration level of 100 µg⋅kg-1 soil (dry 
weight). When necessary an organic solvent was used for application, the solvent was 
allowed to evaporate completely from the soil surface prior to the start of the 
experiment. All tests were performed in the darkness at a temperature of 20 ± 2°C. A 
total amount of 393 mL artificial rain (0.01 mol⋅L-1 CaCl2) corresponding to a rate of 
200 mm was added within 48 h drop wise on each soil column, which simulated an 
extremely high rainfall. Glass sinter disks on top of the columns ensured an even 
distribution of the artificial rain.  
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At the end of the experiments, the amounts of the non-labelled pharmaceuticals, 
respectively the total radioactivity contained in the leachates were determined. The time 
dependent leaching behaviour of the test substances was not investigated, since the 
leachates were collected in one fraction. Additionally, in the studies using 14C-labelled 
substances, the total radioactivity in different layers of the soil columns was measured. 
For this purpose, the soil columns were divided in six sections, each about 5 cm high. 
 
Figure 3.4: Cylindrical sectional glass column (350 mm long, 50 mm diameter) with 
glass tubes and a glass drip outlet including a metal rack 
Characterization of applied soils 
The soils selected for the leaching studies (Figure 3.5) covered a wide range of the 
soil spectrum with respect to organic content and pH (Table 3.4). Deviating from OECD 
guideline No. 312 OECD, 2003a two different soils, LUFA 2.2 (LU) and Euro Soil 5 
(E5) were used in the studies with non-labelled compounds, whereas in the studies 
using 14C-iopromide and 14C-diazepam a third soil was tested (Neuenkirchen; collected 
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north of Braunschweig, Niedersachsen, Germany). The third soil was included to 
improve the comparability with studies performed in parallel to this project. EuroSoil 5 
was sampled at the site near Gatow (Schleswig-Holstein, Germany) where the original 
EUROSOIL (Kuhnt and Muntau, 1992) was taken, the soil LUFA 2.2 was obtained from 
the LUFA Speyer (Germany) and the third soil was collected north of Braunschweig 
(Niedersachsen, Germany). Data on the soil characteristics are given in Table 3.4. 
 
Figure 3.5: Soils used in the leaching studies (LUFA 2.2; EuroSoil 5; Neuenkirchen) 
Table 3.4 :  Soils applied in leaching experiments 
 LUFA 2.2 EuroSoil 5 Neuenkirchen 
pH (CaCl2) 5.8 2.9 7.0 
Corg [%] 2.3 6.3 1.3 
Org. content [%] 4.0 10.8 2.2 
C/N-Ratio 13 (1) --- --- 
Ntotal [mg/kg dw] --- --- 2600 (3) 
CEC [cmolc/kg] 11 (1) --- --- 
Water content [%] 10.7 2.2 22.7 
WHC [%]  51 25 (4) 33 
Soil texture loamy sand (1) loamy sand (4) silty loam(3) 
Clay [%] 8.2 (1) 8.4 (4) 17.0 (3) 
Silt [%] 17.0 (1) 17.7 (4) 78.4 (3) 
Sand [%] 74.8 (1) 73.9 (4) 4.7 (3) 
Soil type Gleysol (2) Podsol Luvisol (3) 
Sampling depth 0-10 cm (1) 0-10 cm 0-10 cm (3) 
Sampling horizon Ah (1) Ah Ap (3) 
Vegetation hay meadow (1) pine forest winter wheat (3) 
Sampling date 10. July 2001 (1) 12. July 2001 10. August 2001 
CEC = cation exchange capacity; WHC = water holding capacity; (1) data based on standard certificate of 
analysis, Landwirtschaftliche Untersuchungs-und Forschungsanstalt Speyer; (2) pers. comm. Weller, 2001, 
(Landwirtschaftliche Untersuchungs- und Forschungsanstalt Speyer); (3) data provided by Institut für 
Geoökologie, TU Braunschweig; (4) data provided by Fa. Geocomp, Bad Vilbel. 
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Sampling procedure and sample handling 
During the test period the leachates were collected in amber glass bottles (Figure 
3.6). After allowing the columns to drain, the concentrations of test substance 
respectively the total radioactivity were determined by methods described in the 
chapters 3.5 and 3.6. Additionally, in the studies using 14C-labelled test substances, the 
total radioactivity was measured in 5 cm soil layers when at the end of the experiments 
the sectionable glass columns were divided into six layers. After homogenization of the 
individual soil layers, sub-samples were combusted in a sample oxidizer and the 
radioactivity were measured by LSC (see chapter 3.6). The amounts of test substance, 
respectively total radioactivity, were given for each soil layer and leachate in relative 
concentrations normalized by the applied initial dose.  
 
Figure 3.6:  Soil columns in a soil leaching study (1: PTFE-tube; 2: glass sinter disk; 
3: soil column wrapped with aluminium foil; 4: glass bottle containing 
artificial rain; 5: peristaltic pump; 6: leachate collecting) 
1
2
4
5
6
3
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3.4  Materials and instrumentation for chemical analysis  
The following reference compounds, chemicals and solvents have been incorporated 
in this work: 
Lipid regulators and metabolites 
 Bezafibrate, clofibric acid, gemfibrozil (Sigma, Deisenhofen, Germany)  
Antiphlogistics and metabolites 
 Diclofenac, fenoprofen, ibuprofen, indomethacin, ketoprofen, naproxen, 
paracetamol, (Sigma, Deisenhofen, Germany), 2-hydroxy-ibuprofen (µ-Mol, 
Luckenwalde, Germany) 
Parasiticides 
 Ivermectin (Sigma, Deisenhofen, Germany) 
Antiepileptics and tranquilizers  
 Carbamazepine, diazepam, oxazepam, (Sigma, Deisenhofen, Germany), 10,11-
dihydro-10,11-dihydroxy-carbamazepine (µ-Mol, Luckenwalde, Germany) 
Iopromide derivatives 
 Iopromide, desmethoxy-iopromide, ATH, DAMI, ATI (courtesy from Schering, 
Berlin, Germany) 
Internal and surrogate standards 
 Abamectin, fenoprop (Riedel-de-Haen, Seelze Germany), 10,11-dihydro-
carbamazepine (Alltech, USA), paracetamol-D4 (Cerilliant, Austin, USA) 
14C-labelled reference compounds 
 14C-Diazepam, [2-14C], radiochemical purity 99.8 %, specific activity  
7.22 MBq⋅mg-1, (Amersham Pharmacia Biotech UK Limited, Little Chalfont, 
UK) 
 14C-Ibuprofen, [carboxyl-14C], radiochemical purity > 99 %, specific activity 
8.97 MBq⋅mg-1 (American Radiolabeled Chemicals Inc., St. Louis, MO, US) 
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 14C-4-acetaminophen, [ring-UL-14C], radiochemical purity > 99 %, specific 
activity 1.54 MBq⋅mg-1 (Sigma-Aldrich, Steinheim, Germany) 
 14C-iopromide, [ring-14C], radiochemical purity > 98 %, specific activity 
1.86 MBq⋅mg-1 (courtesy from Schering AG, Berlin, Germany) 
 14C-4-nitrophenol, [ring-14C], radiochemical purity 99 %, specific radioactivity 
2.66 MBq⋅mg-1 (American Radiolabeled Chemicals Inc., St. Louis, MO, USA) 
Chemicals and solvents 
 Acetic acid (100 %, p.a.), amyl alcohol, sulphuric acid (suprapur), ammonia 
(25 %, p.a.), ammonium acetate (p.a.), KH2PO4, K2HPO4, (Merck, Darmstadt, 
Germany 
 Acetone, acetonitrile, chloroform, ethyl acetate, methanol, 2-methyl-propanol, 
n-hexane, toluene, all suprasolv (Merck, Darmstadt, Germany) 
 
The following instruments and materials were applied for the analyses and 
experiments:    
LC tandem MS 
 Perkin-Elmer Series Autosampler Series 200 connected to a Perkin-Elmer 
quaternary pump Series 200 and an AS–2000a auto sampler, Perkin Elmer Sciex 
API 365 tandem MS with ESI and APCI-interface 
Columns for HPLC 
 EcoCart (125 x 3 mm) LiChrospher 100 RP-C18 endcapped (5 µm) (Merck, 
Darmstadt) 
 EcoCart (125 x 3 mm) LiChrospher RP-C18 (5 µm) (Merck, Darmstadt) 
 EcoCart (125 x 3 mm) column cartridge (Merck, Darmstadt) 
Radiometry 
 Liquid scintillation counter Tricarb 2500 TR (Canberra Packard, Dreieich, 
Germany) 
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 LSC-Cocktails: EcoPlus (Roth, Karlsruhe, Germany), Ultima Gold F and 
Permafluor E+ (Canberra Packard, Dreieich, Germany);  
 Sample Oxidizer, TriCarb 307 (Canberra Packard, Dreieich, Germany) 
 Carbon dioxide absorbent Carbo-Sorb E (Canberra Packard, Dreieich, 
Germany) 
 Combusto-Cones (Canberra Packard, Dreieich, Germany) 
 14C-Spec-Chec (Canberra Packard, Dreieich, Germany) 
 TLC-Radio-Scanner 1052 with Digital Signal Analyzer 1006 (Berthold GmbH, 
Wildbad, Germany) 
 TLC Plates 20 × 20 cm, KG 60, F254 (Merck, Darmstadt, Germany) 
Material and equipment for sample preparation 
 Lyophilizer Alpha 2-4 (Christ, Osterode am Harz, Germany) 
 Rotary evaporator RE 111, water jet pump and vacuum controller (Büchi, 
Konstanz, Germany) 
 Syringe filter Spartan 13/20 0.45 µm (Schleicher & Schuell, Dassel, Germany 
 Syringe filter PTFE 0.22 µm (Roth, Karlsruhe, Germany)  
 Glass fiber filter (< 1 µm) (Schleicher & Schuell, Dassel, Germany) 
 Glass cartridges 3 mL (Mallinckrodt Baker, Griesheim, Germany) 
 PTFE-frits (ICT, Bad Homburg, Germany) 
 Solid phase materials: Isolute ENV+, RP-C18 end capped (ICT, Bad Homburg, 
Germany), LiChrolute RP-C18 (40 – 63 µm), LiChrolute EN (40 – 120 µm) 
(Merck, Darmstadt, Germany) 
 Glass vials 10 mL with stretched tip (0.2 mL) and screw caps, (Glassblowing, 
Mainz, Germany) 
 LC vials 500 µL PP with PTFE caps (A-Z Analysenzubehör, Mainz, Germany) 
 Centrifugation flasks 250 mL, PPCO (Nalge Nunc International, Rochester, 
NY) 
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3.5 Analysis of pharmaceuticals with mass spectrometry 
3.5.1 Acidic pharmaceuticals 
Lipid regulators and analgesic pharmaceuticals were presumably the first 
prescription pharmaceuticals detected in the environment (Garrison et al., 1976, Hignite 
and Azarnoff, 1977). In recent years numerous methods have been reported for the 
detection of these pharmaceuticals, often containing carboxyl groups. Predominantly 
analysis in environmental compartments has been applied via GC/MS (Buser et al., 
1998, Heberer et al., 1997, Heberer and Stan, 1996, Sacher et al., 2001, Stumpf et al., 
1998, Stumpf et al., 1999, Ternes, 2001b, Weigel et al., 2002) but also by LC/MS 
(Ahrer et al., 2001, la Farré et al., 2001, Miao et al., 2002) and CE/MS (Ahrer et al., 
2001).   
Within the present work, the acidic pharmaceuticals were analyzed in leachate 
samples following a procedure, originally described by Ternes et al., 1998b using SPE 
enrichment, derivatization with diazomethane and GC/MS detection. Since this method 
included a derivatization step with the carcinogenic diazomethane, an entirely new 
method was developed, which allowed for the analysis of water and sediment by LC-
tandem MS detection (Löffler and Ternes, 2003).   
The new method included an SPE for aqueous samples of various origins, applying a 
polymer based mixed-bed material, which attained a high extraction efficiency and 
retained analytes based on reversed phase and cation-exchange mechanisms. This 
enabled for a limited sample clean-up since cationic compounds extracted remained 
attached to the SPE-material during elution and were thus removed from the sample 
extract. Furthermore, an LC-tandem MS method was developed, using atmospheric 
pressure chemical ionization (APCI) for the acidic analytes.  
Optionally, a sediment extraction procedure was developed which utilized the newly 
established SPE step as an clean-up of the sediment extracts. This was in response to the 
extracts being highly loaded with matrix impurities. 
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3.5.2 Neutral pharmaceuticals 
The term neutral pharmaceuticals relates to those pharmaceuticals, such as 
carbamazepine and diazepam, which are extractable using reversed phase SPE materials 
with a neutral pH. These compounds have been found in various environmental waters 
using gas- and liquid chromatography mass spectrometry (Meisenheimer and Ternes, 
2000, Öllers et al., 2001, Sacher et al., 2001).  
The analytical method applied for the analysis of various neutral pharmaceuticals is 
based on methods already reported (Ternes et al., 2001, Ternes et al., 1998a), but were 
extended to allow for the detection of two additional analytes. These were the main 
human metabolites of carbamazepine and diazepam, 10,11-dihydro-10,11-dihydroxy-
carbamazepine and oxazepam. Again, a solvent extraction procedure was developed for 
the determination of the analytes in sediment. The SPE, normally applied for the 
enrichment of the neutral pharmaceuticals in aqueous matrices, served here as a clean-
up step for the sediment extracts.  
3.5.3 Iopromide derivatives and paracetamol 
The iopromide derivatives were analyzed, based on the procedure recently described 
(Hirsch et al., 2000, Ternes and Hirsch, 2000) for aqueous matrices. The current method 
was developed for the determination of the analytes in aqueous matrices and sediment. 
In addition to the iopromide derivatives, the analgesic paracetamol was included into 
the method. Since the recoveries of the iopromide derivatives ATH and ATI in SPE 
were generally low, they were excluded as analytes in method development. The SPE 
was used as an enrichment procedure for aqueous matrices and as clean-up for sediment 
extracts.   
Sediment extraction 
All sediment samples were sieved prior to analysis (2 mm mesh), in order to remove 
the coarse sediment fraction. Sediment samples (50 g) were filled in PPCO flasks and 
were spiked with 800 ng of DMI, the surrogate standard for the iopromide derivatives, 
and 800 ng of paracetamol-D4 the surrogate standard for paracetamol. Sediments were 
then extracted using 2 × 45 mL methanol and successively 2 × 45 mL acetone in an 
ultrasonic bath. The slurries of the solvent/sediment mixtures were thoroughly hand 
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shaken and then ultrasonicated for 15 min. After extraction, the slurries were 
centrifuged for 7 min at 5400 rpm and the supernatant solvent phases were filtered, 
combined and evaporated at 40°C, 150 – 250 mbar by a rotary evaporator until only 
water remained. The resulting extracts and methanol rinses (3 × 1 mL) were combined 
and diluted with 500 mL of uncontaminated groundwater, which is known to be free of 
anthropogenic organic contamination. 
SPE of water samples and aqueous sediment extracts 
Water samples or aqueous sediment extracts were, if necessary, filled up to 500 mL 
with groundwater and adjusted to a pH 2.8 using H2SO4 (3.5 mol⋅L-1). Then, the 
surrogate standards DMI and paracetamol-D4 were spiked to the samples. Glass 
cartridges were manually packed with 250 mg of ENV+ and 100 mg of RP-C18ec-
material on the top and were conditioned prior to sample extraction with 6 mL of n-
hexane, 2 mL of acetone, 10 mL of methanol and 10 mL of groundwater. Aqueous 
samples (either water or aqueous sediment extracts) were passed through the SPE 
cartridges at a flow rate of 10 mL⋅min-1, since lower flow rates were crucial for good 
recoveries. Afterwards the cartridges were dried with nitrogen for 1 h. The RP-C18ec 
material was removed, while keeping the ENV+ material in the cartridges which were 
then eluted with 4 × 1 mL of methanol. All extracts were evaporated to dryness in a 
gentle nitrogen stream and the residue was finally dissolved in 50 µL of methanol and 
450 µL of phosphate buffer (pH 7, 20 mM KH2PO4/K2HPO4). 
HPLC conditions 
Prior to injection all wastewater samples and sediment extracts were filtered 
(0.45 µm, Spartan 13/20, Schleicher & Schuell, Dassel, Germany). The Perkin Elmer 
HPLC system consisted of a Series 200 in-line degasser and a quaternary pump 
connected to an AS–2000a autosampler. The injection volume was always 50 µl. For 
the chromatography of the X-ray contrast medium and paracetamol a 125 × 3 mm 
LiChrospher RP-18ec column (5 µm) (Merck, Germany) was applied and kept at 5°C. 
A isocratic flow of 0.2 mL⋅min-1 of the mobile phase was used for the LC-analysis 
containing a 5 mmol⋅L-1 ammonium acetate (pH 5.7) and acetonitrile (90:10, v/v).  
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MS/MS detection 
The iopromide derivatives and paracetamol analyzed using a Perkin-Elmer Sciex 365 
triple-stage quadrupole mass spectrometer equipped with turbo electrospray ionization 
(ESI). Analyses were performed at 400°C in the positive ion mode, with a spray voltage 
of 4.6 kV. Potential differences between skimmer and orifice varied from 14 to 35 V 
and ring electrode voltages from 140 to 190 V. Nitrogen was used as the curtain gas and 
the nebulizer gas at flow rates of 1 and 0.7 L⋅min-1, respectively. The eluent was split 
1:10 in the electrospray interface, resulting in a effective spray rate of 20 µL⋅min-1 into 
the mass spectrometer. MS/MS parameters were optimized in the continuous flow 
mode. Conditions for the measurement of precursor ions were optimized in the single 
MS scan mode. The protonated molecular ions were used as the precursor ions for 
subsequent MS/MS experiments. Product ion spectra were recorded by scanning Q3 
over the relevant mass range. After the determination of the product ions, the conditions 
for the nitrogen-collision-induced dissociation (CID) were optimized. Precursor and 
product ions of the individual compounds are shown in  
Table 3.5. 
Table 3.5: Retention times and fragmentation of iopromide derivatives and 
paracetamol 
Compound Retention time (min) Precursor and product ions (m/z)  
ATI 3.3 559.5 
432.81
[MH]+ 
[M-HI+H]+ 
ATH 4.9 632.7 
541.81
[MH]+ 
[M-C3H9NO2+H]+ 
DMI 5.6 761.8 
543.11
[MH]+ 
[M-HI-C3H9NO2+H]+ 
Iopromide 7.4 791.8 
572.81
[MH]+ 
[M-HI-C3H9NO2+H]+ 
Paracetamol 8.8 152.2 
133.8 
110.01
[MH]+ 
[M-H2O+H]+ 
[M-C2H4O+H]+ 
Paracetamol-D4 8.8 156.0 
113.81
95.6 
[MH]+ 
[M-C2H4O+H]+ 
[M-H2O-C2H4O+H]+ 
DAMI 9.5 719.7 
628.91
[MH]+ 
[M-C3H9NO2+H]+ 
1: Product ion used for quantification 
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Determination of recoveries, LOQs and calibration  
 Individual recoveries for the SPE procedure were measured by spiking groundwater, 
soil leachates, surface water and wastewater.  
The efficiency of the solvent extraction step was determined for paracetamol using 
autoclaved sediment, spiked with a 14C-labelled standard, which was extracted after a 
contact time of approximately 14 h following the described extraction sequence. 
Finally, overall recoveries were obtained by spiking autoclaved sediment at two 
levels and analyzing the samples after a contact time of approximately 14 h as described 
above. The recoveries were calculated relative to a non-extracted standard. Calibration 
curves were prepared for each compound from the spiked groundwater samples by 
plotting the peak area of the respective MRM-transition versus the analyte 
concentration. In each calibration series, a blank sample and a recovery sample were 
included. Requiring a S/N-ratio > 10, the LOQs were set as the second lowest 
calibration point in the linear regression.  
Method characterization 
Groundwater and soil leachates 
Recoveries for the SPE of groundwater were quantitative for the iopromide 
derivatives and only slightly lower for paracetamol, as shown in Table 3.6. A 
compensation led to excellent relative recoveries ranging from 89 ± 9 to 104 ± 4 %. In 
soil leachates the recoveries differed to some extent. Iopromide and DMI were both 
recovered at the 83 ± 6 % level, while the iopromide metabolite DAMI was over 
determined with a 123 ± 5 % recovery. A relative recovery of 100 ± 7 % was obtained 
for iopromide, whereas the compensation increased the recovery to 143 ± 8 %, and thus 
quantification had to be done without compensation. Nevertheless, all recoveries had a 
low statistical error of < 10 %, exhibiting a reproducible enrichment procedure. 
All LOQs of the analytes in groundwater and soil leachates were 0.04 µg⋅L-1. The 
calibration curves, for the quantification of the iopromide derivatives and paracetamol 
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in all aqueous matrices and sediment, were prepared from spiked groundwater and 
attained regression coefficients always > 0.99. 
Table 3.6:  Recoveries (%) and confidence intervals (P=95 %) of iopromide, an 
iopromide metabolite and paracetamol for the SPE of spiked 
groundwater and soil leachates 
 Groundwater Soil leachates 
Compound LOQ (µg⋅L-1) 
Absolute
Recovery 
(%) 
Relative 
Recovery 
(%) 
LOQ 
(µg⋅L-1) 
Absolute 
recovery 
(%) 
Relative 
recovery 
(%) 
DAMI 0.04 97 ± 3 99 ± 5 0.04 123 ± 5 143 ± 8
Iopromide 0.04 87 ± 5 89 ± 9 0.04 83 ± 6 100 ± 7
DMI 0.04 97 ± 7 -  0.04 83 ± 6  -  
Paracetamol - 81 ± 9 104 ± 4 -  -   -  
Paracetamol-D4 0.04 78 ± 8 -  0.04  -   -  
 
Surface water 
The SPE method was also well suited for the surface water. Recoveries in surface 
water ranged from 87 ± 7 to 102 ± 11 % and after compensation between 100 ± 9 % and 
115 ± 6 % (Table 3.7). However, the method allowed for the determination of the 
analytes in groundwater, soil leachates and surface water with a LOQ of 0.04 µg⋅L-1.  
Table 3.7:  Recoveries (%) and confidence intervals (P=95 %) of iopromide, an 
iopromide metabolite and paracetamol for the SPE of surface water 
(n=4) spiked with 1 µg⋅L-1 
  Surface water 
Compound LOQ (µg⋅L-1)
Absolute 
Recovery 
(%) 
Relative 
Recovery 
(%) 
DAMI 0.04 87 ± 7 100 ± 9 
Iopromide 0.04 92 ± 8 105 ± 10
DMI - 87 ± 4 -  
Paracetamol 0.04 102 ± 11 115 ± 6 
Paracetamol-D4 - 89 ± 5 -  
1 The native analyte concentration of a sample was subtracted from the concentration of spiked samples 
for the calculation of the recoveries  
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Sediment 
The solvent extraction yielded an almost quantitative recovery of 95 ± 3 % 14C-
paracetamol. More than 89 % were attained within the first 2 extraction sequences 
(Table 3.8).  
Table 3.8:  Recoveries (%) and confidential intervals (P=95 %, n=4) for 
paracetamol after extraction of 50 g sediment spiked with 14C-
paracetamol at 20 ng⋅g-1 
 Paracetamol recovery (%) 
First extraction 73 ± 2 
Second extraction 17 ± 2 
Third extraction 2 ± 1 
Fourth extraction 3 ± 2 
Sum 95 ± 3 
 
Overall recoveries of the analytes in sediment were quantitative at a spiking level of 
20 ng⋅g-1, except for the surrogate standard DMI (Table 3.9). The latter was found at a 
significantly lower level of 54 ± 4 %. Hence, DMI was not appropriate as a surrogate 
standard for the determination of iopromide and its’ metabolite DAMI in sediments. In 
contrast to that finding, the compensation of the iopromide derivatives and paracetamol 
using paracetamol-D4 provided good relative recoveries between 101 ± 19 and 
117 ± 6 %.  
The recoveries at the lower spiking level of 3 ng⋅g-1 differed from those at the high 
spiking level. For iopromide and its’ metabolite DAMI the recoveries were decreased 
and ranged between 70 ± 4 and 77 ± 4 %, while the recovery of DMI was constant at 
50 ± 4 %. A paracetamol signal was found in non-spiked sediment samples, resulting 
either from contamination with paracetamol or from interfering matrix components. 
Therefore, the background signal was subtracted from the paracetamol signal in the 
spiked samples. A chromatogram of a standard sample is shown in Figure 3.7. 
Paracetamol was recovered with 52 ± 25 %, while the deuterated surrogate standard 
provided recoveries of 100 ± 11 %. The strong difference in the recovery rates of 
paracetamol and its’ deuterated standard might have been the result of the different 
spiking levels applied, since the surrogate standard was spiked in all experiments at the 
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same concentration of 16 ng⋅g-1 sediment. Hence, neither DMI nor paracetamol-D4 were 
appropriate surrogate standards and quantification was always conducted without 
compensation. The LOQs for iopromide and DAMI was set to 3 ng⋅g-1 while 
paracetamol’s was 20 ng⋅g-1.  
Table 3.9:  LOQs (ng⋅g-1), recoveries (%) and confidence intervals (P=95 %) of 
iopromide derivatives and paracetamol for the overall method at two 
spiking levels (20 ng⋅g-1 and 3 ng⋅g-1), using paracetamol-D4 as 
surrogate standard for all analytes (contact time ∼ 14 h)  
  Spiking level 20 ng⋅g-1 (n=3)Spiking level 3 ng⋅g-1 (n=4)
Compound LOQ (ng⋅g-1) 
Absolute 
recovery 
(%) 
Relative 
recovery 
(%) 
Absolute 
recovery 
(%) 
Relative 
recovery 
(%) 
DAMI 3 92 ± 19  101 ± 19 77 ± 4 79 ± 18 
Iopromide 3 100 ± 18  106 ± 17 70 ± 4 71 ± 7 
DMI - 54 ± 11  -  50 ± 4  -  
Paracetamol 20 102 ± 21  117 ± 6 52 ± 25 53 ± 29 
Paracetamol-D4 - 88 ± 18  -  100 ± 11  -  
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Figure 3.7:  Total ion chromatogram of a standard (500 ng) with iopromide 
derivatives and paracetamol (IO = iopromide, PAR = paracetamol) 
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3.5.4 Ivermectin 
Analytical methods for avermectin derivatives that apply mass spectrometry 
detection, are available for a wide range of biological matrices, such as vegetables, 
fruits, tissues and milk (Heller and Schenck, 1993, Tumipseed et al., 1999, Valenzuela 
et al., 2000, Wu et al., 2001, Yoshii et al., 2000). Unfortunately, most methods for their 
environmental detection apply fluorescence detection and achieve only a very limited 
specificity (Cannavan et al., 2000). Recently, Reyzer and Brodbelt published an SPME 
method for the detection of abamectin in water samples, with LC-tandem MS detection 
(Reyzer and Brodbelt, 2001). Usually SPME does not allow for a quantitative 
enrichment of the analyte from the samples and, therefore, the sensitivity was relatively 
low (LOQ > 1 µg⋅L-1).  
In the current work, a LC tandem MS method was developed for the determination of 
the parasiticide ivermectin in environmental waters and sediment (Löffler and Ternes, 
2003). As described by Reising, 1998, abamectin was applied as the surrogate standard 
and allowed for an effective compensation of virtually all analyte losses, since both 
compounds show very similar properties.  
3.6 Radiometric analysis of 14C-labelled pharmaceuticals 
Radio tracer techniques are useful tools in chemistry and environmental sciences. 
The analysis of samples containing radio-labelled compounds is usually divided in two 
major steps. At first, the total radioactivity in the various system compartments is 
determined. A balance of radioactivity can then be conducted, comparing the quantity 
of radioactivity originally applied versus the quantity found after sampling. This 
provides basic information on the distribution of the radioactivity in the system 
compartments. The second step is the chemical analysis of the radio-labelled 
compounds in the different system compartments which allows for the identification 
and quantification of test compound and its’ metabolites.  
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3.6.1 Analysis of the total radioactivity in environmental samples 
Water samples 
The total radioactivity in the water samples was determined by liquid scintillation 
counting (LSC) immediately after sampling. The water aliquots were mixed with an 
appropriate amount of scintillation cocktail (Ultima Gold F) and measured in the liquid 
scintillation counter. 
Sediment and soil 
The total amount of radioactivity included in sediment or soil samples was 
determined by the combustion of aliquots in a sample oxidizer. Aliquots of 1 g wet 
sediment were filled in Combusto-cones (paper-foam tubes) and were mixed with 
400 µL of amyl alcohol to enhance the combustion process. The samples were then 
combusted in a platinum heating coil under an oxygen atmosphere. The released 14CO2 
was automatically trapped in an absorbent (Carbo-Sorb E) and mixed with scintillation 
cocktail (Permafluor E+) before it was finally measured by LSC. Recovery rates of the 
sample oxidizer were determined prior to measurement in 3 replicates and after 8 to 16 
samples, by combusting cellulose samples spiked with a defined amount of a 14C-
standard (Spec-Check).  
All samples were measured in 3 or 4 replicates to minimize the variability. Since a 
small memory effect occurred, a blank was analyzed after each set of sample replicates. 
For quantification of the radioactivity in the samples, the recovery rates and the memory 
effects were considered. 
Soda lime CO2-traps 
For the analysis of the trap material, the CO2 sorbed to the soda lime had to be 
transferred quantitatively into the liquid phase for LSC-measurement. Soda lime 
samples of 30 g were mixed with 75 mL of hydrochloric acid and were stirred until 
complete dissolution of the soda lime pellets occurred. Nitrogen was led gently through 
the soda lime/hydrochloric acid mixture and the CO2 in the resulting gas current was 
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sequentially trapped in an absorbent (Carbo-Sorb E). After addition of the scintillation 
cocktail, the 14CO2 was then quantified by LSC.  
3.6.2 Sample preparation for chemical analysis 
Prior to analysis, the analytes in aqueous samples had to be concentrated. The 
enrichment via SPE, used for non-labelled analytes, is more or less specific for 
compounds of a certain range of polarity. However, the polarity of an analyte and its’ 
TPs usually differ significantly. Thus, an SPE optimized for a certain analyte is 
presumably less effective for transformation products. A solution for that problem was 
the use of lyophilization under mild vacuum since a discrimination of polar metabolites 
was largely avoided. 
Lyophilization procedure for surface water containing ibuprofen, diazepam, 
iopromide and paracetamol 
The water samples were lyophilized for 1 – 2 d at –82°C and a vacuum of 0.15 mbar, 
while keeping the screw cap of the storage vessels semi-closed to prevent losses and 
cross contamination. Residues were transferred into small glass tubes with 3 × 1 mL of 
methanol and 1 mL of acetone. Then, the solvent was evaporated under a gentle 
nitrogen-stream and the samples were dissolved in 1.5 mL methanol. All extracts were 
filtered using 0.22 µm PTFE syringe filters and refrigerated until measurement.  
Evaporation procedure for surface water containing iopromide 
Water samples of 15 mL were mixed with 180 mL acetonitrile. The liquid phase was 
evaporated to dryness by a rotary evaporator at 40°C and 150 mbar. Residues were 
successively dissolved under ultrasonic conditions in 3 mL of methanol and 3 mL 
acetone and were transferred into smaller tubes. The solvents were entirely removed in 
a gentle nitrogen stream and the remaining residues were dissolved in 1.5 mL of 
methanol. Then, the extracts were filtered using 0.22 µm PTFE syringe filters and 
refrigerated until measurement.  
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Extraction of ibuprofen, diazepam and paracetamol in sediment 
Analytes in sediment samples were solvent extracted according to the extraction 
sequences already described in the methods of the non-labelled analytes. After the 
removal of the extraction solvent, the remaining aqueous phase was diluted 1:12 with 
acetonitrile and was then azeotropically evaporated to dryness by a rotary evaporator at 
40°C and 150 mbar. The residues were successively dissolved under ultrasonic 
treatment in 3 mL of methanol and 3 mL acetone and were transferred into smaller 
tubes. The resulting solution was evaporated to dryness in a gentle nitrogen stream and 
the residues were re-dissolved in 1.5 mL of methanol. Extracts were filtered using 
0.22 µm PTFE syringe filters.  
Determination of recoveries, LOQ and calibration  
The efficiency of the combustion process was checked by combusting sediment 
samples spiked in triplicate at various levels, and measuring the recovered radioactivity. 
For further recovery experiments, native surface water (15 mL) was spiked with the 
radio-labelled analytes. Samples were prepared as described in chapter 3.6.2.  
Overall recoveries for the lyophilization procedure were calculated by comparing the 
quantity of radioactivity found in the final sample extracts with the respective quantity 
initially spiked to the surface water samples. Efficiencies of the solvent extractions were 
determined as already described in the methods of the individual non-labelled analytes. 
Quantification of radioactivity in the liquid samples was attained using a TriCarb 2500 
TR liquid scintillation counter (Packard, Dreieich, Germany). The measuring time 
varied, depending on the radioactivity in the samples ranged between 5 and 20 min. 
Calibration of the counter was done every day by measuring standard samples and the 
background radioactivity. The counter TriCarb 2500 TR provided, quench correction 
via external standardization, an automatic efficiency control and luminescence detection 
and correction. Luminescence interferences were further minimized by measuring all 
samples after a decay period of at least 5 h after preparation. The LOQ for 
quantification with LSC was not compound specific and set to 60 dpm per sample, 
calculated as the three times the mean 14C-background radioactivity of 20 dpm per 
sample.  
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Method characterization 
The efficiency of the sediment combustion process was 94 ± 2 % at all spiking levels 
ranging from 60 – 100,000 dpm⋅g-1 sediment (non-dried) and was considered for 
quantification. Losses occurred were presumably due to the occlusion of radioactivity 
into the inorganic sediment matter during combustion and from losses caused by 
incomplete oxidation caused by the water content in the samples.  
The recoveries of the four radio-labelled analytes attained in lyophilization of spiked 
surface water are shown in Table 3.10 which shows its’ excellent suitability for the 
analytes. However, the recovery of iopromide during lyophilization was strongly 
dependant on the vacuum applied.  
Hence, an alternative concentration procedure was established for iopromide via 
rotary evaporation. Acetonitrile was added to the aqueous samples, to form an 
azeotropic mixture with water, which allowed for an evaporation of water at more 
gentle conditions. This method achieved a recovery of 88 ± 10 % and was comparable 
with those of the lyophilization procedure. As already mentioned, the solvent extraction 
procedures attained extraction efficiencies between 94 ± 4 and 95 ± 8 %.  
Table 3.10:  Recoveries and confidence intervals (P=95 %, n=10) of various 14C-
labelled analytes for the lyophilization and the evaporation method for 
surface water 
Recovery (%) for Compound Lyophilization Evaporation 
14C-Diazepam 95 ± 2 -  
14C-Ibuprofen 90 ± 2 -  
14C-Iopromide 91 ± 9 88 ± 10 
14C-Paracetamol 87 ± 4 -  
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3.6.3 Radio - thin layer chromatography  
For radio-TLC analysis, the 14C-labelled test compound and at least one possible 
metabolite, either labelled or non-labelled, were used as standards. The TLC conditions 
were chosen according to the best separation of the respective test compound from its’ 
metabolites or similar derivatives. Silica gel TLC plates, Merck (Darmstadt, Germany) 
20 × 20 cm 60 µm, with a 254 nm fluorescence coating and a preconditioning zone were 
used for all chromatographic separations. The plates were activated for 1 h at 110°C and 
were divided into six tracks, of which two, were reserved for reference standards. 
Compositions of the mobile phases for the different analytes are shown in Table 3.11. 
The gas phase in the developing tank was equilibrated with the mobile phase prior to the 
development of the plates. Samples and standards were spotted in the pre-concentration 
zone 1 cm above the bottom of the plate. All plates were developed to a distance of at 
least 15 cm and were then dried in a fume hood.  
The positions of the bands resulting from non-labelled reference compounds were 
determined using UV light at 254 nm. Then, the TLC-plates were scanned for 10 –
 30 min with an autoradiograph (Berthold, Wildbad, Germany) at an amplifier voltage 
of 900 V, while applying a mixture of argon, methane and methylal (90:10:1.5) as purge 
gas. 
The software Chroma 3D (Berthold, Wildbad, Germany) was used to evaluate the 
data of the autoradiography. All TLC plates were analyzed by integrating measured 
values in certain plate areas as rectangular area segments. At first, all signals on a plate 
were integrated, then all signals in each of the six tracks and finally all signals in each 
of the four to six track sections. Compounds were identified according to their Rf-
values. 
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Table 3.11:  Mobile phase compositions, Rf -values and references  
Compounds Rf-value Mobile phase for TLC-separation Method source 
 
Iopromide  
  
 
 
 
DAMI 0.47 2-Methyl-propanol-1/propanol-2 
/ammonia 25 % 
Kalsch, 1999 
Iopromide 0.37 (50 : 30 : 20, v/v)  
ATH 0.32   
ATI 0.22   
 
Diazepam 
   
Diazepam 0.66 Chloroform/acetone Sarin et al., 1998 
Oxazepam 0.31 (85 : 15, v/v)  
 
Ibuprofen 
   
Ibuprofen 0.75 Chloroform/methanol/acetic acid American 
Radiolabeled 
Chemicals Inc., 
2001 
2-Hydroxy 
ibuprofen 
0.58 (85 : 15, v/v)  
 
Paracetamol 
   
4-Nitrophenol 0.54 Toluene/methanol/acetic acid American 
Radiolabeled 
Chemicals Inc., 
1994 
Paracetamol 0.36 (90 : 16 : 8, v/v)  
  
3.6.4 Calibration and quantification 
The aim of the TLC analysis was the separation of the radioactive test compounds 
from their corresponding metabolites and the quantitative determination of the sample 
composition. 
In contrast to other detection methods, such as mass spectrometry, the response of 
the autoradiographical detection is not substance specific and depends on quantity of 
radioactivity present in a certain area of a TLC plate. Hence, the same calibration could 
be applied for all analytes. The linearity and sensitivity of the detector was determined 
by measuring a non-developed TLC-plate that was spiked with 6 different quantities of 
radioactivity in triplicates. A reliable quantification was attained between 250 and 
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75,000 dpm per spot. For quantification, the background signals per unit area of each 
track were determined in the upper undeveloped part of a track. Background correction 
was then achieved by subtracting the respective background signal from the measured 
values in each segment of a track. 
3.6.5 Verification of radiochemical purity 
The radio-TLC analysis of the applied radiotracer compounds, exhibited the presence 
of significant amounts of radio-labelled impurities, despite a higher certified purity in 
the iopromide, paracetamol and 4-nitrophenol standard (Table 3.12). Therefore, a 
correction was conducted to avoid incorrect results, from contaminations in the radio-
labelled standards. For that, the percentage of contaminations in the radio-labelled 
standard was determined on each plate. The percentage of possible metabolites in the 
samples on a plate were then corrected by subtraction of the threefold percentage of 
observed contaminations with a corresponding Rf-value. 
Table 3.12:  Certified and measured radiochemical purities of radio-labelled analytes 
Compound Certified purity
(%) 
Measured purity
(%) 
Observed contaminations 
Iopromide > 98 91 1 
Diazepam 99.8 100 - 
Ibuprofen > 99 100 - 
4-Nitrophenol 99 89 2 
Paracetamol > 99 95 1 
 
3.7 Calculation of DT50 and DT90-values 
The amount of the respective test substance in percent of the initial amount is given 
in tabular form and graphically. Based on this data, dissipation times (DT50 and DT90-
values) were calculated separately for the water phase as well as for the whole test 
system (water and sediment together) using the statistical software Origin 6.0 (Microcal 
Software Inc., Northampton, MA, USA). According to the EU guidance on the 
Persistence in Soil (European Commission and Directorate General for Agriculture, 
2000) the regressions were accomplished considering at least 5 sampling times. 
Regression curves were calculated from first order kinetics depending on best fit. When 
the data did not follow a first order kinetics, a software package obtained from the BBA 
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(Biologische Bundesanstalt für Land- und Forstwirtschaft) was used. In those very few 
cases (Ibuprofen) where no fit could be achieved at all the DT-values were estimated. 
The determination coefficients r2 obtained were always > 0.95. In addition, the 
regression coefficients were calculated, indicating also the fit of the curve (again, they 
were always > 0.95). Finally, the degradation rate per day was determined.  
Considering that the duration of the tests was 100 days, numerical dissipation values 
are given only if the calculated number was not higher than one year. Instead, all values 
calculated as being between one and two years are given as “> 365 days”. All values 
calculated as being even higher are given as “>> 365 days”.     
3.8 Quality assurance  
Quality assurance plays a major role in the preparation of scientific results. The 
provision of accurate, reliable and well documented data is central to scientists involved 
in such areas as i.e. development and manufacture of drugs, testing of the environmental 
behaviour of chemicals, food control or drinking water analysis. 
All data exhibited in this work was attained following several basic criteria to ensure 
the desired quality of the results. The methods applied and developed were 
characterized considering specificity, accuracy, precision and the respective limit of 
quantification, to prove the reliability of these methods and to guarantee the quality of 
data generated therewith.  
An important part of the present work was the development of analytical methods. 
Additionally, water/sediment tests were conducted and the obtained samples were 
analyzed using the new analytical methods. The following measurements were taken to 
assure the quality of the data generated:  
 The reproducibility of analytical procedures was verified regularly by 
standard addition experiments. Further, all sample series included blanks and 
the recovery rates were checked to compare enriched and non-enriched 
standard samples. 
 All analytical results obtained were verified for their plausibility, i.e. recovery 
rates of analytes in different matrices. 
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 Analytical methods included, as far as possible, the use of internal and 
surrogate standards to compensate analyte losses throughout the sample 
preparation. 
 The stability of the reference compounds was continuously controlled by 
comparing previously used calibration series with freshly prepared ones. 
 The radiochemical purities of the 14C-labelled substances was checked. 
 Analytical scales, pH meters, redox meters and oxymeters were calibrated at 
least monthly, their function verified daily and the results reported in control 
cards.  
 After elucidation of an adequate material for SPE enrichment, the same 
material charge was used throughout the work 
 All LC separations were conducted under thermostatic control of the 
columns, to preclude temperature related shifts in chromatographic retention 
times. 
 Realization and documentation of all relevant operations in the conducted 
water/sediment and leaching tests according to the principles of good 
laboratory practice (GLP). 
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4 RESULTS AND DISCUSSION 
4.1 Water/sediment studies  
4.1.1 Principles and limitations of water/sediment tests 
Water/sediment studies are usually required for the registration of new active 
substances in pesticide formulations but they can also be applied to any chemical with a 
possible relevant occurrence in the aquatic environment. The general aim of those 
studies is the investigation of fate and persistence of a chemical under controlled 
laboratory conditions. The generated data is then utilized for conclusions on the 
environmental behaviour of a chemical and the risks linked therein. 
This approach was used to investigate pharmaceuticals which are detected in the 
aquatic environment of many countries. In fate studies, the test compounds are usually 
applied as 14C-radiotracers. That allows for a relatively easy and reliable quantification 
of all relevant processes, such as distribution to the various compartments, 
metabolization, mineralization and the formation of bound residues. Due to the lack of 
14C-labelled standards commercially available, non-labelled pharmaceuticals were also 
utilized in the test systems. The latter usually allow only for a measurement of their 
dissipation and not for a process differentiation between transformation, mineralization 
and formation of bound residues. Therefore, a complete mass balancing is usually not 
possible using non-labelled test compounds.  
Since the fate of a chemical in the water/sediment test system depends not only on its 
physico-chemical properties but also on the conditions of the test system itself (e.g. the 
pH in the water phase or the grain size distribution of the sediment used), it is essential 
to cover a broad range of different waters and sediments. However, due to practical 
limitations, it was not possible to test more than one sediment. Therefore, a sandy 
sediment with a low content of organic matter was selected in order to minimize 
sorption in the experiments. Furthermore, this represents a “worst-case” situation, since 
such sediments often contain a low microbial biomass, which also means that the 
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degradation of organic chemicals is usually low (e.g. the persistence of chemicals is 
higher than in “rich” sediments with a very active micro flora).  
The experimental set-up of the water/sediment test system allowed for a widely 
parallel development of the independent test vessels over a period of 100 d. The test set-
up was designed relatively robust, since the test vessels were shaken in batches of 24 
flasks for every test compound on an automatic shaker during the entire test period of 
100 d. Therefore, very sensitive sets, i.e. continuous gas flow through, were avoided and 
gas exchange with the environment was attained simply by diffusion through the CO2-
trap.  
A weakness of this experimental design became obvious in the tests with 
14C-ibuprofen and 14C-paracetamol, where extensive mineralization occurred and the 
balance of recovered radioactivity was partially incomplete. Especially in the tests with 
ibuprofen a wide balance gap was observed in the course of the experiment, whereas at 
the end of the test the balance was rather complete. This was most likely caused by 
losses of volatile 14CO2 during the sampling procedure. After 2 weeks the formation of 
14CO2 was fairly advanced and 14CO2 was present widely dissolved in the water. During 
the sampling procedure, 14CO2 was presumably withdrawn from the balance by 
volatilization with the gas phase of the test system after opening of the test vessels. An 
additional volatilization from the water or the sediment compartment cannot be 
excluded. These assumptions were further supported by the increasing recovery of 
radioactivity towards the end of the test, considering that losses from the test vessels did 
not occur in the course of the test. In fact, the progressive demobilization of 14CO2 in 
the trap material reduced the losses by volatilization. 
The losses might be at least partly overcome by bubbling a gentle nitrogen stream 
through the water compartment of the closed test vessels before opening for sampling, 
so that the demobilization of 14CO2 is enhanced. Another deficit of the test set-up can be 
seen in its´ static conditions, where the consumed nutrients will not be replaced. Hence, 
it cannot be excluded that a co-metabolic transformation of test compounds stops in the 
course of the experiment due to a lack of nutrients. In all other respects the test system, 
originally developed for the investigation of pesticides, is suitable for studying 
pharmaceuticals. 
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4.1.2 Behaviour of 14C-paracetamol 
In the experiments with 14C-paracetamol, the radioactivity dissipated rapidly out of 
the water and after 14 d only 13.10 ± 0.03 % of the initial radioactivity was left in the 
water compartment (Figure 4.1). On the other hand, the percentage of radioactivity in 
the sediment increased rapidly within 8 days. After that time, 57 ± 3 % of the 
paracetamol was located in the sediment. The percentage of radioactivity in the 
sediment remained then constant at approximately 60 % until the end of the experiment. 
At day 100, 19 ± 3 % of the initially applied radioactivity (IAR) was found in the CO2 
traps. It has to be noted, that the balance of radioactivity recovered was not entirely 
complete. After day 14, a loss of 20 % of the IAR was observed. This loss remained 
almost constant until the end of the experiment.  
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Figure 4.1:  Distribution of radioactivity in the water/sediment systems spiked with 
14C-paracetamol 
The composition of the radioactivity in the water phase was investigated using radio 
thin layer chromatography after concentration of the water volume by lyophilization 
(Figure 4.2). Immediately after spiking a transformation product (TP) was found in the 
water phase. The TP occurred in the course of the first two weeks with a maximum of 
4 ± 2 % and was not detected thereafter, suggesting further degradation or sorption. 
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However, it was observed that at day 7 the recovery of the radioactivity dropped by 
more than 50 % in the water phase. Later on, only negligible amounts of radioactivity 
were found in the lyophilized water samples. It can be presumed that during 
lyophilization the dissipation of volatile degradation products, most likely 14CO2, caused 
the observed losses of radioactivity. 
In the water phase paracetamol was found to be quickly eliminated with a DT50 of 
3.1 d and a DT90 of 10.4 d. To some extent it was even mineralized forming CO2. 
Figure 4.2:  Fate of 14C-paracetamol in the water compartment of the water/sediment 
system detected by radio-thin layer chromatography 
Solvent extraction of the sediments with acetone and methanol resulted only traces of 
radioactivity, while after combustion of the extracted sediment major radioactivity was 
found. Therefore, most of the initial radioactivity was reserved to compounds sorbed 
onto sediments and is classified as non-extractable (bound) residues. These bound 
residues = non-extracted residues are defined as chemical species originating from 
chemicals that cannot be extracted by methods which do not significantly change the 
chemical nature of these residues (European Commission and Directorate General for 
Agriculture, 2000). 
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This result corresponds to the findings of terrestrial studies in which the sum of the 
parent compound and its TPs were bound covalently to soil by various binding 
mechanisms or were entrapped in the soil matrix (Gevao et al., 2000, Northcott and 
Jones, 2000). Recovery experiments for the solvent extraction of 14C-paracetamol from 
non-autoclaved sediment showed that only 10 % of the radioactivity applied was 
extractable after a contact time of 14 h, whereas paracetamol was recovered 
quantitatively in experiments with autoclaved sediment. That is in good agreement with 
observations of Kreuzig, 2002, who also reported a rapid bio-transformation of 
paracetamol into non-extractable residues after an application onto bioactive soils. 
Paracetamol however, remained entirely extractable in autoclaved soils. With respect to 
the reported biodegradation of paracetamol, it is important to note that soil bacteria 
capable for the degradation of paracetamol could be isolated by Ahmed et al., 2001. 
Ready biodegradability of paracetamol in the environment was first quoted by 
Richardson and Bowron, 1985. Also Moehle et al., 1999 reported biodegradation of 
paracetamol in batch experiments with activated sludge and Ternes, 1998 found major 
elimination of paracetamol during STP passage.  
The rapid movement of paracetamol into the sediment cannot be explained by its’ 
lipophilicity, which is relatively low (log KOW = 0.49, pKa = 9.5) (Stuer-Lauridsen et al., 
2000). It is assumed that degradation products of paracetamol were attached covalently 
to the sediment matrix or were incorporated into the biomass of the sediments.  
No DT-values for paracetamol in the water/sediment system could be calculated. 
However, regarding the high amount of radioactivity bound to the sediment, DT-values 
of paracetamol or, probably, its TPs of more than 100 d are estimated. 
Summary: DT-values for paracetamol 
Water phase: 
Function and degradation rate: First order   d = 0.22 per day 
DT-values:    DT50: 3.1 d     DT90: 10.4 d  
Regression coefficient:  0.9984    Accepted (> 0.95) 
Water/sediment system:  
Kinetics and degradation rate: Not possible to determine 
DT-values:    Not possible to determine (> 100 d) 
Remark:     High amount of bound residues 
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4.1.3 Behaviour of 14C-ibuprofen 
The radioactivity of the 14C-labelled ibuprofen (mixture of R/S-diasteromers) 
dissipated rapidly from the water compartment as shown in Figure 4.3. After 100 d, less 
than 5 % of the IAR was detected in this compartment. The radioactivity was found to 
some extent in the sediment, where a flat maximum of 17 ± 1 % IAR was attained after 
14 d. It is remarkable, that the quantity of radioactivity in the CO2 traps increased very 
quickly. Total radioactivity found in the test vessels dropped to 73 ± 1 % after 14 d and 
increased to 90.2 ± 0.5 % after 100 d. 
For the correct interpretation of the results it has to be noted that, in contrast to all 
other radio-labelled pharmaceuticals applied, ibuprofen was 14C-radio-labelled in the 
carboxyl moiety. Therefore, the radio-label of the [carboxyl-14C]-ibuprofen can be 
cleaved relatively easy from the original molecule by decarboxylation, while the rest of 
the molecule remains unchanged. In this respect, it is important to mention that the 
ibuprofen metabolites known from humans are still containing the carboxyl group 
(Buser et al., 1999, Stumpf et al., 1998, Winkler et al., 2001, Zwiener et al., 2002).  
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Figure 4.3:  Distribution of radioactivity in the water/sediment systems spiked with 
14C-ibuprofen 
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Ibuprofen dissipation in the water phase was minor until day 8 (Figure 4.4). 
Afterwards, a total loss of radioactivity was observed similar to the observations for 
paracetamol. It can be assumed that these losses were caused by the presence of volatile 
radio-labelled degradation products dissolved in the water, such as 14CO2. The rapid 
transformation of ibuprofen is exhibited by a total of 56.61 ± 0.04 % IAR after 14 d and 
more than 70 % after 100 d present as 14CO2 and/or other volatile TPs. After day 8 only 
volatile TPs of ibuprofen were detected in the water (Figure 4.5). Due to their limited 
percentage of radioactivity, sediment samples were not further analyzed. 
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Figure 4.4:  Fate of 14C-ibuprofen in the water phase of the water/sediment system 
In recovery experiments of the solvent extraction, only 25 % of the radioactivity 
applied from 14C-ibuprofen was extractable from non-autoclaved sediment after a 
contact time of 14 h. To the contrary, ibuprofen was recovered quantitatively, when 
using autoclaved sediment. Hence, it can be presumed that 14C-ibuprofen was 
susceptible to rapid bio-transformation in the sediment.  
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Figure 4.5:  Calculated percentage of volatile TPs and measured 14CO2 in the test 
with ibuprofen detected by radio-thin layer chromatography 
Ibuprofen showed a low affinity for sorption onto sediment despite a log KOW of 3.5 
for the non-dissociated acid. Given its’ pKa-value of 4.9 (Jones et al., 2002), the 
sorption should be strongly influenced by the pH of the sediment. Under the conditions 
present in the sediment (pH 7.5), ibuprofen was widely dissociated and displayed 
therefore a very low lipophilicity (shown in Figure 4.6). 
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Figure 4.6:  Dissociation equilibrium of ibuprofen 
Richardson and Bowron, 1985 reported an inherent biodegradability of ibuprofen. 
Later, Stumpf et al., 1998 isolated the human ibuprofen metabolites 2-hydroxy-
ibuprofen and carboxy-ibuprofen and found their occurrence in municipal STP effluents 
and surface waters. Ibuprofen is degraded to a major extent (> 75 %) during sewage 
treatment, as recently shown (Stumpf et al., 1999, Ternes, 1998). Furthermore, Winkler 
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et al., 2001 investigated the biodegradation of ibuprofen in surface water biofilm 
systems and found DT50-values between 1 and 6 d, depending on the river water applied 
(Winkler et al., 2001). They and other authors reported the rapid degradation of 
ibuprofen and the formation of 2 and 3 TPs. These TPs corresponded to approximately 
10 % of the initial ibuprofen quantity, varying with the conditions in STP- and surface 
water experiments (Buser et al., 1999, Zwiener et al., 2002). Hence, for the majority of 
ibuprofen degraded, the TPs and the transformation pathway is still unknown.  
Ibuprofen TPs could not be detected in the aerobic water compartments, presumably 
due to the rapid degradation process. After a lag period of eight days, complete 
mineralization towards volatile TPs occurred within the next six days. Therefore, in 
agreement with other authors (Buser et al., 1999, Winkler et al., 2001, Zwiener et al., 
2002), ibuprofen was completely degradable in the water compartment under the 
present conditions, resulting in a DT50-value of 10 d and a DT90 of 13 d. Since the data 
did not follow a certain kinetic function, these values were estimated using the graphical 
representation of the raw data. 
 
Summary: DT-values for ibuprofen 
Water phase: 
Function and degradation rate: Not possible to determine  
DT-values:    DT50: 10 d     DT90: 13 d  
Regression coefficient:  Not possible to determine  
Remark:    DT-values estimated based on raw data 
Water/sediment system: 
Kinetics and degradation rate: Not possible to determine 
DT-values:    Not possible to determine (< 20 d) 
Remark:     Complete degradation in the water phase 
  
4.1.4 Behaviour of 2-hydroxy-ibuprofen and comparison with 
ibuprofen 
The ibuprofen metabolite 2-hydroxy-ibuprofen dissipated rapidly out of the water 
compartment under oxic conditions, but was never found in the sediment (Figure 4.7). 
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After 28 d, its´ concentration was below the limit of quantification. A re-formation of 
the parent compound can be excluded, since ibuprofen was never detected.  
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Figure 4.7:  Behaviour of 2-hydroxy-ibuprofen in the water/sediment systems  
The occurrence of 2-hydroxy-ibuprofen and other ibuprofen metabolites in human 
urine, wastewater and other environmental waters has already been reported (Buser et 
al., 1999, Stumpf et al., 1998). In laboratory tests (Winkler et al., 2001, Zwiener et al., 
2002), 2-hydroxy-ibuprofen was mainly formed under aerobic conditions.  
2-Hydroxy-ibuprofen was not found in the sediment, an it can be assumed that it was 
rapidly (bio)transformed in the sediment. The DT50 of 6.7 d and DT90 of 22 d of 2-
hydroxy-ibuprofen are low and in agreement with reports on its degradability (Winkler 
et al., 2001). Again, no different values for the water/sediment system have to be 
considered. Due to the additional hydroxy moiety 2-hydroxy-ibuprofen possesses a 
higher polarity than ibuprofen, resulting in a reduced affinity towards the sediment.  
A comparison of the degradability of ibuprofen and its’ metabolite 2-hydroxy-
ibuprofen shows a similar behaviour for both compounds. After a lag phase of about 6 
days both compounds are rapidly degraded (Figure 4.8). While ibuprofen was totally 
degraded until day 14, the metabolite 2-hydroxy-ibuprofen was still present in the water 
phase on a low level.  
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Figure 4.8:  Comparison of the behaviour of ibuprofen and 2-hydroxy-ibuprofen 
 Summary: DT-values for 2-hydroxy-ibuprofen 
Water phase: 
Function and degradation rate: First order    d = 0.10 per day 
DT-values:    DT50: 6.7 d     DT90: 22 d  
Regression coefficient:  0.9682    Accepted (> 0.95)  
Water/sediment system: 
Kinetics and degradation rate: Not possible to determine 
DT-values:    Not possible to determine (< 30 d) 
Remark:     Almost complete degradation in the water phase 
 
4.1.5 Behaviour of clofibric acid 
The concentration of clofibric acid in the water decreased steadily until the end of the 
experiment (Figure 4.9). By that time, 49 ± 2 % of the initial concentration was still 
present in the water compartment. The sediment compartment never contained more 
than 12 ± 1 % of the initial quantity. This is equivalent to the ratio of pore water and 
total water in the system. A total of 55 ± 3 % clofibric acid was found in the entire 
water/sediment system at the end of the experiment.  
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Figure 4.9:  Behaviour of clofibric acid in the water/sediment systems 
Clofibric acid displayed a low affinity for the sediment. At pH 7.7 in the sediment, 
clofibric acid was widely dissociated (calculated low pKa-value of 2.84), and was thus, 
sorbed onto the sediment only to a negligible extent (Schwarzenbach et al., 2003). This 
corresponds with the distinct attenuation of clofibric acid in soil leaching experiments 
with a very acidic soil with pH of 2.9, while only little retardation was observed using a 
soil with a more common pH of 5.8 (see chapter 4.3.3). These results also are in 
consistence with other authors (Heberer, 2002a, Lenhard, 2000, Scheytt et al., 1998, 
Scheytt et al., 2001), who reported an almost tracer-like movement of clofibric acid in 
soil columns and during river bank filtration.  
Clofibric acid was considerably stable in the water/sediment system and disappeared 
slowly. Based on the time-concentration curves DT50 values of 82 d and 119 d and DT90 
values of 274 d and >365 d were calculated for clofibric acid in the water compartment 
and the entire water/sediment system, respectively.  
That is principally in good agreement with findings of other authors. In batch 
experiments with fresh field soil Lenhard, 2000 observed no biodegradation of clofibric 
acid. In wastewater treatment only little or no elimination of clofibric acid was observed 
(Heberer et al., 2002, Stumpf et al., 1999, Ternes, 1998). Consequently, clofibric acid is 
introduced to a high portion into surface waters. It is present ubiquitously in the aquatic 
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environment and was found at concentrations of 1 ng⋅L-1 North Sea (Buser et al., 1998, 
Weigel et al., 2002). 
Summary: DT-values for clofibric acid 
Water phase: 
Function and degradation rate: First order    d = 0.0084 per day 
DT-values:    DT50: 82 d     DT90: 274 d  
Regression coefficient:  0.9912    Accepted (> 0.95)  
Water/sediment system: 
Kinetics and degradation rate: First order    d = 0.0058 per day 
DT-values:    DT50: 119 d     DT90: > 365 d  
Regression coefficient:  0.9992    Accepted (> 0.95)  
 
4.1.6 Behaviour of 14C-diazepam 
After the application of 14C-diazepam, the substance was constantly transferred into 
the sediment (Figure 4.10). Even after 100 d an equilibrium between water and 
sediment seemed not to be totally attained. The time-concentration curve of the 
radioactivity in the sediment showed a rapid increase within the first 14 d. By then more 
than 30 % of the initial radioactivity were localized in the sediment. After that, the 
percentage of radioactivity in the sediment levelled off and at the end of the experiment, 
60 ± 6 % of the initial radioactivity was still found in the sediment. Mineralization was 
only observed to a minor extent. At the end of the experiment the CO2-traps contained 
only 1.49 ± 0.04 % of the initial radioactivity. A balance of radioactivity, at that time, 
showed that more than 90 % of the initial radioactivity could be recovered in the test 
systems.  
The TLC analysis of water samples exhibited that almost the entire radioactivity in 
this compartment was still present as diazepam, 95 ± 7 % at day 100. In the course of 
the experiment, at least two TPs occurred at very low levels (see Figure 4.11). TP 1 
appeared only at day 14 and the second TP was initially observed after day 7 for the 
first time. In the TLC analysis, TP 1 remained entirely at the spot of TLC-application, 
whereas TP 2 showed a slightly higher mobility but had a diffuse signal without a sharp 
defined Rf-value. The sum of both TPs never exceeded 5 %. Radio-TLC analysis of the 
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extracts, suggested that the entire radioactivity in sediment samples was extractable and 
could be uniformly identified as diazepam. 
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Figure 4.10:  Distribution of radioactivity in the water/sediment systems spiked with 
14C-diazepam 
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Figure 4.11:  Fate of 14C-diazepam in the water phase of the water/sediment system 
Under the pH conditions in sediment and water, the weak base diazepam (pKa = 3.4) 
(Hilal et al., 1996) should have been present in its’ neutral, non-protonated form.  
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Hence, the rapid sorption of diazepam onto the sediment can be expected to be 
caused mainly by non ionic interactions with the sediment (log POW = 2.85) (Stuer-
Lauridsen et al., 2000).  
A strong sorption of diazepam onto soil particles was also observed in the soil 
column leaching experiments (see chapter 4.3.4). In these experiments, the entire 
radioactivity initially applied as 14C-diazepam, remained in the uppermost soil layers.  
An elimination of diazepam, respectively the formation of TPs, occurred only to a 
minor extent in the water/sediment system (Figure 4.12). 
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 Figure 4.12:  Formation of CO2 by mineralization of 14C-diazepam 
More than 87 % of the initial diazepam quantity was recovered at the end of the 
experiment. In the water compartment, a DT50-value of 34 d and a DT90-value of 113 d 
were calculated. Corresponding dissipation times in the water/sediment system were 
calculated to be even higher (DT50-value > 365 d, DT90-value >> 365 d). The 
tranquilizer diazepam is applied in medicine in relatively low quantities (Table 1.1). 
Hence, reports on its occurrence in various aqueous compartments, such as STP 
effluents and rivers (Ternes et al., 2001, Zuccato et al., 2000) indicate a distinct 
environmental stability.  
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Summary: DT-values for diazepam 
Water phase: 
Function and degradation rate: First order    d = 0.020 per day 
DT-values:    DT50: 34 d     DT90: 113 d  
Regression coefficient:  0.9841    Accepted (> 0.95)  
Water/sediment system: 
Kinetics and degradation rate: First order    d = 0.0016 per day 
DT-values:    DT50: > 365 d    DT90: >> 365 d  
Regression coefficient:  0.9991    Accepted (> 0.95)  
 
4.1.7 Behaviour of oxazepam and comparison with diazepam 
Additionally, oxazepam, the main metabolite of diazepam in humans, was tested 
with a non-labelled compound in the water/sediment system. The oxazepam 
concentration in the water compartment decreased relatively fast within the first month 
and ranged at a level of 14.7 ± 0.4 % of its’ initial concentration at the end of the 
experiments (Figure 4.13). Oxazepam moved distinctly into the sediment compartment, 
where 27 ± 4 % were localized after two weeks. After that, the oxazepam content of the 
sediment remained almost constant until the end of the experiment. Finally, 33 ± 1 % of 
the initial oxazepam quantity was recovered in the test systems.  
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Figure 4.13:  Behaviour of oxazepam in the water/sediment system 
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The partitioning behaviour of oxazepam was presumably influenced mainly by its’ 
lipophilicity, given that oxazepam was present non-protonated in the water/sediment 
system (log KOW = 2.24, pKa = 1.7) (Hansch et al., 1990, Hilal et al., 1996). For the 
water compartment, a DT50 of 19 d and a DT90 of 63 d was calculated. Dissipation times 
for the entire water/sediment system, considering oxazepam also sorbed reversible onto 
the sediment, were significantly higher with a DT50 of 54 d and a DT90 of 179 d 
(assuming a second order function, the fit of the regression curve was as good as for a 
first order one, but in that case both DT90 values in the water sediment system would be 
as twice as high). The data indicates a delayed primary degradation of oxazepam in the 
water/sediment systems (Beek, 2001). However, the data available for this non-labelled 
test substance does not allow for a differentiation of transformation, mineralization and 
the formation of non-extractable or bound residues as cause for the dissipation. 
Up till now, few findings of oxazepam have been reported in sewage effluent (250 
ng⋅L-1) and river water (70 ng⋅L-1) (Heberer, 2002b, Heberer et al., 2002), indicating a 
distinct stability in the environment.  
 
Summary: DT-values for oxazepam 
Water phase: 
Function and degradation rate: First order    d = 0.036 per day 
DT-values:    DT50: 19 d     DT90: 63 d  
Regression coefficient:  0.9936    Accepted (> 0.95)  
Remark:  Assuming a second order function, the DT50 would 
remain the same but the DT90 would be doubled. 
Water/sediment system: 
Kinetics and degradation rate: First order    d = 0.013 per day 
DT-values:    DT50: 54 d     DT90: 179 d  
Regression coefficient:  0.9981    Accepted (> 0.95)  
Remark:  Assuming a second order function, the DT50 would 
remain the same but the DT90 would be doubled. 
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The elimination rates of the diazepam and oxazepam were very similar until day 8 
(see Figure 4.14). Afterwards, the quantity of oxazepam recovered decreased strongly, 
whereas that of diazepam remained more or less constant. 
In humans, diazepam is rapidly demethylated and then metabolized into oxazepam, 
which is then excreted directly or in the conjugated form (Mutschler, 1997). Under the 
conditions of the test system, diazepam was not transferred into oxazepam or into any 
other TP with appreciable quantities. That result underlines the low comparability of 
human and environmental transformation processes. Nevertheless, oxazepam, as 
frequently found for phase I metabolites, shows a higher polarity and was more 
amendable to conversion processes than the parent compound diazepam. Hence, 
diazepam exhibited a higher persistence than oxazepam in the environmental test 
system. 
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Figure 4.14:  Comparison of the behaviour of diazepam and oxazepam in a 
water/sediment system 
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4.1.8 Behaviour of carbamazepine 
 The antiepileptic drug carbamazepine moved from the water phase into the sediment 
until a steady state level was achieved at about day 58 (Figure 4.15). Carbamazepine 
displayed a high persistence in the system. An initial slow decrease occurred up until 
day 57 and a total of 83 ± 6 % of the initial carbamazepine quantity was still present in 
the system by the end of the experiment.  
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Figure 4.15:  Behaviour of carbamazepine in the water/sediment system 
Based on its’ moderate lipophilicity (log POW= 2.25) (Jones et al., 2002), and its 
presence in a non-charged form under environmental conditions sorption could be 
expected (estimated pKa-values of 13.9 for the deprotonation (Jones et al., 2002) and 
< 1 for the protonation of the amino groups). The respective sediment study, the 
behaviour in soil columns (see chapter 4.3.1) and its´ behaviour in contact with 
activated carbon (Ternes et al., 2002b) seems to support that assumption. On the other 
hand, the negligible removal during bank filtration (Sacher et al., 1998), wastewater 
irrigation (Ternes, 2003), wastewater treatment (Ternes, 1998, Ternes, 2000) or soil 
passage (Drewes et al., 2002, Lenhard, 2000) were contradictory. The respective 
sorption mechanisms are still unclear. 
Ternes, 2000 found a similar course of the time/concentration curve for 
carbamazepine in the water phase of water/soil shake flask experiments with field fresh 
soil. In contrast to the results presented herein, he reported the total elimination of 
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carbamazepine from the water phase after a lag period of 30 d. Hence, it cannot be 
excluded that the virtually constant concentration of carbamazepine in the 
water/sediment systems might have significantly decreased after an adaptation time of 
yet unknown length. The DT50 and the DT90 for carbamazepine in the water 
compartment were calculated as 52 d and 173 d, whereas the respective DT-values for 
the entire water/sediment system were calculated as 333 d and >> 365 d.  
However the high stability of carbamazepine in the water sediment system is 
consistent with reports of Moehle et al., 1999 who found no primary degradation of 
carbamazepine in batch experiments with activated sludge. Carbamazepine also was 
widely resistant towards aerobic or anaerobic biodegradation in batch experiments with 
surface water and groundwater (Ternes et al., 2002b). Thus, it is ubiquitously present in 
environmental waters (Ternes, 1998) and was even detected in the marine ecosystem 
(Weigel et al., 2001). 
 
Summary: DT-values for carbamazepine 
Water phase: 
Function and degradation rate: First order    d = 0.013 per day 
DT-values:    DT50: 52 d     DT90: 173 d  
Regression coefficient:  0.9936    Accepted (> 0.95)  
Water/sediment system: 
Kinetics and degradation rate: First order    d = 0.0021 per day 
DT-values:    DT50: 333 d     DT90: >>365 d  
Regression coefficient:  0.9994    Accepted (> 0.95)  
 
4.1.9 Behaviour of 10,11-dihydro-10,11-dihydroxy-carbamazepine 
and comparison with carbamazepine 
The carbamazepine metabolite 10,11-dihydro-10,11-dihydroxy-carbamazepine 
dissipated rapidly out of the water compartment in the first 28 d (Figure 4.16). Then, the 
concentration of the test compound remained constant within the statistical error at 
36 ± 1 %. The test compound was found only to a minor extent in the sediment, where 
at no time more than 6 ± 1 % of the initial quantity could be detected.  
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Figure 4.16:  Behaviour of 10,11-dihydro-10,11-dihydroxy-carbamazepine in the 
water/sediment system 
Compared to the parent compound carbamazepine, the twofold hydroxylated and 
thus, more polar metabolite 10,11-dihydro-10,11-dihydroxy-carbamazepine, exhibited a 
significantly reduced affinity for the sediment. The apparent low level of the test 
compound in the sediment was checked and confirmed in additional experiments. 
Calculated DT50-values of 21 and 34 d for the metabolite in the water compartment and 
the water/sediment system, respectively, were lower than for carbamazepine. DT90-
values could not be calculated but they are larger than 365 d. Oxidation and cleavage of 
the dihydroxy moiety might play a role in the further degradation of 10,11-dihydro-
10,11-dihydroxy-carbamazepine. Those reactions have been elucidated in the 
biodegradation pathway of various aromatic compounds in the environment and involve 
frequently bacteria and fungi with a broad substrate specificity (Beek, 2001, Díaz et al., 
2001, Pointing, 2001, Reardon et al., 2000).  
After 28 days, the total quantities of 10,11-dihydro-10,11-dihydroxy-carbamazepine 
detected remained more or less constant on a level of about 38% of the initial 
concentration until the end of the test. In natural waters and soils, threshold 
concentrations for the degradation of contaminants have been reported before (Klimek 
et al., 2001, Kovar et al., 2002). However, in the case of the described experiments it 
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cannot be excluded that the static conditions might have lead to a major consumption of 
essential nutrients and therefore, to a stop of the assumed co-metabolic degradation.  
Despite the low DT50-value of 10,11-dihydro-10,11-dihydroxy-carbamazepine, its’ 
stability in the water compartment was relatively high. At a spiking level of 100 ng⋅g-1 
of sediment, more than 30 % of the test compound remained non-degraded in the test 
system at the end of the test. This is supported by Miao and Metcalfe, 2003 who stated a 
low degradability of 10,11-dihydro-10,11-dihydroxy-carbamazepine in sewage 
treatment. 
 
Summary: DT-values for 10,11-dihydro-10,11-dihydroxy-carbamazepine  
Water phase: 
Function and degradation rate: Root second order    
DT-values:    DT50: 21 d    DT90: > 365 d  
Regression coefficient:  0.9111    Best fit available 
Water/sediment system: 
Function and degradation rate: Root second order    
DT-values:    DT50: 34 d     DT90: > 365 d  
Regression coefficient:  0.8897    Best fit available 
Remark:    High portion remained non-degraded in sediment.  
 
4.1.10 Behaviour of ivermectin 
The parasiticide ivermectin moved rapidly from the water compartment into the 
sediment. After the course of 2 weeks, only 13 ± 6 % of the initial ivermectin 
concentration was left in the water compartment (Figure 4.17). A maximum 
concentration of ivermectin in the sediment was attained with 42 ± 2 % at day 7. 
Afterwards the percentage of ivermectin in the sediment decreased slowly to 16 ± 3 % 
by the end of the test. The total quantity of ivermectin found in the test system showed a 
sharp drop after the first 2 weeks and decreased much slower afterwards. The kinetics in 
both the water phase as well as in the entire water/sediment system followed a root first 
order function.   
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Figure 4.17:  Behaviour of ivermectin in the water/sediment systems 
The rapid and extensive sorption of ivermectin onto the sediment should have been 
mainly attributable to its’ lipophilicity (log POW = 3.22; Edwards et al., 2001, KOC = 
12,600-15,700; Halley et al., 1989a). Furthermore, additional specific interactions with 
soil such as a formation of adducts with cations in the sediment are likely (Ali et al., 
2000, Cerny et al., 1994, Tolls, 2001).  
An appreciable sorption of ivermectin onto sediment was also observed by Cannavan 
et al., 2000, who recovered a large portion of the ivermectin quantity applied as a feed 
additive for a marine fish farm in the top layers of the underlying sediment body.  
Mainly as a result of the rapid sorption of ivermectin, its’ DT50/90-values in the water 
phase were very low, with 2.9 d and 32 d respectively. Ivermectin disappeared within 
13 d by 50 % from the water/sediment system and the DT90 was estimated to be 144 d.  
In contrast, the persistence of ivermectin, reported by Davies and Rodger, 2000 from 
experiments with marine sediments with DT50 ≥ 100 d, was significantly higher. Strong 
differences in the DT50 of ivermectin under varying test conditions were also reported 
by Halley et al., 1989a, who found ivermectin half lives in soil of ≥ 93 d under 
laboratory conditions, whereas half lives under field conditions were about 1-2 weeks. 
Hence, the specific test conditions, such as temperature, are of high importance for the 
transformation kinetic.  
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Since the test was conducted with non-labelled ivermectin, possibly occurring TPs, 
the formation of non-extractable residues and mineralization products could not be 
quantified. In literature, an extensive metabolization of ivermectin and the formation of 
bound residues in soil were reported by Halley et al., 1989a. For abamectin, a closely 
related avermectin derivative the transformation in soil was studied in more detail by 
Bull et al., 1984. Using 3H- and 14C-labelled abamectin, he found the formation of at 
least 13 radioactive degradation products under aerobic conditions. Additional 
mineralization occurred at a level of less than 4 % of the IAR. The major soil 
degradation products were an 8α-hydroxyl-derivative and the corresponding opened 
ring aldehyde derivative of abamectin. In contrast to that, during a 3-month test period 
under anaerobic conditions, he found neither an apparent degradation of abamectin nor 
a formation of non-extractable residues. Hence, the formation of ivermectin TPs under 
the aerobic conditions in the water/sediment system is likely.  
 
Summary: DT-values for ivermectin  
Water phase: 
Function and degradation rate: Root first order    
DT-values:    DT50: 2.9 d    DT90: 10 d  
Regression coefficient:  0.9300    Best fit available 
Water/sediment system: 
Function and degradation rate: Root first order    
DT-values:    DT50: 13 d     DT90: > 144 d  
Regression coefficient:  0.9502    Accepted (> 0.95) 
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4.2 Determination of Kd-values 
The measured concentration levels in water and sediments were used for a 
calculation of KOC- and Kd-values, determining the distribution pattern between water 
and sediment phase. For each of the 6 compounds with a complete data set for water 
and sediment, the maximum values are given in Table 4.13. These maximum values 
were usually determined after 30 d or later and should therefore be close to distribution 
equilibrium.  
Additionally, KOC-values were predicted using the correlation between the 
octanol/water distribution coefficient KOW and the sorption coefficient KOC. For that 3 
semi-empirical methods were applied following the approaches used by Stuer-
Lauridsen et al., 2000 Kd = 0.41 × KOW, Karickhoff, 1981 log KOC = 0.989 × log KOW - 
0.346 and Gerstl, 1990 log KOC = 0.679 log KOW + 0.663. Since clofibric acid was 
dissociated in the sediment the DOW was used in the calculation instead of the KOW.  
The KOCvalues of the polar compounds clofibric acid and CBZ-Diol were relatively 
low < 30 L⋅kg-1 and for carbamazepine, oxazepam and diazepam KOCvalues obtained 
were between 83 and 192 L⋅kg-1 (Table 4.13). Ivermectin with the highest KOW 
exhibited the highest KOC with 1172 L⋅kg-1. All three model approaches attained a high 
conformity for the 6 compounds, within a factor of 3 which is comparable to typical 
deviations in KOC reported for a given compound on differing sediments (Delle Site, 
2001). Additionally, the experimental KOC-values for clofibric acid and diazepam were 
very similar to KOC-values measured in sewage sludge (Ternes et al., submitted) and for 
diazepam in soils (Kreuzig et al., 2003). However, the wide variation in the KOC of 
carbamazepine are presumably caused by the yet not understood sorption mechanisms. 
Albeit the KOC determined for ivermectin was relatively high, it has to be noted that 
Halley et al. reported KOC-values for ivermectin in soils (Halley et al., 1989a) which 
were even an order of magnitude higher than those from the water sediment study. 
These deviations in the distribution coefficients might result from variations in the 
74  RESULTS AND DISCUSSION  
matrix composition and its impact on sorption processes. Although the main purpose of 
experiments was not the determination of the distribution coefficients of the 
pharmaceuticals investigated, it must be noted that the KOC-values obtained were in 
good agreement with estimated and experimental data previously reported.  
Table 4.13:  Experimental and predicted KOC- and Kd-values for the sorption onto 
sediment 
L⋅kg-1 
Experimental 
 
KOC     Kd 
Estimated
(Lit. a)  
KOC     Kd
Estimated
(Lit. b)  
KOC     Kd
Estimated
(Lit. c) 
KOC     Kd
Experimental 
(Lit. d,e,f) 
KOC     Kd 
Clofibric acid 26 0.3 0 0 0 0 0.2 0 14d 0.1d 
Diazepam 192 3.0 290 4.6 297 4.7 396 6.2 62
d 
500e 
1.0d 
4-7e 
Oxazepam 152 2.2 71 1.0 74 1.1 153 2.2 - 
Carbamazepine 83 1.3 73 1.2 76 1.2 155 2.5 3.5d 0.1d 
CBZ-DIOL 29 0.3 - - - - 
Ivermectin 1172 11.7 680 67 690 68 707 69 15700    227   
 
a Stuer-Lauridsen et al., 2000; b Karickhoff, 1981; c Gerstl, 1990; d in sewage sludge 
(Ternes et al., submitted); e in soil (Kreuzig et al., 2003); e in soil Halley et al., 1989a 
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4.3  Soil-leaching-Study  
4.3.1 Principles and limitations of soil leaching studies 
Soil leaching studies are usually required as part of the registration of new active 
substances in pesticide formulations. As already mentioned (see Chapter 4.1.1), the 
results of such studies are utilized for environmental risk assessment (ERA) purposes.  
This approach was used to investigate pharmaceuticals which might pose a risk for 
groundwater contamination. This particular test was chosen, since for more realistic 
scenarios, e.g. covering the possible infiltration of these pharmaceuticals from river 
water through sediment and subsoil into the groundwater, no adequate methods are 
available. In fate studies, the test compounds are usually applied as 14C-radiotracers in 
order to facilitate their quantification. Due to the lack of 14C-labelled standards 
commercially available, for some test substances non-labelled pharmaceuticals were 
also utilized in the test systems. In that case it is often more difficult to study the 
distribution of the test substance in the soil column and to measure the drugs in the 
leachate, due to analytical reasons.  
Since the fate of a chemical in the soil leaching test system depends on its physico-
chemical properties as well as on the soil properties used, it is essential to cover a broad 
range of different soils (the OECD guideline requires at least three soils). However, due 
to practical limitations, only two different soils, LUFA 2.2 and Euro Soil 5 were used in 
the studies with non-labelled compounds. In the studies using 14C-iopromide and 14C-
diazepam a third soil was tested additionally (Neuenkirchen). These soils were selected 
in order to cover a broad range of soil properties:  
- Euro Soil 5 (a soil of a German pine forest) is an acidic sandy soil with a high 
content of organic matter, representing forest sites of Northern Germany; 
- LUFA 2.2 is a standard sandy loam soil with a medium pH value and a medium 
content of organic matter, being common at many German crop sites;  
- Neuenkirchen is also a common agricultural soil but with a low content of organic 
matter, also being used by the colleagues at the University of Braunschweig (Kreuzig 
2002). 
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Due to the limitations of the experimental set-up the soil leaching studies presented 
in this report should be regarded as a screening approach. Neither the usage of disturbed 
soil nor the size of the soil columns nor the duration of the test is directly relevant for 
field situations. As a result of this simplified laboratory approach the observed 
variability of the results between the two columns (= replicates) per treatment were 
usually very low. Therefore, the test system, originally developed for the investigation 
of pesticides, can be considered as suitable as a first approach to study the leaching 
potential of pharmaceuticals. 
4.3.2 Carbamazepine  
In all tests using non-labelled carbamazepine the leachate volumes were in the 
required range of 92–104 % recovery of the applied artificial rain (OECD, 2003a). 
Carbamazepine was retained in both soil substrates (Table 4.14). It was not detected in 
the leachates of LUFA soil 2.2 and Euro-Soil 5 and can therefore be classified as non-
mobile. 
Table 4.14:  Leaching of carbamazepine (CAR) in LUFA 2.2 and EuroSoil 5. The 
recovery in the leachate is given in % of the spiked test substance for 
each soil column (A and B) 
 LUFA 2.2 EuroSoil 5 
 CAR_A CAR_B CAR_A CAR_B 
Volume leachate [Ml] 368.8 390.6 361.2 366.1 
Concentration 
[ng/leachate] n.d. n.d. n.d. n.d. 
Recovery in leachate [%] < 1 % < 1 % < 1 % < 1 % 
n.d. = not detectable 
 
The mobility of carbamazepine (log KOW=3.5; Jones et al., 2002) did not differ in 
the two soils investigated. Obviously, the retention of carbamazepine was not 
decisively affected by the distinctly differing properties of both soils (in particular 
Corg and pH). The latter should be due to the fact that carbamazepine was always 
present in its neutral form, given pKa values of 13.9 Jones et al., 2002 for the 
deprotonation and approximately < 1 for the protonation. However, carbamazepine 
was frequently detected in groundwater (Heberer, 2002a, Sacher et al., 2001, Ternes, 
2001a, Ternes, 2000). This might be explained by the fact that groundwater 
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contamination occurs mainly over river sediments and subsoil from receiving waters 
(Mersmann et al., 2002). Drewes et al., 2002 observed no attenuation of 
carbamazepine in subsoil during bank filtration. Therefore, it might be assumed that 
the water volume applied was too low for a comparable leaching of carbamazepine. It 
is also conceivable that the usage of topsoil instead of subsoil resulted in effects as 
increasing sorption and/or biodegradation, although the latter is less likely. In order to 
elucidate these assumptions, it would be helpful to repeat the experiments with radio-
labelled carbamazepine, which was not available in the study performed, including a 
chemical analysis of the radioactivity in soils and leachates. Since topsoil and subsoil 
may differ significantly in Corg, bacterial community, and further properties, the 
results from the current leaching tests performed with top soil have only a limited 
transferability for subsoil or aquifer scenarios. 
4.3.3 Clofibric acid 
The leachate volumes from three of four soil columns used in the tests with non-
labelled clofibric acid were in the required range of 92–104 % recovery of the applied 
artificial rain (OECD, 2003a). The leachate volume from one LUFA 2.2 column 
(CLO_A) was slightly above this range (106.2%). This deviation from the required 
quality criteria should have no influence on the overall assessment of the leaching 
potential of clofibric acid. 60.5 % of the clofibric acid applied to the test substrate was 
detected in the LUFA 2.2 leachate (mean of the two columns), while only 3.5 % (mean 
of the two columns) was detected in the leachate of EuroSoil 5 (Table 4.15). Based on 
these results clofibric acid could be assumed as highly mobile in the LUFA 2.2 and as 
only slightly mobile in EuroSoil 5. 
Table 4.15:  Leaching of clofibric acid (CLO) in LUFA 2.2 and EuroSoil 5. The 
recovery in the leachate is given in % of the spiked test substance for 
each soil column (A and B) 
 LUFA 2.2 EuroSoil 5 
 CLO_A CLO_B CLO_A CLO_B 
Volume leachate [mL] 417.2 387.8 369.0 372.8 
Concentration 
[ng/leachate] 
34080 34460 1877 2651 
Recovery in leachate [%] 69 52 3 4 
 
78  RESULTS AND DISCUSSION  
The sorption behaviour and thus, the mobility of organic acids (e.g. salicylic acid) in 
soils is strongly pH dependent (Dubus et al., 2001). Organic acids are widely present in 
their neutral, undissociated form at pH conditions below their pKa-value 
(Schwarzenbach et al., 2003). This results in a distinctly higher lipophilicity and usually 
in a higher tendency to sorb onto organic soil matter for the undissociated acids 
compared with their more polar dissociated form.  
It can be assumed that the relatively low pH of 2.9 in the EuroSoil 5 led to an 
appreciable higher retention of clofibric acid (estimated pKa of 2.84, log POW = 2.57 
Hansch et al., 1990), compared to the LUFA 2.2 soil, due to enhanced sorption of the 
undissociated acid onto soil particles. In LUFA 2.2 soil with a more common pH of 5.8 
a significantly higher mobility of clofibric acid was observed. This is in good agreement 
with findings of Scheytt et al., 2001 and Heberer, 2002a, who reported an almost tracer-
like movement of clofibric acid in soil columns and during riverbank filtration.  
Although a transformation of clofibric acid in the leaching experiment cannot 
entirely be excluded, it is very unlikely since clofibric acid remained widely persistent 
in the water/sediment test and during wastewater treatment, riverbank filtration and 
under other environmental conditions as reported by various authors (Heberer et al., 
2002, Stumpf et al., 1999, Weigel et al., 2002, Winkler et al., 2001). It can be concluded 
that groundwater contamination due to the infiltration of clofibric acid through topsoil is 
likely. 
4.3.4 Diazepam 
Non-labelled 
In all experiments using non-labelled diazepam the leachate volumes were in the 
required range of 92–104 % recovery of the applied artificial rain (OECD, 2003a). The 
non-labelled diazepam was retained in both soil substrates (Table 4.16). It was not 
detected in the leachates of LUFA soil 2.2 and Euro-Soil 5 and can therefore be 
classified as non-mobile. 
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Table 4.16:  Leaching of non-labelled diazepam (DIA) in LUFA 2.2 and EuroSoil 5. 
The recovery in the leachate is given in % of the spiked test substance for 
each soil column (A and B) 
 LUFA 2.2 EuroSoil 5 
 DIA_A DIA_B DIA_A DIA_B 
Volume leachate [mL] 385.0 382.6 381.7 391.8 
Concentration 
[ng/leachate] n.d. n.d. n.d. n.d. 
Recovery in leachate [%] << 1 % << 1 % << 1 % << 1 % 
n.d. = not detectable 
14C-Diazepam 
In the tests using 14C-diazepam the leachate volumes from the LUFA 2.2 and 
EuroSoil 5 columns were in the required range of 92–104 % recovery of the applied 
artificial rain (OECD, 2003a). The leachate volumes from the Neuenkirchen soil 
columns were slightly above this range (108 %). This deviation from the required 
quality criteria should have no influence on the comparability of the tests and the 
overall assessment of the leaching potential of 14C-diazepam. Comparable to the studies 
using non-labelled diazepam no radioactivity was detected in the leachates of the three 
tested soils (EuroSoil 5, LUFA 2.2, Neuenkirchen). In EuroSoil 5 14C-diazepam was 
only measured in the uppermost soil layer (0 – 5 cm), whereas in Neuenkirchen soil and 
LUFA-Soil 2.2 it was found up to a soil depth of 15 respectively 20 cm (Figure 4.18 -
Figure 4.20). Beyond these depths only negligible amounts of radioactivity (< 0.5 %) 
were detected. Therefore, it can be concluded that 14C-diazepam is totally immobile in 
EuroSoil 5 and partly immobile in LUFA-Soil 2.2 and Neuenkirchen soil.  
 
 
80  RESULTS AND DISCUSSION  
 
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
0-5
5-10
10-15
15-20
20-25
25-30
Leachate
So
il 
de
pt
h 
[c
m
]
Recovery 
 n.d.
 n.d.
 n.d.
 
Figure 4.18:  Leaching of 14C-diazepam in LUFA 2.2. Recovery rates in % of applied 
test substance in soil and leachates (means of measured soil aliquots of 
both columns (n=8); error bars: SD; n.d.: recovery < 0.5 %) 
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Figure 4.19:  Leaching of 14C-diazepam in EuroSoil 5. Recovery rates in % of applied 
test substance in soil and leachates (means of measured soil aliquots of 
both columns (n=8); error bars: SD; n.d.: recovery < 0.5 %) 
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Figure 4.20:  Leaching of 14C-diazepam in Neuenkirchen soil. Recovery rates in % of 
applied test substance in soil and leachates (means of measured soil 
aliquots of both columns (n=8); error bars: SD; n.d.: recovery < 0.5 %) 
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The relatively high standard deviations of soil aliquots measured (∼ 1 g per aliquot), 
especially in EuroSoil 5 (Table 4.17) indicate that the radioactive compounds were very 
inhomogeneously distributed in the different soil layers. This phenomenon could be 
explained by the low mobility of 14C-diazepam and may also cause the low total 
recovery rate in the Euro-Soil 5 soil columns (mean 77.5 %). According to the OECD 
draft guideline the recovery should range from 90–110 % for labelled substances. This 
deviation from the required quality criteria should have no influence on the overall 
assessment of the leaching potential of diazepam. 
Table 4.17:  Leaching of 14C-diazepam (14DIA) in LUFA 2.2, EuroSoil 5 and 
Neuenkirchen soil. Recovery in % of the spiked test substance for each 
soil column (A and B) 
 LUFA 2.2 EuroSoil 5 Neuenkirchen 
 14DIA_A 14DIA_B 14DIA_A 14DIA_B 14DIA_A 14DIA_B
recovery in soil [%] 97 108 67 88 98 86 
recovery in leachate [%] n.d. n.d. n.d. n.d. n.d. n.d. 
total recovery [%] 97 108 67 88 98 86 
n.d.: recovery < 0.5 % 
Diazepam is a lipophilic substance with a log KOW of 2.82 and a pKa of 3.3 (Stuer-
Lauridsen et al., 2000) and showed a very low mobility in all soils. Even in the 
relatively acidic EuroSoil 5 a significantly increased mobility due to a protonated 
amino moiety was not observed. It can be expected that its’ leaching behaviour was 
mainly determined by the organic carbon content of the soils. An extensive 
transformation of diazepam in the soil is unlikely, since diazepam was widely stable in 
the water/sediment test under aerobic conditions and transformation products might 
have shown certain mobility in the soil due their increased polarity. Therefore, the 
leaching potential for diazepam is estimated as very low. 
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4.3.5 Ibuprofen 
In all tests using non-labelled ibuprofen the leachate volumes were in the required 
range of 92–104 % recovery of the applied artificial rain (OECD, 2003a). Ibuprofen was 
retained in both soil substrates. It was not detected in the leachates of LUFA soil 2.2 and 
EuroSoil 5 and therefore can be classified as non-mobile (Table 4.18). 
Table 4.18:  Leaching of ibuprofen (IBU) in LUFA 2.2 and EuroSoil 5. The recovery 
in the leachate is given in % of the spiked test substance for each soil 
column (A and B) 
 LUFA 2.2 EuroSoil 5 
 IBU_A IBU_B IBU_A IBU_B 
Volume leachate [mL] 371.5 386.1 378.2 378.7 
Concentration 
[ng/leachate] n.d. n.d. n.d. n.d. 
Recovery in leachate [%] < 1 % < 1 % < 1 % < 1 % 
n.d. = not detectable 
The weak organic acid ibuprofen contains a carboxylic moiety with a pKa of 4.9 
(Merck, 2001) and a distinct lipophilicity in its’ undissociated form (log KOW of 3.5; 
Jones et al., 2002, Stuer-Lauridsen et al., 2000). In both tested soils with a pH of 5.8 
(LUFA-Soil 2.2) and 2.9 (EuroSoil 5), the carboxyl group of ibuprofen should be at least 
partly protonated leading to a sorption onto soil particles. Furthermore, it is known that 
ibuprofen can be transformed easily in sediments (see chapter 4.1.3) and under other 
environmental conditions (Ternes, 1998, Winkler et al., 2001). Since ibuprofen was not 
found in the soil leachates, it can be expected that the soil passage means an effective 
barrier for ibuprofen, due to sorption and/or by microbial degradation. However, the 
leaching potential of ibuprofen in basic soils with a pH clearly above its dissociation 
constant needs to be further investigated.  
4.3.6 Ivermectin 
In all tests using non-labelled ivermectin the leachate volumes were in the required 
range of 92–104 % recovery of the applied artificial rain (OECD, 2003a). Ivermectin 
was retained in both soil substrates (Table 4.19). It was not detected in the leachates of 
LUFA soil 2.2 and Euro-Soil 5 and can therefore be classified as non-mobile. 
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Table 4.19:  Leaching of ivermectin (IV) in LUFA 2.2 and EuroSoil 5. The recovery in 
the leachate is given in % of the spiked test substance for each soil 
column (A and B) 
 LUFA 2.2 EuroSoil 5 
 IV_A IV_B IV_A IV_B 
Volume leachate [mL] 376.2 375.3 379.9 367.5 
Concentration 
[ng/leachate] n.d. n.d. n.d. n.d. 
Recovery in leachate [%] < 1 % < 1 % < 1 % < 1 % 
n.d. = not detectable 
Concluding from the experimental data, ivermectin shows no leaching potential in 
soil columns. Comparable data for ivermectin were reported by Halley et al., 1989b, and 
for the ivermectin derivative abamectin by Gruber et al., 1990 and by Bull et al., 1984. 
The immobility of the test compound in the soils tested and its tendency to sorb onto 
soil particles should at least partly deviate from its high lipophilicity (log KOW = 3.22, 
KOC = 12,660-15,700 Halley et al., 1989a).  
However, Tolls could not assign the soil affinity of avermectins exclusively to their 
lipophilicity (Tolls, 2001). LC-MS data shows that ivermectin is capable to form 
adducts with cations, such as ammonium or sodium (Ali et al., 2000). Hence, there is 
some reason for the presumption of a specific binding of ivermectin to soil, which might 
deviate from the formation of adducts or complexes with immobile inorganic soil 
matter. 
4.4 A special case: Iopromide and its TPs 
4.4.1 Water/sediment study  
Iopromide is a very polar, highly water soluble compound (770 g⋅L-1) (Steger-
Hartmann et al., 1999) and therefore, the radioactivity initially related to 14C-iopromide 
remained mainly in the water compartment during the test (Figure 4.21). Even after 
100 d more than 65 % of the IAR were still located in the water phase. The quantity of 
radioactivity in the sediment increased almost linearly to 21 ± 1 % at the end of the 
experiment. Only negligible amounts of radioactivity were found in the CO2 traps, and 
therefore relevant mineralization did not occur. The balance of radioactivity showed a 
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small deficit, which increased in the course of the experiment but never exceeded 
11 ± 5 %. 
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Figure 4.21:  Distribution of radioactivity in the water/sediment system spiked with 
14C-iopromide 
The presence of 14C-iopromide equivalents in the sediment should mainly be 
attributable to its’ occurrence in the sediment pore-water, which contributed about 13 % 
to the total water amount in the test system. With regard to its’ low lipophilicity (log 
POW = -2.33) and missing moieties for known specific interactions (Steger-Hartmann et 
al., 1999), iopromide should have been sorbed onto the sediment particles only to a 
minor extent. 
The radioactivity in the water phase was analyzed by radio-TLC, whereas the 
sediment was not further investigated. After a lag period of two weeks, 14C-iopromide 
was transformed, resulting in total transformation after 100 d following a first order 
kinetic (Figure 4.22).  
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Figure 4.22:  Fate of 14C-iopromide in the water phase of the water/sediment system  
TP A occurred with a maximum of 20 ± 1 % at day 28 and was object to further 
degradation. At least three other TPs were formed and occurred in increasing 
percentages. After 100 d the TPs A, B and C occurred with 9 ± 1, 30 ± 2 and 24 ± 2 %, 
respectively and TP D appeared with 4.3 ± 0.1 %. The deviations within the individual 
test vessels were very low, which shows the widely similar development of the 
independent test vessels. 
For TP A and ATI, similar Rf-values were observed, while TP B matched very well 
with the Rf-value of ATH (shown in Table 4.20, for chemical structures see Table 2.3). 
A formation of the iopromide TP DAMI, as found by Steger-Hartmann (Steger-
Hartmann et al., 1998, Steger-Hartmann et al., 2001) in laboratory-STP’s can be 
excluded. Kalsch, 1992 also observed the formation of at least 3 different iopromide 
TPs in water/sediment systems and a laboratory STP. He found a similar pattern of Rf-
values for the unknown TPs formed, using the same method for TLC- analysis. 
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 Table 4.20:  Rf-values for iopromide and TPs of iopromide 
Compound Rf-value 
TP A 0.21 
ATI 0.23 
TP B 0.33 
ATH 0.33 
IO 0.39 
DAMI 0.47 
TP C 0.74 
TP D 0.89 
 
For iopromide in the water phase, a DT50 of 30 d and a DT90 of 99 d was calculated. 
Iopromide is amendable towards microbial degradation (Steger-Hartmann et al., 1998, 
Steger-Hartmann et al., 1999, Steger-Hartmann et al., 2001). In a somewhat similar 
study with iopromide, TPs formed were relatively stable, an appreciable mineralization 
did not occur. Kalsch reported also the degradation of iopromide in water/sediment 
systems, following a first order kinetic (Kalsch, 1992, Kalsch, 1999). The absence of a 
lag period in Kalsch’s experiments might have been caused by the river water used, 
which is known to contain iopromide residues (Ternes and Hirsch, 2000). Iopromide 
can be effectively removed during bank filtration (Putschew et al., 2000) and occurs in 
groundwater only at the low ng⋅L-1-level (Putschew et al., 2000, Sacher et al., 2001, 
Ternes and Hirsch, 2000).  
Summary: DT-values for iopromide 
Water phase: 
Function and degradation rate: First order    d = 0.0233 per day 
DT-values:    DT50: 30 d     DT90: 99 d  
Regression coefficient:  0.9909    Accepted (> 0.95)  
Water/sediment system: 
Kinetics and degradation rate: Not possible to determine 
DT-values:    Not possible to determine (< 100 d) 
Remark:     Complete transformation in the water phase 
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4.4.2 Soil-Leaching Study 
4.4.2.1 Non-labelled iopromide 
In all tests using non-labelled iopromide the leachate volumes were in the required 
range of 92–104 % recovery of the applied artificial rain (OECD, 2003a). Non-labelled 
iopromide was retained in LUFA soil 2.2. It was not detected in the leachates of LUFA 
soil 2.2, while 37.5 % (mean of the two columns) of the test substance applied was 
detected in the leachate of EuroSoil 5 (Table 4.21). 
Table 4.21:  Leaching of non-labelled iopromide (IO) in LUFA 2.2 and EuroSoil 5. 
The recovery in the leachate is given in % of the spiked test substance for 
each soil column (A and B) 
 LUFA 2.2 EuroSoil 5 
 IO_A IO_B IO_A IO_B 
Volume leachate [mL] 389.9 398.4 406.7 401.4 
Concentration 
[ng/leachate] n.d. n.d. 20793 30112 
Recovery in leachate [%] 0 0 30.6 44.3 
n.d. = not detectable 
4.4.2.2 Radio-labelled iopromide 
In the tests using 14C-iopromide the leachate volumes from the LUFA 2.2 and 
EuroSoil 5 columns were in the required range of 92–104 % recovery of the applied 
artificial rain (OECD, 2003a). The leachate volumes from the Neuenkirchen soil 
columns were slightly above this range (108 %). This deviation from the required 
quality criteria should have no influence on the comparability of the tests and the 
overall assessment of the leaching potential of 14C-iopromide. High percentages of the 
IAR were found in the leachates of EuroSoil 5 (59.0 %), LUFA 2.2 (78.5 %) and 
Neuenkirchen soil (46.5 %) (Table 4.22). The mobility of 14C-iopromide was slightly 
higher in LUFA 2.2 soil than in Euro-Soil 5 and Neuenkirchen soil (Figure 4.23 - Figure 
4.25). Based on these data it can be presumed that the mobility of 14C-iopromide in the 
three soils tested is high. 
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Table 4.22:  Leaching of 14C-iopromide (14C-IO) in LUFA 2.2, EuroSoil 5 and 
Neuenkirchen soil. Recovery in % of the spiked test substance for each 
soil column (A and B) 
 LUFA 2.2 EuroSoil 5 Neuenkirchen 
 14C-IO_A 14C-IO_B 14C-IO_A 14C-IO_B 14C-IO_A 14C-IO_B
Recovery in soil [%] 21 19 43 50 52 57 
Recovery in leachate [%] 78 79 62 56 50 43 
Total recovery [%] 99 98 105 106 102 100 
n.d.: recovery < 0.5 % 
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Figure 4.23:  Leaching of 14C-iopromide in LUFA 2.2. Recovery rates in % of applied 
test substance in soil and leachates (means of measured soil aliquots of 
both columns (n=8); error bars: SD; n.d.: recovery < 0.5 %) 
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Figure 4.24:  Leaching of 14C-iopromide in EuroSoil 5. Recovery rates in % of applied 
test substance in soil and leachates (means of measured soil aliquots of 
both columns (n=8); error bars: SD; n.d.: recovery < 0.5 %) 
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Figure 4.25:  Leaching of 14C-iopromide in Neuenkirchen soil. Recovery rates in % of 
applied test substance in soil and leachates (means of measured soil 
aliquots of both columns (n=8); error bars: SD; n.d.: recovery < 0.5 %) 
Iopromide is a polar compound (log KOW of -2.33) and a high water solubility 
(Steger-Hartmann et al., 1999). Its tendency for a binding to soil particles can be 
expected to be very low, since specific interaction with soil particles are unknown for 
iopromide. Due to its high polarity, iopromide leaches rapidly through the soil, nearly 
unimpeded by interactions with soil particles. 
In experiments with 14C-labelled iopromide, more than 50 % of the radioactivity 
applied was found in the leachates of both soils. 14C-iopromide was retained slightly 
more by the EuroSoil 5 and the Neuenkirchen soil than by the LUFA 2.2. This could be 
explained by the coarser soil texture and therefore the faster leaching of the water in the 
LUFA 2.2 soil columns. 
However, in the study with non-labelled test substance a relative high percentage of 
the applied amount (38.6 %) was leached when using EuroSoil 5, while with LUFA 2.2 
no iopromide could be detected in the leachate with LC tandem MS. To verify this 
significantly different behaviour of 14C-iopromide and non-labelled iopromide in both 
soils further experiments were conducted. In a second study using non-labelled 
iopromide the results of the first experiment were confirmed. The major difference in 
the performance of the tests using labelled and non-labelled iopromide was the mode of 
application. 14C-iopromide was kindly provided by the Schering AG and stored in the 
laboratories of ECT dissolved in ethanol. This ethanol-solution was diluted with water 
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and the resulting solutions were applied to the soil columns, whereas the non-labelled 
test substance was applied dissolved in water only. To exclude the possibility that traces 
of the organic solvent influenced the mobility of the 14C-iopromide in a second 
experiment the radioactive compound were applied to LUFA 2.2 soil columns after the 
ethanol was evaporated in a nitrogen stream and subsequently the 14C-iopromide was 
dissolved in water. At the end of the test 71.4% (mean of two columns) of the spiked 
radioactivity was found in the leachates. These results indicate that traces of ethanol in 
the application solution did not increase significantly the mobility of iopromide.  
In order to clarify these virtually contrary results, leachate samples of the 
experiments with 14C-labelled iopromide were analysed by radio TLC, applying several 
potential environmental transformation products (TPs) as reference compounds. TLC 
analysis showed that iopromide was completely transformed in LUFA 2.2 soil, under 
formation of at least three TPs at percentages between 14 ± 3% and 63 ± 2% (Table 
4.23). 
Table 4.23:  Composition of radioactivity in leachates of the soils Lufa 2.2 and 
EuroSoil 5 in % (2 replicates; error = mean absolute deviation) 
Compound Rf-value Lufa 2.2 EuroSoil 5 
TP A’  0.20 63 ± 2  15 ± 9 
ATI 0.22 - - 
TP B` 0.31 23 ± 1 - 
ATH 0.32 - - 
IO 0.37 - 85 ± 9 
DAMI 0.47 - - 
TP C` 0.70 14 ± 3 - 
Total - 100 100 
 
The Rf-values of the TPs A´ and B´ almost matched with those of the reference 
compounds ATI and ATH, respectively. In order to determine whether ATI or ATH 
were formed as TPs, additional LC-tandem MS experiments were conducted using soil 
leachates from the experiments with non-labelled iopromide. Although parameters for 
the detection of ATI in MRM experiments were optimized, the sensitivity for ATI 
remained low. The MRM experiments for ATH were conducted as described by Ternes 
and Hirsch, 2000.  
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Leachate samples spiked with 2 µg ATI showed the sharp ATI peak (Figure 4.26) 
with a retention time of 3.3 min, which was not observed in non-spiked samples. 
Additionally, a broad TP peak was observed for the MRM-transition of ATI which had 
a retention time of 4.1 min. The TP peak was also observed in non-spiked samples. 
Therefore, it is obvious that the TP in the soil leachates was not ATI, but showed a 
strong cross-selectivity to ATI. 
However, it cannot be entirely excluded that ATI was present in the leachate, due to 
the poor sensitivity in the measurement for this compound. The iopromide derivative 
ATH which was neither found by Ternes and Hirsch, 2000 nor by Putschew et al., 2001 
in various environmental waters, was not observed in the leachates, nor was the 
iopromide TP DAMI (Steger-Hartmann et al., 2001). 
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Figure 4.26:  Chromatograms showing the MRM-transition of ATI for soil leachates 
non-spiked (A) and spiked (B) with ATI  
During passage of EuroSoil 5, 14C-iopromide was transformed only to a minor 
extent, while 85 ± 9 % of the iopromide remained unchanged (Table 4.23). The TP 
formed had the same Rf-value as TP A , which was presumably formed in both soils. 
Additional experiments on the identification of the unknown iopromide TPs were not 
conducted.  
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Finally, the results of the experiments with 14C-labelled and non-labelled iopromide 
were linked to investigate the comparability of the experiments. In both experiments 
with soil LUFA 2.2 iopromide was never found in the leachates neither labelled nor 
non-labelled (Table 4.24), indicating that iopromide was entirely transformed during 
passage of LUFA 2.2 soil. In EuroSoil 5 a partial transformation occurred, resulting in 
50 ± 1 % and 38 ± 7 % of the initially applied quantity of 14C-iopromide and non-
labelled iopromide, respectively, in the leachates. This shows that both analytical 
methods led reproducibly to the same results. 
 Table 4.24:  Percentage of initially applied 14C-labelled and non-labelled iopromide 
recovered unchanged in soil leachates (2 replicates; error = mean 
absolute deviation) 
 LUFA 2.2 EuroSoil 5 
14C-labelled iopromide  0 % 50 ± 1 % 
non-labelled iopromide 0 % 38 ± 7 % 
 
It might be assumed that the varying mobility of the iopromide equivalents in the 
three soils was mainly a result of the differing extent of transformation.  
Hence, the at least partial transformation of iopromide during soil passage gives 
some evidence, that the removal of iopromide during riverbank filtration is caused by 
degradation (Putschew et al., 2000). It can be concluded that the introduction of 
iopromide onto soils means a certain risk for groundwater contamination, since in any 
case a groundwater contamination with iopromide or its TPs is very likely. 
Comparison of iopromide transformation in water/sediment systems and soil columns 
The iopromide TPs formed in both test systems displayed almost identical Rf-values 
(Table 4.25). This might indicate that the TPs A, B, C formed in the water/sediment 
tests, respectively the TPs A´, B´, C´ of the soil leaching experiments, were identical. 
Therefore, it can be presumed, that these TPs are frequently formed under a wide range 
of environmental conditions.  
 
 
 93  
Table 4.25:  Rf-values for iopromide and corresponding TPs 
Water/sediment test Leaching test 
Compound Rf-value Compound Rf-value 
TP A 0.21 TP A´ 0.20 
ATI 0.23 ATI 0.22 
TP B 0.33 TP B´ 0.31 
ATH 0.33 ATH 0.32 
IO 0.39 IO 0.37 
DAMI 0.47 DAMI 0.47 
TP C 0.74 TP C´ 0.70 
TP D 0.89 - - 
 
The transformation velocity in LUFA 2.2 soil 5 was high in comparison to the 
transformation of iopromide in the water/sediment system. In the latter experiment TPs 
appeared not until 28 d and a total transformation was observed after 100 d. It is 
conceivable that iopromide was transformed in all cases following mainly the same 
transformation, but with different kinetics. This might give reason for a detailed 
elucidation of the environmental fate of iopromide in the future. 
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5 ENVIRONMENTAL RISK ASSESSMENT  
5.1 General principle 
Pharmaceuticals are potentially harmful environmental contaminants as they are 
biologically active and often have a low biodegradability (Christensen, 1998). Since 
1993, an environmental risk assessment (ERA) for new drugs has been implemented by 
the European Union, 1993. For the registration of veterinary pharmaceuticals an 
environmental assessment became obligatory in 1997 (EU, 1997) and VICH guidance 
paper are available (European Union, 2002, European Union, 2004). A corresponding 
guideline for human pharmaceuticals is still under discussion (2001, European Union, 
2002, Rönnefahrt and Koschorrek, 2002, Straub, 2002). However, an environmental 
risk assessment for pharmaceuticals follows basically the same rules which have been 
established for other chemicals (Römbke et al., 2001).  
The whole ERA is an iterative, tiered process in that the exposure and effect analysis 
can be repeated twice with increasing complexity. In general, the ERA consists of the 
steps shown in Figure 5.1.  
For the exposure and effect analysis a number of standardized tests have been 
published (e.g. by the OECD, 2003b), allowing for a comparable assessment of fate and 
ecotoxicological effects. In recent years several reports have been published on the 
effects and the environmental risk of pharmaceuticals in the aquatic and, less often, 
terrestrial environment (Christensen, 1998, Davies et al., 1998, Henschel et al., 1997, 
Jones et al., 2002, Pascoe et al., 2003, Schulman et al., 2002, Steger-Hartmann et al., 
2001, Stuer-Lauridsen et al., 2000, Van Wezel and Jager, 2002, Wollenberger et al., 
2000). However, in comparison to other chemicals (in particular pesticides) still little 
data is available on the fate and effects of pharmaceuticals in the environment (Golet, 
2002, Tixier et al., 2003). 
Within the last ten years, several concepts for an environmental risk assessment 
(ERA) of pharmaceuticals have been proposed (e.g. Römbke et al., 2001, Stuer-
Lauridsen et al., 2000). Due to the lack of data in comparison to other chemicals, in 
particular pesticides, the performance of an ERA is difficult for pharmaceuticals. 
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Therefore, only few examples of ERAs for this group of chemicals in the compartments 
sediment, soil or groundwater have been published so far, but the number is increasing 
recently (e.g. Boxall et al., 2000, Ferrari et al., 2003, Halling-Sorensen et al., 2000, 
Steger-Hartmann et al., 1999, Webb, 2001).  
Figure 5.1:  General principles of an environmental risk assessment process, adapted 
from Römbke et al., 2001 
In the following, the pharmaceuticals tested in this project will be evaluated 
concerning their fate in the aquatic environment (surface water and sediment) as well as 
regarding their potential impact on the groundwater.  
HAZARD IDENTIFICATION 
Evaluation, which environmental compartments (i.e. surface water, soil) 
are likely to be affected based on the properties of the compound and the 
use pattern 
EXPOSURE ASSESSMENT
Calculation of the predicted 
environmental concentrations 
(PEC) 
EFFECT ASSESSMENT 
Calculation of the predicted no 
effect concentrations (PNEC) 
(incl. safety factors) 
RISK ASSESSMENT 
Comparison of (measured or estimated) exposure data with (on different 
investigation levels, i.e. laboratory, microcosms, field) measured or 
estimated effect data (separately for the main environmental 
compartments)
RISK CHARACTERIZATION 
Assessment of the probability that an environmental risk is likely to occur 
by calculating the PEC/PNEC ratio (< 1 or > 1) 
RISK MANAGEMENT 
Measures, in order to avoid or to minimize an environmental risk as part 
of the registration or re-registration decision 
96  ENVIRONMENTAL RISK ASSESSMENT  
5.2 Degradation and metabolization in water/sediment systems 
5.2.1 Assessment approach 
The results of water/sediment tests, performed as part of the registration of 
pesticides, are not assessed on their own (i.e. no „Cut-off“-values exists, meaning that 
no DT-value has been defined by the regulatory authorities which, if exceeded, prevents 
the registration of a pesticide). Instead, the data is used for the calculation of PECs 
(Predicted Environmental Concentrations), which are then used for a PEC/PNEC 
comparison or as a trigger for further effect testing (EU, 1991). Since such a 
comparison was not possible in this project due to the lack of effect data, another 
approach based purely on the results of fate tests was chosen.  
The characterization of the persistence of a substance from water/sediment tests is 
done mainly according to Beek, 2001, a procedure which has been proposed for the 
evaluation of environmentally relevant chemicals in Germany. In Table 5.1 the 
following classification parameters are shown: i) the time necessary for 50 % 
dissipation of the test compound (DT50) in the water compartment, ii) the extent of 
mineralization after 100 d, and iii) the extent of bound residues present after 100 d.  
Table 5.1:  Persistence classes according to Beek, 2001  
First criterion: primary degradation 
DT50 in water Class Assessment 
< 10 d I Rapid primary degradation 
10 – 30 d II Delayed primary degradation 
30 – 100 d III Slow primary degradation 
> 100 d IV Negligible primary degradation 
Second Criterion: mineralization (after 100 d) 
CO2 Class Assessment 
> 50 % I Extensive mineralization 
25 – 50 % II Moderate mineralization 
10 – 25 % III Limited mineralization 
< 10 % IV Negligible mineralization 
Third criterion: bound residues (after 100 d) 
Amount Class Assessment 
< 10 % I Low plateau 
10 – 25 % II Moderate plateau 
25 – 50 % III High plateau 
> 50 % IV Very high plateau 
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The resulting classes of the three criteria were equally taken for the calculation of the 
overall persistence category applying the following calculation (average by rounding): 
 categoryePersistenc
classestheofSum =
3
 (5.3)
Depending on the certain degradation kinetic of a substance, the shape of the 
degradation curve as well as the transformation scheme are considered for obtaining the 
overall persistence category. Finally the persistence of a chemical is assessed as one of 
the four persistence categories shown in Table 5.2.  
Table 5.2:  Persistence categories  
Category number Category name 
I Low persistence 
II Moderate persistence 
III High persistence 
IV Not biodegradable 
In most experiments with non-labelled compounds the persistence cannot be entirely 
assessed according to Beek, 2001, since detailed data on the dissipation processes, such 
as transformation and mineralization, can usually not be obtained. In such and related 
cases, the respective substance was preliminarily classified by expert knowledge. It has 
to be stated again that this approach is not considered to be an alternative to a “full” 
environmental risk assessment (i.e. a PEC/PNEC comparison), but should be seen as a 
first evaluation in case effect data are not available. 
 
5.2.2 Assessment of the individual test substances 
Before discussing the individual compounds, it has to be noted that the transferability 
of results attained in lab-scale experiments to large scale systems or even real 
environmental processes is limited, conditioned by fundamental differences in size, 
complexity and incubation of the systems (Rönnefahrt et al., 1997). However, the test 
conditions selected were a worst-case scenario, since the application of organic carbon 
poor sediment with a relative low TOC is associated with a relatively low microbial 
activity. Frequently, it is also accompanied with a relatively low extent of analyte 
sorption onto the sediment. Therefore, real environmental conditions, which include 
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photo degradation (Andreozzi et al., 2003, Andreozzi et al., 2002, Buser et al., 1998, 
Lam et al., 2003, Poiger et al., 2001, Tixier et al., 2003) and nutrient replacement, 
should in general lead to a more efficient elimination of pharmaceutical residues. 
However, the data obtained allows for a principal estimation of the environmental fate 
and distribution of the selected pharmaceuticals and TPs which showed a wide range of 
different behaviours with respect to degradation/dissipation, affinity to the sediment and 
persistence (Table 5.3).  
Table 5.3:  Dissipation times, extent of mineralization and sediment sorption and 
persistence classification of pharmaceuticals tested in water/sediment 
test systems 
 DT50 (d)1 
DT90 
(d)1 
Minerali-
zation 
(% C0) 
Sorption to 
sediment 
(% C0) 
Classification3 
Paracetamol -
4 
(3.1) 
-4  
(10.4) 19 57
2 3.5 (Category IV) I = Low persistence 
Ibuprofen -
5 
(10) 
-5 
(13) 77 9 
1.0 (Category I) 
I = Low persistence 
2-Hydroxy-
ibuprofen 
-4 
(6.7) 
-4 
(22) n.d. < LOQ 
1.0 (Category I) 
I = Low persistence 
Clofibric acid 119 (82) 
> 365 
(274) n.d. 12 
3.0 (Category III) 
III = High persistence 
Diazepam > 365 (34) 
>> 365 
(113) < 2 60 
4.0 (Category IV) 
IV = Not biodegradable 
Oxazepam 54  (19) 
179 
(63) n.d. 29 
3.0 (Category III) 
III = High persistence 
Carbamazepine 333 (52) 
> >365 
(173) n.d. 40 
3.5 (Category IV) 
IV = Not biodegradable 
10,11-Dihydro-
10,11-hydroxy- 
carbamazepine 
34 
(21) 
> 365 
(> 365) n.d. < 10 
2.0 (Category II) 
III = High persistence 
Iopromide -
5 
(30) 
-5 
(99) < 1 < 25 
3.0 (Category III) 
III = High persistence 
Ivermectin 13 (2.9) 
144 
(10) n.d. 16 
2.0 (Category II) 
II = Moderate persistence 
1 dissipation times for entire water/sediment system, respective values for the water compartment are shown in 
brackets, 2 Present as non-extractable residues, n.d. = not determined, 3 numerically according to Beek, 2001 (upper 
line) and after a plausibility check (i.e. expert knowledge (lower line); final classification is given in italics, 4 no 
value because the compound was never found in the sediment, 5 no value because the compound was not TLC 
analyzed in the sediment  
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5.2.2.1 Paracetamol 
The results indicate that paracetamol is eliminated from the water phase in the 
water/sediment system. It can be suggested from the rapid and extensive binding onto 
the sediment that paracetamol, but more likely its TPs, are incorporated into the biomass 
and may potentially accumulate in sediments. Since paracetamol or its TPs were not 
extractable, even not under drastic conditions, it can be expected that the bio availability 
in the sediment is low. 
Consequently, following the classification of Beek, 2001, paracetamol has to be 
considered as highly persistent in the water/sediment test system (see Table 5.3). 
However, taking into account what is known about this substance a categorization with 
“low persistence” is more likely. However, a profound assessment can only be done 
after elucidation the nature of the non-extractable residues. 
5.2.2.2 Ibuprofen 
Ibuprofen, which carried a 14C-labelled carboxylic moiety, seemed to be mineralized 
by more than 75 % in the course of the experiment, displaying a ready degradability in 
surface water (see Table 5.3). However, de-carboxylation as a major or even solely 
process cannot be ruled out. In surface waters, a distinct degradation of this substance 
should be expected. Since ibuprofen is continuously discharged via STP effluents, the 
micro organisms in the receiving waters should be adapted on its’ degradation. 
Ibuprofen displayed no potential for accumulation in sediments due to its’ rapid 
degradability and its’ relatively low lipophilicity under common pH conditions in 
environmental waters and sediments. 
According to Beek`s classification scheme ibuprofen is categorized as “lowly 
persistent” (Beek, 2001).  
5.2.2.3 2-Hydroxy-ibuprofen 
With regard to the present data, 2-hydroxy-ibuprofen can be expected to undergo 
rapid degradation in surface waters and should display neither significant persistence 
nor accumulation in the sediments and suspended matter (see Table 5.3).  
Since a categorization according to (Beek, 2001) was not possible 2-hydroxy-
ibuprofen is classified as “lowly persistent”. 
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5.2.2.4 Clofibric acid 
The high stability of clofibric acid in surface waters reported in the literature could 
be confirmed according to the results of the water/sediment test system shown here. The 
low affinity towards the sediment confirms that clofibric acid shows no potential for 
accumulation in sediments (see Table 5.3).  
Despite the fact that a complete classification according to Beek, 2001 was not 
possible, clofibric acid is categorized with “highly persistent” due to the high DT-values 
and the existing monitoring data. 
5.2.2.5 Diazepam 
Based on the experimental data it is clear that diazepam is hardly degraded in surface 
waters (excluding light induced degradation) and that it is therefore persistent in the 
aquatic environment. Due to its’ behaviour, an accumulation in sediments, especially in 
those with high Corg levels, can be expected (see Table 5.3). 
According to Beek, 2001 diazepam is categorized as “not biodegradable”. This is 
consistent with findings of (Kreuzig, 2003), who found diazepam to be highly stable in 
soils. 
5.2.2.6 Oxazepam 
Oxazepam should be eliminated to some extent in surface waters. With respect to its´ 
moderate lipophilicity and Kd values, the potential for accumulation of oxazepam in 
natural sediments cannot be ruled out. 
The persistence according to Beek, 2001 could not fully be assessed. However, 
according to the DT-value and its sorption to the sediment a categorization as “highly 
persistent” is the most appropriate (see Table 5.3).  
5.2.2.7 Carbamazepine 
The results of the water/sediment test suggest, in agreement with other authors, that 
carbamazepine is widely resistant to elimination in natural surface waters (excluding 
light induced degradation). For carbamazepine, a moderate potential for accumulation 
in sediments, especially in those with a high Corg cannot be excluded (see Table 5.3).  
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Based on the existing data and literature experiences carbamazepine has to be 
categorized as “not biodegradable” (Beek, 2001).  
5.2.2.8 10,11-Dihydro-10,11-dihydroxy-carbamazepine 
The compound 10,11-dihydro-10,11-dihydroxy-carbamazepine disappeared quickly 
in the first days but remained almost stable at a level of 35 % after the first month until 
the end of the test. This might indicate the presence of threshold concentrations in the 
degradation of this TP or was caused by a deficit of nutrients which are essential for the 
respective degrading micro organisms. Significant sorption of 10,11-dihydro-10,11-
dihydroxy-carbamazepine onto sediments can be excluded. A degradation of the TP in 
surface waters might occur, but due to the threshold concentration found a final 
conclusion is impossible to be taken.  
Despite the fact that a classification according to Beek, 2001 is not fully possible, the 
DT-values, the negligible sorption to the sediment and recent monitoring data (Miao 
and Metcalfe, 2003) indicate at least a “moderate persistence” (see Table 5.3). In fact, 
the time course of this substance in the water phase make a categorization as “highly 
persistent” more likely.  
5.2.2.9 Iopromide 
Iopromide can be in principal transformed in surface waters, even though the extent 
of the transformation may be low due to the slow kinetics. An accumulation in 
sediments can be excluded. For the X-ray contrast medium iopromide, at least four 
relatively stable TPs were detected of which three occurred at a level of > 10 %. These 
TPs were also observed in soil column leaching experiments, where iopromide was 
transformed between 15 and 100 % during soil passage. It is suggested that iopromide is 
transformed into the observed TPs under various environmental conditions. 
According to Beek, 2001, iopromide has to be classified as “highly persistent” in 
water/sediment systems (see Table 5.3) when considering also the formation of stable 
TPs. 
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5.2.2.10 Ivermectin 
In surface waters a rapid elimination of ivermectin from the water compartment can 
be presumed. Due to the elevated sorption properties of ivermectin, an accumulation in 
natural sediments is likely, in particular for anaerobic sediments with a high Corg. 
A formal classification according to Beek, 2001 is difficult to be done. However, due 
to the low DT-values and the transitory sorption in the sediment, it is proposed to 
categorize this parasiticide as “moderately persistent” (see Table 5.3). This proposal is 
in accordance with literature data from the compartment soil (Edwards et al., 2001). 
5.2.2.11 Final note 
The phase I metabolites 10,11-dihydro-10,11-dihydroxy-carbamazepine, 2-hydroxy-
ibuprofen and oxazepam showed lower system half lives than the parent compounds, 
reflecting the comparably elevated accessibility of phase I metabolites towards further 
degradation reactions. These main human metabolites were never found as TPs in the 
water sediment systems. Thus, the transformation of the selected pharmaceuticals in 
humans and in the environmental systems was totally different. Therefore, the 
transferability of pharmacological data towards environmental behaviour is limited and 
for a reliable assessment of the environmental fate of pharmaceuticals, appropriate tests 
are indispensable. 
5.3  Mobility and transformation in column leaching systems 
Especially the compartment groundwater is a subject of high interest not only from 
an ecotoxicological point of view but mainly due to toxicological reasons. In most 
member states of the European Union groundwater is the main source of drinking water. 
Therefore, the assessment of potential risks of chemicals to human health via 
groundwater contamination must always be considered. In order to evaluate the risk for 
this compartment in an ERA, usually adsorption/desorption kinetics and the leaching 
behaviour are used as the main endpoints. 
For the assessment of the leaching potential of pharmaceuticals existing concepts 
should be applied. Already in the 1980th the Biologische Bundesanstalt für Land- und 
Forstwirtschaft (Braunschweig, Germany) required for the registration of pesticides the 
evaluation of their leaching potential. As a first step always a laboratory leaching study 
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using small disturbed soil columns had to be performed (Biologische Bundesanstalt für 
Land und Forstwirtschaft, 1986). Depending on the results of this study and taking into 
account the persistence of the test substance, a data refinement could be required. For 
substances with a DT90 < 100 d, a recovery of more than 10% of the test item and its 
TPs in the leachate served as a trigger for further tests, e.g. leaching with aged residues, 
lysimeter tests or even field studies. For substances with a DT90 > 100 d a recovery rate 
of > 5% triggers a data refinement. Later on, in a guideline describing the performance 
of semi-field lysimeter studies, the BBA specified the trigger values (Biologische 
Bundesanstalt für Land und Forstwirtschaft, 1990).  
A data refinement (i.e. modelling and - depending on the results of the model 
predictions - further studies) were necessary if one of the following criteria is fulfilled: 
a) water solubility of the test substance is higher than 30 mg/L; b) adsorption coefficient 
Koc is below 500; c) Kd-value is below 10 L⋅kg-1 and d) the soil persistence, given as 
DT50 is higher than 21 days. 
In the current practice of pesticide registration according to EU guideline 91/414 
(EWG, 1991), the investigation of the mobility of these substances in soil starts also 
with small laboratory columns (EU, 1991). In addition, the same test has to be done 
with aged residues. Taking into consideration the results of these tests as well as the 
persistence of the test substance in soil and its adsorption/desorption behaviour, it has to 
be decided whether a field lysimeter study must be performed. In any case the expected 
concentration of the test substance in the groundwater has to be calculated. If according 
to the modeling this concentration is higher than 0.1 µg/L, the substance cannot be 
registered, unless it has been shown via data refinement, that no unacceptable effects of 
the substance on the groundwater will occur (EU, 1997). This data refinement is usually 
focusing on real field conditions (either by performing a field study or by further model 
calculations) to show that under such conditions the test substance will not exceed the 
trigger value in the groundwater. 
Since it was not possible to model the potential concentration of the six test 
pharmaceuticals in the groundwater (this would be the most appropriate approach 
followed by EU as well as national authorities today), the results gained so far were 
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assessed using the criteria of the BBA guidelines. According to the BBA trigger values 
a data refinement would be required as follows (Table 5.4): 
Table 5.4:  Reasons for a data refinement for certain pharmaceuticals    
Reason for data refinement Compounds 
 
Detection of test substance and its TPs 
in the leachate of disturbed soil 
columns > 10% (respective 5%) 
 
 
 
iopromide, clofibric acid 
 
Water solubility > 30 mg/L 
 
 
iopromide, clofibric acid, diazepam 
 
Koc < 500  
 
 
iopromide, clofibric acid, diazepam, 
carbamazepine 
 
 
Kd < 10  
 
 
iopromide, clofibric acid, diazepam, 
carbamazepine 
 
 
The DT90-criterion could not be applied, given that no soil DT-values are available 
for the compounds investigated. Since four of the pharmaceuticals investigated exceed 
at least one of the trigger values further modelling and testing with iopromide, clofibric 
acid, diazepam and carbamazepine will be necessary.  
The case of carbamazepine shows clearly that the studies with the disturbed soil 
columns should only be considered as a first screening approach. No carbamazepine 
was detected in the leachates of the soil columns. However, carbamazepine is known to 
be present in groundwater very often (Heberer, 2002a, Sacher et al., 2001, Ternes, 
2000). Decisions in environmental risk assessment should not be based only on the 
results of these soil column leaching studies. Therefore - as foreseen in the BBA-
scheme - the compound’s properties (e.g. water solubility, Koc, Kd) should be regarded 
in addition to the soil column experiments. In the case of ibuprofen no leaching 
potential was evaluated using the BBA-approach. However, taken into account that the 
soil column experiments were performed with non-labelled ibuprofen and also 
considering the high potential mobility of ibuprofen due to its pH dependent 
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dissociation, a data refinement is recommended. Especially the pH dependent mobility 
of ibuprofen should be investigated further. Only the veterinary pharmaceutical 
ivermectin fulfills the BBA registration criteria for pesticides; i.e. no further 
investigations are required. 
In the cases where data refinements are required, registration restrictions and/or risk 
reduction measures have to be identified, if the potential to leach cannot definitely be 
excluded in further studies. However, a direct transfer of the risk mitigation steps 
developed for pesticides seems questionable due to the medical importance of 
pharmaceuticals. In other words, the benefits of the use of a certain pharmaceutical have 
always to be taken into consideration. 
The observed mobility of clofibric acid and iopromide (including its TPs) in the soil 
columns indicates a risk for the occurrence in groundwater. This result could be 
confirmed by the occurrence of both substances in the groundwater of several German 
regions (Heberer, 1995, Ternes, 2001a, Ternes, 2000, Ternes and Hirsch, 2000). 
Substances which enter the aquifer may pose a problem not only for short-term periods. 
Due to the low microbial activity in the deeper soil layers these contaminants may be 
persistent in the aquifer over decades (DVWK, 1988) and therefore rather cause a long 
term risk. In addition, the discrepancy between the lack of mobility in the laboratory 
columns and literature data (occurrence in groundwater) in the case of carbamazepine 
requires further investigations. In particular, the hypothesis that the mobility differs 
between columns filled with top soil in comparison to the use of sub-soils or river 
sediments. 
Despite the fact that these pharmaceuticals were able to enter the groundwater, no 
concept to assess their ecotoxicological risk in this compartment is available. However, 
for the assessment of groundwater contaminations (Röder et al., 1999) developed 
criteria to establish threshold levels, which can be used for a precautionary protection of 
this precious compartment. Despite an increased contaminant level above the geogenic 
background, groundwater can be classified as minor polluted, if no relevant 
ecotoxicological effects will be observed and the quality criteria of the Drinking Water 
Directive (or analogous values) are fulfilled. 
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Currently, no data on the effects of pharmaceuticals on organisms in the 
compartment groundwater are available (Health Council of the Netherlands, 1996). 
Furthermore, until now no tools are existing to predict the effects of pollutants to 
groundwater organisms or ecosystematic parameters. Hence, in the year 2002 the 
German Environmental Agency, Berlin, initiated a project to identify suitable 
groundwater test-organisms. Based on the results of this project the next step has to be 
the development of useful test-systems, in order to determine the toxicity of selected 
contaminants to groundwater organisms. Depending on their ecotoxicological effects 
threshold levels especially for pharmaceuticals which have a potential to leach into the 
groundwater (e.g. clofibric acid and iopromide) should be defined in the near future. 
With respect to the human-toxicological risk of pharmaceuticals the requirements of 
the Drinking Water Directive have to be fulfilled (European Union, 1998, Van der 
Tenck et al., 1999). Herein a threshold level of 0.1 µg/L is defined for pesticides. Such 
quality criteria do not exist for pharmaceuticals yet. Since various pharmaceuticals like 
clofibric acid or iopromide could be detected in German drinking water (Heberer, 
2002b, Steger-Hartmann et al., 2001, Stumpf et al., 1999, Ternes, 2001a, Ternes et al., 
2002a) over the last decade, threshold levels have to be defined in the near future; in 
particular for those pharmaceuticals which have a potential to leach into the 
groundwater. Both chemicals are obviously able to pass the elimination procedures 
involved in drinking water processing. Based on a PECdrinking water (Predicted 
Environmental Concentration), Webb et al., 2003 calculated the uptake via drinking 
water of clofibric acid and iopromide by a “model human”. Assuming a daily 
consumption of 2 L drinking water the author calculated an uptake of clofibric acid of 
14.3 mg (1% of a daily dose) and 112 mg iopromide (< 1% of a daily dose) over a life 
time of 70 years. Therefore, direct pharmaceutical effects associated with the uptake of 
both pharmaceuticals by the consumption of drinking water can be excluded, although a 
general risk for long term effects cannot be ruled out. 
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6 OUTLOOK 
As mentioned already, some results of the current project will require further studies 
not covered so far. Especially, we propose to consider the following subjects: 
6.1 Modeling 
The results gained in the water/sediment as well as the leaching tests should be 
complemented by further tests with differing test conditions, e.g. other sediments, soils, 
temperatures. This would allow for a more general modelling of the fate of the 
pharmaceuticals investigated which is necessary for a profound risk assessment of the 
pharmaceuticals.   
6.2 “Ageing” of compounds in soils and sediments 
The leaching tests performed here are based on a screening approach. Therefore, the 
compounds assessed as being mobile should be tested after a period of “ageing” in the 
same soil according to the OECD draft guideline. For this purpose we propose the 
mobile compounds clofibric acid and radio-labelled iopromide. In addition, the 
available test method, currently focusing on top soils, should be modified in order to 
simulate sub-soils or even river sediments, thus being representative for those 
environmental compartments relevant for the supplement of groundwater.  
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7 FINAL CONCLUSIONS 
In this study, analytical methods have been developed allowing for the determination 
of pharmaceutical residues in environmental waters and sediment. The new methods 
were applied for the investigation of the fate and distribution behaviour of selected 
pharmaceuticals in aerobic water/sediment systems and in leaching tests. 
Several of the selected pharmaceuticals displayed a high persistence in the 
water/sediment studies conducted and/or a potential for accumulation in sediment 
compartments. These findings indicate an environmental risk, due to the presence of 
pharmaceuticals in the aquatic environment. In addition, two of the tested 
pharmaceuticals proved to be mobile in laboratory soil columns (in a third case, a 
discrepancy between test results and literature data could be clarified). 
For a comprehensive environmental risk assessment of pharmaceuticals, further data 
on the fate in other compartments, i.e. in soil and anaerobic sediments, and on the 
(eco)toxicicological effects have to be generated. In general, it should be a future aim of 
the research to elucidate the environmental transformation of pharmaceuticals to allow 
for a balancing of their elimination in the various environmental compartments.  
It is common sense in the European Union that the environmental risk of new 
pharmaceuticals and their metabolites should be generally evaluated as an obligatory 
prerequisite for their registration. The situation for approved pharmaceuticals is 
different. Many of these have been introduced into the environment for a long time, 
causing an environmental exposure of widely unknown portion.  
In the light of a potential accumulation of pharmaceutical residues in sediments, 
future monitoring programs are strongly recommended to elucidate the pharmaceutical 
contamination of aquatic sediments. Based on these results and effect data, priority 
substances among the approved pharmaceuticals should be identified, to which a 
supplementary ERA is demanded. In addition, the potential risk of pharmaceuticals to 
the groundwater has also to be taken into account. Laboratory tests (for new substances) 
as well as monitoring programs (for existing pharmaceuticals) as well as effect tests are 
necessary to protect this highly relevant compartment.    
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ANNEX                           A 
10 ANNEX 
Properties of water and sediment at the sampling site in the Wickerbach and at the set-up of the test 
 
 
Study
sediment
Date T (°C) pH O2 (%) O2 (mg/L) pH Date pH Redox (mV) O2 (%) O2 (mg/L) pH Redox (mV)
WS/IO 26/01/2001 4.6 7.8 100 7.3 02/02/2001 73 7.3 7.3
WS/DIA 03/07/2001 15.9 6.8 92.9 8.9 7.3 17/07/2001 7.5 459 99.7 10.7 7.7 155
WS/IBU + OXA 06/09/2001 12.9 6.3 106 11.1 7.3 17/09/2001 7.5 354 100.1 10.9 7.5 111
WS/PAR + CAN 17/10/2001 12.8 6.5 91 9.7 7.8 23/10/2001 7.7 501 99.3 10.2 7.6 223
WS/COH 07/12/2001 6.2 7.2 94.1 8.9 7.5 14/12/2001 7.6 473 102 11.1 7.5 198
WS/CLO + HI 27/12/2001 6.0 8.2 99 7.6 10/01/2002 8.1 576 105 11.8 7.4 528
WS/IV 26/02/2002 6.0 8.1 101 7.5 18/03/2002 7.7 431 99.8 10.5 7.5 389
sedimentwater water
Sediment+water sampling Wickerbach Test set-up
ANNEX                           B 
Course of the temperature during the experiments 
Study Test vessel-no: Mean SD Min Max
Day: -20 -17 -16 -14 -6 0 1 2 7 14 27 58 100
WS/IO 21 22.0 21.8 20.5 20.2 21.8 19.7 20.1 20.1 19.3 19.7 20.5 19.9 21.4 20.5 0.9 19.3 22.0
22 22.0 21.9 20.4 20.2 21.8 19.7 20.1 20.1 19.3 19.7 20.5 19.9 21.4 20.5 0.9 19.3 22.0
23 21.9 21.9 20.4 20.2 21.8 19.7 20.2 20.0 19.3 19.7 20.5 20.0 21.4 20.5 0.9 19.3 21.9
24 21.2 21.8 20.4 20.2 21.8 19.7 20.1 19.9 19.3 19.7 20.5 20.0 21.4 20.5 0.8 19.3 21.8
25 22.1 21.9 20.3 20.3 21.9 19.7 20.1 19.9 19.3 19.7 20.5 19.8 21.4 20.5 1.0 19.3 22.1
26 21.8 21.9 20.4 20.2 21.9 19.6 20.3 20.0 19.3 19.7 20.5 20.0 21.4 20.5 0.9 19.3 21.9
Mean/day 21.8 21.9 20.4 20.2 21.8 19.7 20.2 20.0 19.3 19.7 20.5 19.9 21.4
Day: -12 -8 -5 -1 0 1 2 7 14 27 58 100
WS/DIA 21 21.9 22.4 22.1 22.9 22.9 22.2 22.9 22.3 22.4 22.2 20.6 20.5 22.1 0.8 20.5 22.9
22 21.8 22.5 22.1 22.9 22.8 22.2 22.5 22.2 22.9 22.0 20.6 20.5 22.1 0.8 20.5 22.9
23 21.8 22.6 22.0 22.9 22.9 22.2 22.6 22.2 22.4 22.0 20.5 20.5 22.1 0.8 20.5 22.9
24 21.7 22.5 22.1 22.9 22.9 22.3 22.5 22.2 22.8 22.0 20.3 20.8 22.1 0.8 20.3 22.9
Mean/day 21.8 22.5 22.1 22.9 22.9 22.2 22.6 22.2 22.6 22.1 20.5 20.6
Day: -4 -2 1 2 8 14 28 56 100
WS/IBU + OXA 21 21.1 21.2 20.5 20.0 20.5 20.7 20.3 20.8 19.4 20.5 0.6 19.4 21.2
22 21.1 21.4 20.7 20.1 20.3 20.7 20.2 20.8 19.5 20.5 0.6 19.5 21.4
23 21.1 21.3 20.8 20.0 20.5 20.7 20.2 20.6 19.4 20.5 0.6 19.4 21.3
24 21.1 21.5 20.8 20.1 20.5 20.7 20.4 20.5 19.5 20.6 0.6 19.5 21.5
Mean/day 21.1 21.4 20.7 20.1 20.5 20.7 20.3 20.7 19.5
Day: -4 -2 0 1 2 7 15 29 57 100
WS/PAR + CAN 21 19.9 20.6 20.7 20.4 20.1 19.3 20.5 20.0 20.5 19.9 20.2 0.4 19.3 20.7
22 20.0 20.5 20.7 20.4 20.2 19.3 20.4 20.2 20.4 19.9 20.2 0.4 19.3 20.7
23 20.1 20.5 20.6 20.4 20.2 19.4 20.5 20.0 20.5 19.8 20.2 0.4 19.4 20.6
24 20.2 20.3 20.7 20.4 20.1 19.3 20.5 20.1 20.5 20.1 20.2 0.4 19.3 20.7
Mean/day 20.1 20.5 20.7 20.4 20.2 19.3 20.5 20.1 20.5 19.9
Day: -7 -2 0 1 2 8 14 28 56 100
WS/COH 21 19.6 19.8 19.9 19.8 20.0 20.2 19.9 20.1 20.0 19.9 19.9 0.2 19.6 20.2
22 19.6 19.8 19.9 19.9 20.0 20.0 19.9 20.0 20.0 20.0 19.9 0.1 19.6 20.0
23 19.7 19.7 19.9 20.0 20.0 20.1 19.7 20.1 20.0 19.8 19.9 0.2 19.7 20.1
24 19.8 19.7 19.9 19.9 20.0 20.0 19.8 20.0 20.0 19.9 19.9 0.1 19.7 20.0
Mean/day 19.7 19.8 19.9 19.9 20.0 20.1 19.8 20.1 20.0 19.9
Day: -6 -2 0 1 2 7 14 28 56 100
WS/CLO + HI 21 19.7 19.9 20.1 19.8 19.9 20.0 19.9 20.0 20.4 21.6 20.1 0.5 19.7 21.6
22 19.8 19.9 20.0 19.7 19.9 20.0 19.9 20.2 20.4 21.5 20.1 0.5 19.7 21.5
23 19.8 19.9 19.9 19.9 20.0 20.0 19.9 20.0 20.6 21.7 20.2 0.6 19.8 21.7
24 19.8 19.9 20.1 19.8 19.9 20.1 19.9 20.2 20.5 21.6 20.2 0.5 19.8 21.6
Mean/day 19.8 19.9 20.0 19.8 19.9 20.0 19.9 20.1 20.5 21.6
Day: -1 0 1 2 7 14 29 56 100
WS/IV 21 20.0 19.8 19.8 20.1 20.1 20.9 20.2 20.0 20.3 20.1 0.3 19.8 20.9
22 19.9 19.8 19.9 19.9 20.0 20.9 20.2 20.1 20.1 20.1 0.3 19.8 20.9
23 19.9 19.7 19.9 19.9 19.9 20.9 20.1 20.0 20.1 20.0 0.3 19.7 20.9
24 19.9 19.8 19.8 20.1 19.9 20.8 20.1 20.0 20.1 20.1 0.3 19.8 20.8
Mean/day 19.9 19.8 19.9 20.0 20.0 20.9 20.2 20.0 20.2
°C
ANNEX                          C 
Course of the pH in the water during the experiments  
Study Test vessel-no: Mean SD Min Max n
Day: -20 -17 -16 -14 -6 0 1 2 7 14 27 58 100
WS/IO 21 8.3 8.2 8.3 8.3 8.3 8.6 8.6 8.3 8.3 8.5 8.8 8.5 8.6 8.4 0.2 8.2 8.8 13
22 8.2 8.2 8.3 8.3 8.3 8.6 8.6 8.3 8.3 8.4 8.9 8.6 8.6 8.4 0.2 8.2 8.9 13
23 8.2 8.2 8.3 8.3 8.3 8.5 8.6 8.5 8.6 8.6 8.9 8.7 8.6 8.5 0.2 8.2 8.9 13
24 8.2 8.3 8.3 8.3 8.3 8.6 8.6 8.6 8.5 8.5 8.9 8.7 8.5 8.5 0.2 8.2 8.9 13
25 8.2 8.3 8.3 8.3 8.3 8.6 8.6 8.5 8.5 8.5 9 8.8 8.5 8.5 0.2 8.2 9 13
26 8.2 8.2 8.3 8.3 8.6 8.5 8.6 8.5 8.5 8.6 9 8.8 8.6 8.5 0.2 8.2 9 13
Mean/day 8.2 8.2 8.3 8.3 8.4 8.6 8.6 8.5 8.5 8.5 8.9 8.7 8.6
Day: -12 -8 -5 -1 0 1 2 7 14 27 58 100
WS/DIA 21 8.3 8.3 8.3 8.5 8.7 8.6 8.6 8.5 8.4 8.8 8.8 8.8 8.6 0.2 8.3 8.8 12
22 8.3 8.3 8.3 8.6 8.6 8.5 8.3 8.4 8.5 8.8 8.8 8.8 8.5 0.2 8.3 8.8 12
23 8.2 8.3 8.3 8.4 8.5 8.4 8.6 8.4 8.4 8.4 8.6 8.6 8.4 0.1 8.2 8.6 12
24 8.3 8.3 8.3 8.5 8.7 8.6 8.8 8.3 8.3 8.4 8.5 8.6 8.5 0.2 8.3 8.8 12
Mean/day 8.3 8.3 8.3 8.5 8.6 8.5 8.6 8.4 8.4 8.6 8.7 8.7
Day: -4 -2 1 2 8 14 28 56 100
WS/IBU + OXA 21 8.4 8.7 8.6 8.5 8.7 8.7 8.7 8.7 8.8 8.6 0.1 8.4 8.8 9
22 8.4 8.7 8.6 8.5 8.7 8.7 8.7 8.7 8.7 8.6 0.1 8.4 8.7 9
23 8.4 8.7 8.6 8.8 8.7 8.7 8.7 8.7 8.7 8.7 0.1 8.4 8.8 9
24 8.4 8.6 8.6 8.8 8.7 8.7 8.7 8.7 8.6 8.6 0.1 8.4 8.8 9
Mean/day 8.4 8.7 8.6 8.7 8.7 8.7 8.7 8.7 8.7
Day: -4 -2 0 1 2 7 15 29 57 100
WS/PAR + CAN 21 8.5 8.5 8.5 8.5 8.6 8.6 8.6 8.7 8.7 8.8 8.6 0.1 8.5 8.8 10
22 8.5 8.5 8.6 8.6 8.6 8.6 8.7 8.7 8.7 8.7 8.6 0.1 8.5 8.7 10
23 8.5 8.5 8.5 8.5 8.6 8.6 8.6 8.6 8.7 8.7 8.6 0.1 8.5 8.7 10
24 8.5 8.5 8.5 8.6 8.6 8.6 8.6 8.7 8.7 8.8 8.6 0.1 8.5 8.8 10
Mean/day 8.5 8.5 8.5 8.6 8.6 8.6 8.6 8.7 8.7 8.8
Day: -7 -2 0 1 2 8 14 28 56 100
WS/COH 21 8.3 8.3 8.2 8.4 8.5 8.7 8.9 8.9 8.9 8.9 8.6 0.3 8.2 8.9 10
22 8.4 8.4 8.5 8.5 8.5 8.6 8.9 8.9 8.9 8.9 8.7 0.2 8.4 8.9 10
23 8.2 8.5 8.4 8.4 8.5 8.7 8.8 8.8 8.9 8.9 8.6 0.2 8.2 8.9 10
24 8.4 8.3 8.4 8.4 8.4 8.6 8.9 8.9 8.9 8.9 8.6 0.3 8.3 8.9 10
Mean/day 8.3 8.4 8.4 8.4 8.5 8.7 8.9 8.9 8.9 8.9
Day: -6 -2 0 1 2 7 14 28 56 100
WS/CLO + HI 21 8.1 8.4 8.4 8.4 8.5 8.6 8.7 8.7 8.7 8.6 8.5 0.2 8.1 8.7 10
22 8.1 8.3 8.4 8.4 8.4 8.6 8.6 8.7 8.8 8.9 8.5 0.2 8.1 8.9 10
23 8.2 8.4 8.4 8.4 8.5 8.5 8.7 8.7 8.8 8.9 8.6 0.2 8.2 8.9 10
24 8.1 8.5 8.5 8.5 8.6 8.6 8.7 8.7 8.8 8.9 8.6 0.2 8.1 8.9 10
Mean/day 8.1 8.4 8.4 8.4 8.5 8.6 8.7 8.7 8.8 8.8
Day: -1 0 1 2 7 14 29 56 100
WS/IV 21 7.8 8.0 8.1 8.2 8.8 8.8 8.8 8.7 8.7 8.4 0.4 7.8 8.8 9
22 7.7 8.1 8.2 8.2 8.7 8.8 8.8 8.9 8.8 8.5 0.4 7.7 8.9 9
23 7.8 8.0 8.1 8.1 8.8 8.8 8.8 8.7 8.6 8.4 0.4 7.8 8.8 9
24 7.7 7.9 8.1 8.2 8.8 8.8 8.8 8.7 8.7 8.4 0.4 7.7 8.8 9
Mean/day 7.8 8.0 8.1 8.2 8.8 8.8 8.8 8.8 8.7
pH
ANNEX                           D 
Course of the redox potential in the water during the experiments  
Study Test vessel-no: Mean SD Min Max n
day: -20 -17 -16 -14 -6 0 1 2 7 14 27 58 100 
WS/IO 21 417 392 375 416 399 400 18 375 417 5
22 386 382 408 417 398 17 382 417 4
23 383 388 406 413 398 14 383 413 4
24 386 393 404 416 400 13 386 416 4
25 383 396 401 410 398 11 383 410 4
26 405 396 398 415 404 9 396 415 4
Mean/day 417 389 388 406 412
day: -12 -8 -5 -1 0 1 2 7 14 27 58 100 
WS/DIA 21 353 417 405 399 397 365 354 320 358 361 381 386 375 28 320 417 12
22 428 398 400 400 385 372 341 356 373 378 392 384 24 341 428 11
23 412 395 406 414 392 376 354 368 407 386 402 392 19 354 414 11
24 423 394 405 408 383 370 349 372 420 397 375 391 23 349 423 11
Mean/day 353 420 398 403 405 381 368 341 364 390 386 389
day: -4 -2 1 2 8 14 28 56 100
WS/IBU + OXA 21 404 406 394 367 351 374 369 390 415 386 21 351 415 9
22 392 406 395 354 349 365 373 367 412 379 23 349 412 9
23 388 408 397 346 344 332 376 372 411 375 29 332 411 9
24 379 406 400 345 342 358 349 398 411 376 28 342 411 9
Mean/day 391 407 397 353 347 357 367 382 412
day: -4 -2 0 1 2 7 15 29 57 100
WS/PAR + CAN 21 408 393 382 361 390 400 372 352 316 395 377 28 316 408 10
22 413 376 326 349 395 400 338 376 350 393 372 29 326 413 10
23 414 388 332 407 349 312 346 375 380 390 369 33 312 414 10
24 413 364 315 354 353 349 360 411 350 384 365 30 315 413 10
Mean/day 412 380 339 368 372 365 354 379 349 391
day: -7 -2 0 1 2 8 14 28 56 100
WS/COH 21 377 314 424 369 396 381 427 386 311 413 380 41 311 427 10
22 364 363 420 373 324 409 430 371 333 412 380 36 324 430 10
23 410 314 419 328 389 378 432 334 393 408 381 41 314 432 10
24 322 356 417 396 316 382 434 387 334 406 375 41 316 434 10
Mean/day 368 337 420 367 356 388 431 370 343 410
day: -6 -2 0 1 2 7 14 28 56 100
WS/CLO + HI 21 318 319 395 382 343 381 442 392 325 352 365 40 318 442 10
22 392 401 393 375 396 364 443 387 364 410 393 23 364 443 10
23 391 347 354 403 410 323 445 405 392 312 378 42 312 445 10
24 332 329 372 342 357 363 445 322 393 365 362 36 322 445 10
Mean/day 358 349 379 376 377 358 444 377 369 360
day: -1 0 1 2 7 14 29 56 100
WS/IV 21 425 395 393 405 417 390 356 353 340 386 30 340 425 9
22 405 423 410 405 424 369 350 392 344 391 30 344 424 9
23 404 409 328 402 434 314 378 315 315 367 48 314 434 9
24 409 423 401 401 374 368 306 356 366 378 35 306 423 9
Mean/day 411 413 383 403 412 360 348 354 341
Redox potential in the water measured by a platinum electrode 
versus a silver/silverchloride reference electrode , c(KCl) 3 mol/L 
[mV]
ANNEX                          E 
Course of the oxygen concentration in the water during the experiments  
Study Test vessel-no: Mean SD Min Max n
Day: -20 -17 -16 -14 -6 0 1 2 7 14 27 58 100
WS/IO 21 7.5 8.5 8.0 8.2 7.5 7.4 6.5 5.0 5.6 5.3 5.4 6.9 7.1 6.8 1.2 5.0 8.5 13
22 7.4 8.4 8.1 8.1 7.7 7.6 6.3 5.0 6.6 5.7 5.9 6.9 7.2 7.0 1.0 5.0 8.4 13
23 7.4 8.4 7.8 8.0 7.7 7.4 7.4 8.0 7.3 7.5 7.6 7.2 7.4 7.6 0.3 7.2 8.4 13
24 7.9 8.4 8.0 8.1 7.8 8.0 6.7 7.8 7.4 7.3 7.6 7.3 7.4 7.7 0.4 6.7 8.4 13
25 7.4 8.6 7.9 8.3 7.8 7.1 6.8 7.6 7.1 7.0 7.2 7.4 7.4 7.5 0.5 6.8 8.6 13
26 7.0 8.4 7.9 8.0 7.3 7.1 7.6 7.6 7.3 7.2 7.1 7.4 7.3 7.5 0.4 7.0 8.4 13
Mean/day 7.4 8.5 8.0 8.1 7.6 7.4 6.9 6.8 6.9 6.7 6.8 7.2 7.3
Day: -12 -8 -5 -1 0 1 2 7 14 27 58 100
WS/DIA 21 7.5 7.5 7.4 6.9 6.6 6.4 4.9 5.6 6.7 8.3 7.5 7.3 6.9 0.9 4.9 8.3 12
22 7.5 7.6 7.4 6.9 6.6 6.1 4.2 6.1 6.2 8.0 7.4 7.5 6.8 1.0 4.2 8.0 12
23 7.3 7.1 7.5 6.7 7.0 6.9 6.6 6.7 6.9 7.3 7.8 7.6 7.1 0.4 6.6 7.8 12
24 7.5 7.5 7.4 6.6 7.2 7.1 6.8 4.4 6.1 7.6 8.1 8.3 7.1 1.0 4.4 8.3 12
Mean/day 7.4 7.4 7.4 6.8 6.9 6.6 5.6 5.7 6.5 7.8 7.7 7.7
Day: -4 -2 1 2 8 14 28 56 100
WS/IBU + OXA 21 8.0 7.8 6.7 3.2 6.8 6.9 7.4 6.5 8.7 6.9 1.6 3.2 8.7 9
22 7.8 7.8 6.7 3.6 6.5 6.7 7.6 6.3 8.6 6.8 1.4 3.6 8.6 9
23 7.5 7.9 7.7 8.0 7.5 7.4 7.4 7.4 8.6 7.7 0.4 7.4 8.6 9
24 8.0 7.8 7.7 8.0 7.7 7.9 8.0 6.7 8.6 7.8 0.5 6.7 8.6 9
Mean/day 7.8 7.8 7.2 5.7 7.1 7.2 7.6 6.7 8.6
Day: -4 -2 0 1 2 7 15 29 57 100
WS/PAR + CAN 21 8.1 8.1 8.3 8.5 8.7 7.8 7.5 6.9 8.9 9.2 8.2 0.7 6.9 9.2 10
22 8.2 7.9 8.8 8.9 8.4 7.4 6.7 6.3 8.6 9.5 8.1 1.0 6.3 9.5 10
23 8.2 8.1 8.9 8.6 7.7 7.6 6.8 7.5 8.4 9.1 8.1 0.7 6.8 9.1 10
24 8.1 8.7 8.7 8.9 7.6 7.5 8.2 7.5 8.0 9.3 8.3 0.6 7.5 9.3 10
Mean/day 8.2 8.2 8.7 8.7 8.1 7.6 7.3 7.1 8.5 9.3
Day: -7 -2 0 1 2 8 14 28 56 100
WS/COH 21 8.0 7.8 8.1 7.6 7.6 8.2 9.0 7.8 8.0 7.6 8.0 0.4 7.6 9.0 10
22 7.4 7.6 8.5 7.7 8.0 8.5 9.3 8.5 8.8 8.5 8.3 0.6 7.4 9.3 10
23 8.0 8.2 8.4 7.4 7.8 8.8 9.2 8.1 7.3 8.2 8.1 0.6 7.3 9.2 10
24 7.8 8.7 8.4 7.5 8.6 8.7 9.2 8.6 7.8 8.2 8.4 0.5 7.5 9.2 10
Mean/day 7.8 8.1 8.4 7.6 8.0 8.6 9.2 8.3 8.0 8.1
Day: -6 -2 0 1 2 7 14 28 56 100
WS/CLO + HI 21 7.7 7.7 7.7 7.7 9.0 7.2 8.8 8.4 8.4 8.6 8.1 0.6 7.2 9.0 10
22 8.6 7.5 8.8 7.5 7.8 7.0 8.6 8.0 8.7 8.5 8.1 0.6 7.0 8.8 10
23 7.5 8.5 8.8 8.5 8.5 8.0 8.5 7.9 8.5 8.3 8.3 0.4 7.5 8.8 10
24 7.4 7.7 8.2 7.7 8.2 7.5 8.6 8.8 8.6 8.2 8.1 0.5 7.4 8.8 10
Mean/day 7.8 7.9 8.4 7.9 8.4 7.4 8.6 8.3 8.6 8.4
Day: -1 0 1 2 7 14 29 56 100
WS/IV 21 7.9 8.0 8.0 9.1 9.3 7.9 9.6 8.2 7.8 8.4 0.7 7.8 9.6 9
22 7.9 8.0 9.0 8.4 9.5 8.0 9.5 8.0 8.8 8.6 0.7 7.9 9.5 9
23 8.4 9.0 7.9 8.5 9.4 7.9 9.3 8.3 8.1 8.5 0.6 7.9 9.4 9
24 8.7 8.2 7.6 8.6 9.4 7.9 9.4 8.7 8.0 8.5 0.6 7.6 9.4 9
Mean/day 8.2 8.3 8.1 8.7 9.4 7.9 9.5 8.3 8.2
Oxygen concentration [mg/L]
ANNEX                           F 
Course of the pH in the sediment during the experiments  
Study-name: Test vessel-no: Mean SD Min Max n
Day: -20 -17 -16 -14 -6 0 1 2 7 14 27 58 100
WS/IO 21 7.8 7.8 7.7 7.6 7.7 7.6 7.6 7.7 0.1 7.6 7.8 7
22 7.8 7.7 7.7 7.6 7.7 7.7 7.5 7.7 0.1 7.5 7.8 7
23 7.7 7.6 7.4 7.5 7.6 7.6 7.5 7.6 0.1 7.4 7.7 7
24 7.7 7.6 7.5 7.5 7.6 7.5 7.5 7.6 0.1 7.5 7.7 7
25 7.6 7.5 7.5 7.5 0.1 7.5 7.6 3
26 7.6 7.7 7.5 7.6 0.1 7.5 7.7 3
Mean/day 7.8 7.7 7.6 7.6 7.6 7.6 7.5
Day: -12 -8 -5 -1 0 1 2 7 14 27 58 100
WS/DIA 21 7.5 7.7 7.7 7.7 7.3 7.6 7.1 7.1 7.4 7.2 7.4 7.4 7.4 0.2 7.1 7.7 12
22 7.7 7.7 7.6 7.7 7.3 7.3 7.3 7.2 7.3 7.6 7.4 7.5 0.2 7.2 7.7 11
23 7.3 7.6 7.7 7.6 7.8 7.5 7.9 8.0 7.6 7.7 7.9 7.8 7.7 0.2 7.3 8.0 12
24 7.4 7.6 7.7 7.7 7.7 7.4 7.9 7.8 7.5 7.7 7.9 7.8 7.7 0.2 7.4 7.9 12
Mean/day 7.4 7.7 7.7 7.7 7.6 7.5 7.6 7.6 7.4 7.5 7.7 7.6
Day: -4 -2 1 2 8 14 28 56 100
WS/IBU + OXA 21 7.7 7.9 8.0 8.0 7.9 7.9 7.9 7.9 8.0 7.9 0.1 7.7 8.0 9
22 7.6 7.8 7.8 7.9 7.9 7.9 7.9 7.9 7.9 7.8 0.1 7.6 7.9 9
23 7.6 8.0 7.8 7.9 7.9 7.9 7.9 7.9 7.9 7.9 0.1 7.6 8.0 9
24 7.6 7.9 7.8 7.9 7.9 7.9 7.9 7.9 7.6 7.8 0.1 7.6 7.9 9
Mean/day 7.6 7.9 7.9 7.9 7.9 7.9 7.9 7.9 7.9
Day: -4 -2 0 1 2 7 15 29 57 100
WS/PAR + CAN 21 7.7 7.7 7.7 7.7 7.7 7.6 7.7 7.8 7.7 7.7 7.7 0.0 7.6 7.8 10
22 7.7 7.7 7.7 7.6 7.7 7.7 7.7 7.7 7.7 7.7 7.7 0.0 7.6 7.7 10
23 7.6 7.6 7.6 7.7 7.6 7.7 7.7 7.8 7.8 7.9 7.7 0.1 7.6 7.9 10
24 7.6 7.6 7.6 7.6 7.7 7.7 7.7 7.8 7.9 7.9 7.7 0.1 7.6 7.9 10
Mean/day 7.7 7.7 7.7 7.7 7.7 7.7 7.7 7.8 7.8 7.8
Day: -7 -2 0 1 2 8 14 28 56 100
WS/COH 21 7.5 7.6 7.6 7.6 7.7 7.8 7.9 7.9 8.0 7.9 7.8 0.2 7.5 8.0 10
22 7.6 7.7 7.7 7.7 7.7 7.8 7.9 7.8 7.8 7.7 7.7 0.1 7.6 7.9 10
23 7.5 7.7 7.8 7.8 7.8 7.9 8.2 8.0 8.1 8.0 7.9 0.2 7.5 8.2 10
24 7.5 7.6 7.7 7.7 7.7 7.8 8.0 8.0 8.1 8.1 7.8 0.2 7.5 8.1 10
Mean/day 7.5 7.7 7.7 7.7 7.7 7.8 8.0 7.9 8.0 7.9
Day: -6 -2 0 1 2 7 14 28 56 100
WS/CLO + HI 21 7.5 7.7 7.7 7.7 7.6 7.8 7.9 7.8 7.8 7.6 7.7 0.1 7.5 7.9 10
22 7.4 7.6 7.6 7.6 7.7 7.7 7.9 7.9 7.8 7.7 7.7 0.2 7.4 7.9 10
23 7.5 7.5 7.5 7.6 7.5 7.8 7.9 7.9 7.9 8.0 7.7 0.2 7.5 8.0 10
24 7.6 7.6 7.5 7.6 7.6 7.7 7.8 7.8 7.9 7.8 7.7 0.1 7.5 7.9 10
Mean/day 7.5 7.6 7.6 7.6 7.6 7.8 7.9 7.9 7.9 7.8
Day: -1 0 1 2 7 14 29 56 100
WS/IV 21 7.7 7.8 7.8 7.8 8.1 7.8 7.6 7.7 7.5 7.8 0.2 7.5 8.1 9
22 7.6 7.7 7.8 7.7 7.8 7.8 8.0 7.7 7.7 7.8 0.1 7.6 8.0 9
23 7.8 7.8 7.8 7.9 7.9 7.9 7.8 7.8 7.6 7.8 0.1 7.6 7.9 9
24 7.6 7.6 7.5 7.6 8.0 7.9 7.6 7.7 7.8 7.7 0.2 7.5 8.0 9
Mean/day 7.7 7.7 7.7 7.8 8.0 7.9 7.8 7.7 7.7
pH
ANNEX                          G 
Course of the redox potential in the sediment during the experiments 
 
Study- name Test vessel-no: Mean SD Min Max
day: -20 -17 -16 -14 -6 0 1 2 7 14 27 58 100 
WS/IO 21 417 392 375 416 399 400 18 375 417
22 386 382 408 417 398 17 382 417
23 383 388 406 413 398 14 383 413
24 386 393 404 416 400 13 386 416
25 383 396 401 410 398 11 383 410
26 405 396 398 415 404 9 396 415
Mean/day 417 389 388 406 412
day: -12 -8 -5 -1 0 1 2 7 14 27 58 100 
WS/DIA 21 353 417 405 399 397 365 354 320 358 361 381 386 375 28 320 417
22 428 398 400 400 385 372 341 356 373 378 392 384 24 341 428
23 412 395 406 414 392 376 354 368 407 386 402 392 19 354 414
24 423 394 405 408 383 370 349 372 420 397 375 391 23 349 423
Mean/day 353 420 398 403 405 381 368 341 364 390 386 389
day: -4 -2 1 2 8 14 28 56 100
WS/IBU + OXA 21 404 406 394 367 351 374 369 390 415 386 21 351 415
22 392 406 395 354 349 365 373 367 412 379 23 349 412
23 388 408 397 346 344 332 376 372 411 375 29 332 411
24 379 406 400 345 342 358 349 398 411 376 28 342 411
Mean/day 391 407 397 353 347 357 367 382 412
day: -4 -2 0 1 2 7 15 29 57 100
WS/PAR + CAN 21 408 393 382 361 390 400 372 352 316 395 377 28 316 408
22 413 376 326 349 395 400 338 376 350 393 372 29 326 413
23 414 388 332 407 349 312 346 375 380 390 369 33 312 414
24 413 364 315 354 353 349 360 411 350 384 365 30 315 413
Mean/day 412 380 339 368 372 365 354 379 349 391
day: -7 -2 0 1 2 8 14 28 56 100
WS/COH 21 377 314 424 369 396 381 427 386 311 413 380 41 311 427
22 364 363 420 373 324 409 430 371 333 412 380 36 324 430
23 410 314 419 328 389 378 432 334 393 408 381 41 314 432
24 322 356 417 396 316 382 434 387 334 406 375 41 316 434
Mean/day 368 337 420 367 356 388 431 370 343 410
day: -6 -2 0 1 2 7 14 28 56 100
WS/CLO + HI 21 318 319 395 382 343 381 442 392 325 352 365 40 318 442
22 392 401 393 375 396 364 443 387 364 410 393 23 364 443
23 391 347 354 403 410 323 445 405 392 312 378 42 312 445
24 332 329 372 342 357 363 445 322 393 365 362 36 322 445
Mean/day 358 349 379 376 377 358 444 377 369 360
day: -1 0 1 2 7 14 29 56 100
WS/IV 21 425 395 393 405 417 390 356 353 340 386 30 340 425
22 405 423 410 405 424 369 350 392 344 391 30 344 424
23 404 409 328 402 434 314 378 315 315 367 48 314 434
24 409 423 401 401 374 368 306 356 366 378 35 306 423
Mean/day 411 413 383 403 412 360 348 354 341
Redox potential in the water measured by a platinum electrode 
versus a silver/silverchloride reference electrode , c(KCl) 3 mol/L 
[mV]
ANNEX                           H 
Water content, microbial, biomass, Corg of the sediment and TOC of the water at the beginning and the end of the experiments 
 
 
Water content Microbial biomass Corg TOC
Study Sampling day
% weight of dry 
weight
Cmic [µg C/g 
sediment (TG)]
org. C in % 
of dry weight [mg C/L]
WS/IO 0 19.7 27.4 1.7 2.7
100 22.8 22.6 2.1 3.7
WS/DIA 0 16.6 32.4 1.5 2.3
100 17.9 33.7 1.7 8.1
WS/IBU + OXA 0 21.3 53.9 1.5 2.2
100 22.5 21.8 1.5 2.3
WS/PAR + CAN 0 20.6 84.3 1.4 8.2
100 19.4 51.9 1.7 8.0
WS/COH 0 18.1 52.0 1.0 3.0
100 18.2 29.1 1.2 3.9
WS/CLO +HI 0 15.8 47.5 1.0 2.3
100 18.8 36.7 1.0 5.0
WS/IV 0 19.7 43.5 1.0 3.0
100 19.4 32.5 1.0 4.2
